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Biotin synthase (BS) catalyses the final sulfur incorporation step in the 
biosynthesis of biotin. Its chemical mechanism, primary amino acid sequence and 
tertiary structure place it in the Radical-SAM-dependent superfamily of >600 
proteins. The gene encoding E. co/i biotin synthase (bloB) has been expressed as a 
histidine-fusion protein (6HisBS) and the recombinant protein purified in a single 
step using immobilised metal-affinity chromatography (IMAC). In addition, a 
number of single and double amino acid mutations of the conserved cysteine residues 
within the 'cys box' were constructed and purified using similar methodology. Wild-
type and mutant 6HisBS proteins were compared using mass spectrometry (LC-ESI-
MS) and UV-visible spectroscopy to probe characteristics altered by the mutation. 
Biotin synthase was analysed for its ability to bind the cofactor pyndoxal 5'-
phosphate (PLP). Two single point mutations (K49Q and K49R) of a putative PLP-
binding residue, Lys 49, were isolated and compared with wild-type BS using a 
combination of biochemical and mass spectrometry techniques. Each protein was 
subjected to enzymatic proteolysis and peptide modification analysed by means of 
MALDI-ToF MS, ESI-QTOF MS and MS/MS. We identified a unique Lys49-
containing fragment of the 6HisBS which corresponds to the PLP modified peptide. 
In contrast, this modified peptide is absent in the mutant proteins. This observation is 
further confirmed by MS/MS sequencing of this MS observed species which shows 
CID of both the peptide backbone and covalently attached PLP moiety. 
Biotin synthase was prepared in the presence of excess PLP and its interaction with 
cyteine monitored with UV-visible spectroscopy. We observed marked changes in 
the UV-vis profile of biotin synthase under these conditions which is consistent 
observations of PLP-dependent cysteine desulferase enzymes. 
Isolation of overexpressed biotin synthase yields protein preparations with variable 
rations of iron sulfur clusters. To study changes in global protein expression ratios 
during biotin synthase overexpression, comparative, 2-dimensional SDS-PAGE 




digestion and mass spectrometric analysis. No significant protein up-regulation of 
other E. coli proteins was observed. 
The X-ray crystal structure of E. co/i biotin synthase was published during this work. 
Data from a single crystal was obtained with protein re-loaded with iron and sulfur, 
thus providing a single snapshot of the structure. Biotin synthase and other Radical-
SAM proteins have a (/a)6 structural core. To further probe the dynamics of the BS 
protein a series of techniques were used to compare the wild-type 6HisBS and 
mutant proteins. Both high resolving gel filtration and cation exchange 
chromatography were used to assess the heterogeneity of the purified proteins. Three 
clearly-distinct species were observed in both mobility and isoelectric point (p1). 
These three species are affected to various degrees with the mutation of one or more 
conserved residues suggesting major structural roles. Purified proteins were 
subjected to time-dependent, limited enzymatic digestion and SDS-PAGE 
visualisation. Protein fragments were mapped to amino acid sequence using a 
secondary, in gel, digestion and MALDI-TOF analysis. This confirmed the solvent-
exposed regions of the protein identified in the crystal structure and identified an 
enzymatically-labile site. This site is observed at a loop region, and proteolysis splits 
the protein monomer structure into two pseudo-domains. 
To confirm this sub-domain structure, the bioB DNA gene sequence was used to 
construct two bioB "pseudo-genes" (encoding N- and C-terminal fragments) which 
were expressed in E. co/i. The proteins expressed from each pseudo-gene were 
insoluble when produced separately, however duel expression of both genes yielded 
a significant quantity of soluble protein which displayed many of the physical 
characteristics of intact biotin synthase. These sections remained intact upon LC-MS 
analysis, which would suggest that each sub-domain has folded in vivo and formed a 
stable complex. These studies highlight the possibility of further sub-structures 
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Chapter One: Introduction 
1.1 - Introduction to biotin 
The first recorded work on what was to become known as biotin took place in 
1901 where a substance was isolated from beer wort by Wilders which he discovered 
stimulated the growth of yeasts. He termed this substance bios (4) but little work was 
done in the following 40 years until Williams found that the substance termed "bios" 
was in fact a mixture of biotin, alanine, myoinositol and pantothenic acid (17). At 
this time "protective compound X" and "vitamin H" were isolated from mammalian 
livers, and both were identical to biotin and were found to protect rats from ingestion 
of dried egg whites. Kogl had isolated pure biotin in 1936 from dried egg yolks as its 
methyl ester (18) and it has since been found to be an essential vitamin for all 
animals and humans. 
Although biotin is produced in minute quantities by bacteria, plants and 
yeasts and is found in very small amounts in the majority of food stuffs (except egg 
yoke which contains 50 j.tg to 100 jtg per egg) the recommended daily intake of 
around 300 ig per day is usually reached by a balanced diet and absorbed from that 
synthesised by intestinal microflora. 
1.1.1 - Structure and Chemical Properties of Biotin 
The empirical formula of biotin was determined in 1936 by Kogl 
(C11H1803N2S) (18) and the X-ray structure elucidated 6 years later by Du Vigneaud 
et al., which showed biotin consisted of an imidazole ring fused cis to a 
tetrahydrothiophene ring with a valeryl side chain (Figure 1.1) (19). 
The structure of biotin contains three asymmetric carbons and so has eight 
optically active forms only one of which is biologically active, the D-(+)- biotin 
isomer. Current commercial synthesis is a laborious 12 step chemical process 
developed by Roche in 1946 (20) with significant improvements made by Lonza AG 
in 1988 (21). The commercial demand for the vitamin is large, so there is current 
industrial interest in improving the chemical synthesis as well as attempting to 
develop a bio-fermentation process for its production. 
Ira 





Mol. Wt.: 244.31 
HN 	NH  
t8 t7 
Figure 1.1 - D-(+)- biotin, consists of imidazole ring fused cis to a 
tetrahydrothiophene ring with a valeryl side chain (* = N-i nitrogen). 
Class 	 Enzyme 
I Carboxylases 	-- Pyruvate carboxylase(PC) 

















Pyruvate to oxaloacetate 
Acetyl CoA to malonyl C0A 
Propionyl CoA to methylmalonyl 
CoA 
3-Methylcrotonyl C0A to 
3-methyiglutaconyl C0A 
Geranyl CoA to carboxygeranyl 
C0A 
Urea to N-carboxyurea 
Methylmalonyl C0A and pyruvate 
to oxaloacetate and propionyl C0A 
Methylmalonyl CoA to propionyl 
CoA and CO2 
Oxaloacetate to pyruvate and CO2 
Biochemical role 
Gluconeogenesis, lipogenesis 
Fatty acid biosynthesis 
Proprionate metabolism 
Catabolism of leucine 
Microbial catabolism of Isoprenold 
compounds 
Bacterial catabolism of urea in 
microbes that lack urease and grow 
on urea as a sole source of carbon 
Fermentation of certain 
carbohydrates to propionate in 
propionibactena 
Last step in lactate fermentation In 
Micrococcus Iactis 
Inducible enzyme in Aerobacter 
aerogenes challenged to grow on 
citrate as a carbon source 
Figure 1.2 - Table of the classification of biotin utilizing enzymes, reaction catalysed and its 
eventual biochemical role. 
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1.1.2 - Biochemical roles of biotin and biotin binding proteins 
The main role of biotin is as a co-factor in a number of carboxylation 
reactions where it functions in vivo as the carrier of activated CO2 for enzymatic 
reactions (22). 
The metabolic processes that are biotin dependent can be classified as shown 
in Figure 1.2. The Carboxylase or Class I enzymes form the majority of reactions 
involving biotin and transfer carbon dioxide derived from hydrogen carbonate to 
acceptor molecules/proteins. The process consists of 2 reversible steps, firstly an 
adenosine 5'-triphosphate (ATP) dependent step involving the formation of 
carboxybiotin, and subsequent transfer of this activated CO2 to the substrate. The 
exact mechanism of the transfer of CO2 to the N-i nitrogen (Figure 1.1) of biotin to 
form carboxybiotin has been the subject of a number of studies (23, 24). A 
mechanism has been put forward which proposes that the substrates bind, and are 
released in a specific order, where one or more of the products are released before all 
the substrates are bound. The final two classes are Transcarboxylases (Class II) and 
Decarboxylases (Class III), in both cases there is no requirement for ATP to 
carboxylate biotin and active CO 2 is transferred from either an acyl derivative or a 
a— or -keto ester to the biotin enzyme (25). 
One of the best characterised carboxy-transfer enzymes is the acetyl-CoA 
carboxylase (ACC) from E. co/i, and it has been shown to contain three subunits 
each of which catalyse partial reactions as described below (Figure 1.3). The E. coli 
ACC consists of three distinct subunits whose function is independent but has an 
absolute requirement for all components for the conversion of acetyl-CoA to 
malonyl-CoA using carbonate and ATP. The biotin moiety is bound to the carrier 
protein biotin carboxyl carrier protein (BCCP) via the biotin carboxylic acid side 
chain to a conserved lysine residue via an amide bond. The flexibility of this 'arm' is 
required to allow rotation of the biotin/carboxybiotin from the active site of subunit 2 
and 3. The 2'" subunit is the biotin carboxyiase (BC) which transfers CO2 from 
carbonate to the Ni nitrogen of biotin at the expense of ATP. The BCCP bound 
carboxybiotin then delivers this activated carbon dioxide to the active site of the 3'' 
carboxy-transferase (CT) subunit. The CT subunit then transfers the activated CO2 to 
-4- 
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acetyl-CoA to form the malonyl-CoA product. The resultant protein bound biotin can 
then be passed back to the biotin carboxylase for further cycles (26, 27). 
















Rotation to next subunit 
Ticetyl-CoA 
l-CoA 
Figure 1.3 - E. co/i acetyl-CoA carboxylase (ACC) consists of 3 protein subunits, biotin 
carboxyl carrier protein (BCCP), biotin carboxylase(BC) and carboxy-transferase (CT). 
Biotin is bound to BCCP via a conserved lysine residue which provides the flexability to 
trarislocate biotin / carboxybiotin to active sites of subunits, thus converting acetyl-CoA to 
malonyl-CoA. 
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1.1.3 - Biotin Binding Proteins 
Two proteins have been shown to have very high specific binding affinities 
for biotin, namely the glycoprotein avidin from egg white (28) and streptavidin 
isolated from Strepromyces avidinii (29). Both proteins are homo-tetramers with 
monomer mass of 17.5 kDa forming a final protein mass of 70 kDa. X-ray 
crystallography has revealed each monomer has folded into a eight stranded anti-
parallel 13-barrel, where the biotin binds between two tryptophan residues at the end 
of the barrel (30). 
Avidin to biotin affinity is one of the strongest non-covalent interactions 
known in biology, where the KD of the interaction is approximately 10 15M. The 
complex is also extremely stable to pH variations, salt concentrations and 
chaotrophic agents such as urea and has thus become an extremely useful affinity tag 
tool in molecular biology (31). 
1.1.4 - Biological and Pathological Effects of Biotin Deficiency 
The long term use of antibiotics can result in a reduction in intestinal 
microflora and this can then result in biotin deficiency (32). A lack of biotin 
obviously results in a lack of enzymatic activity of all biotin dependant enzyme 
systems as well as indirect effects such as impairment of protein and RNA synthesis. 
The resultant pathological effects in mammals include progressive ataxia, dermatitis, 
alopecia, skin lesions, nausea and metabolic acidosis. All symptoms of biotin 
deficiency can be reversed by supplementation of the diet with biotin. 
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1.2- Biosynthesis of Biotin 
1.2.1 - The E. coil biotin operon and regulation of biosynthesis 
The majority of studies of biotin biosynthesis have been based on the E. co/i 
and B. sphaericus pathways and evidence suggests that similar enzymes and 
intermediates are used in all microorganisms and higher plants. 
The E. co/i biotin operon (bio operon) is represented in Figure 1.4 and 
consists of a 5.8 kilobase region containing six open reading frames (ORFs) which 
lie between the ?. attachment site and the urvB gene on the E. co/i genome (33). 
Much of the early genetic work was carried out by del Campillo-Campbell and Rolfe 
and led to the identification of the genes encoded by this region (34, 35). The 
complementation analysis used in this work suggested that the region contains the 
five principle genes in biotin biosynthesis, bioA, bloB, bioF, bioC and bioD (36, 37). 
A gene, bioH, has also been identified that is required for biotin biosynthesis but is 
separately located on the genome of E. co/i outwith the bio operon. 
The E. coil biotin genes are divergently transcribed from two promoters 
(pbioBFCD and pbioA) (38) which are co-repressed at either side of the operator site 
(39, 40). The promoters are AT rich regions flanked by GC regions and it has also 
been established that the operator contains a hyphenated palindromic sequence from 
—20 to +20 that overlaps the promoters which both contain typical Pnbnow box 
motifs of bacterial promoters. 
The control of biotin biosynthesis was first recognised by Pai and Lichstein 
who recorded that the production of biotin decreased as extracellular biotin increased 
(41) and it was found that this was a repression mechanism rather than feedback 
inhibition (42). The regulation of gene expression within the biotin operon is 
achieved by the birA gene product which is a 321 amino acid protein of molecular 
weight 35.5 kDa. It was found that BirA is bifunctional, acting as an ATP-dependent, 
biotin activating enzyme, converting biotin to biotinoyl-AMP (also known as biotin 
5'-adenylate) and transferring this activated form of biotin to the BCCP domains of 
biotin dependent enzymes. BirA from E. co/i also contains an N-terminal DNA 
binding domain that functions as the transcriptional regulator of the biotin operon 
(43). 
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Figure 1.4 - Representation of the 6 kilobase region of the E. co/i biotin 
operon, containing bioA,B,F,C, D & ybhB genes. The promoter regions lie 
between the bioA & bloB genes and are divergently transcribed 
Figure 1.5— Crystal structure of B1rA with biotin bound (10) 
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The intermediate of the biotin activation reaction, BirA-biotinoyl-AMP, binds to the 
40 base pair bio operator, repressing transcription of the genes within the operon. 
This is a remarkable property among DNA binding proteins as it synthesises its own 
co-repressor ligand. Initial structural studies by Howard suggested that BirA contains 
a helix-loop-helix domain similar to other DNA binding proteins based on sequence 
analysis (44). 
This was confirmed when the X-ray crystal structure was determined in 1992 
by Wilson et al. (10). The BirAlbiotinyl-AMP complex dimerises and it is this form 
that is believed to be the actual DNA binding/repressor form. The structure of a 
BirA/biotin dimeric form was recently determined and a model for its interaction 
with the bio operator site proposed (45). The repression of the transcription of the 
operon thus increases proportionaly with biotin/biotinyl-AMP concentration in the 
growth media. This, in turn, leads to an increase in the concentration of the BirA-
biotinyl-AMP repressor complex until a critical in vivo concentration is reached 
which means all operator sites are filled and transcription of the bio genes is fully 
repressed. 
1.2.2 - Biosynthetic pathway in prokaryotes 
The currently accepted biosynthetic pathway in prokaryotes was proposed by 
Eisenberg based on his studies in E. co/i (25) and now it appears that this pathway 
shown in Figure 1.6 is ubiquitous in bactera. 
1.2.3 - Early Steps of Biotin Biosynthesis in E. coil 
In B. sphaericus it was found that the initial precursor to biotin was pimelic 
acid which is converted to pimeloyl-CoA by pimeloyl-CoA synthase (encoded by a 
bioW gene) in the presence of HSCoA, ATP and Mg 24 (46). However in E. co/i no 
such pimeloyl-00A synthetase activity has been detected. In contast, E. co/i contains 
two genes which have been implicated in the early stages of the pathway. Results of 
two 13C labelling studies suggest that pimeloyl-CoA is synthesised directly from 
malonyl-CoA by the bioC gene product via a pathway similar to fatty acid synthesis 
(47, 48). Studies by Lemone et al. suggest that bioC may catalyse the condensation 
IME 
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of acetate units from an initial malonyl-CoA starter unit and subsequent stepwise 
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Figure 1.6 - The E. co/i biotin biosynthetic pathway; 8-Amino--7-oxononanoate 
(41599Da - ANOS) is the product of the bioF gene, 7,8-diaminononanoate 
(47403Da - DANS) is the bioA gene product, dethiobiotin synthase (23917kDa - 
DTBS) is the bioD gene product and biotin synthase (38648Da - BS) is the bloB 
gene product. 
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The other gene implicated in this early stage is the product of the bioH gene and it 
has been suggested that this could be involved in the transfer of pimelate directily to 
CoA thus preventing buildup of intracellular pimelate (49). One study by 
Campopiano et al. showed that bioH binds a single CoA molecule which suggests 
that it may act as a scaffold for the formation of pimeloyl-CoA (50). The recent 
determination of the BioH x-ray crystal structure by a Canadian Structural 
Proteomics Consortium (shown in Figure 1.7), combined with sequence and tertiary 
fold analysis suggests that it could function as a carboxyesterase. Enzymatic activity 
was identified with a range of long-chain esters (51). This study, in conjuction with 
our findings, suggest that BioH plays an enzymatic role in the formation of pimeloyl-
CoA but the precise details of the substrates involved within this putative system are 
yet to be elucidated. A search for protein partners of BioH using antibody pull down 
experiments may reveal some important incites to the exact cellular role. 
1.2.4 - E. coil 8-Amino-7-oxononanoate synthase (AONS) 
After formation of the key precursor pimeloyl-00A, biotin biosynthesis in all 
organisms proceeds in a similar manner. Pimeloyl-CoA is converted to the next 
intermediate in the pathway, 8-Amino-7-oxononanoate (AON) by 8-Amino-7-
oxononanoate synthase (AONS), a 384 amino acid protein with molecular weight of 
41.5 kDa. This enzyme catalyses the decarboxylative condensation of L-alanine with 
pimeloyl-00A to form AON, CO2 and HSCoA. The catalytically active homo-
dimeric form has an absolute requirement for a pyndoxal 5'-phosphate (PLP) 
cofactor for enzymatic activity. The bioF genes from E. co/i and B. sphaericus have 
both been expressed in E. coli, protein purified, (52, 12) and the structure of the E. 
co/i protein has been determined by the Edinburgh group (PDB 1 BSO) (12) as shown 
in Figure 1.8. The protein is a homodimer with an overall structure typical of a type 
II aminotransferase (53). The AONS monomer has 3 domains; the N-terminus wraps 
around the opposing monomer, the second is a large central catalytic domain and a 
third small C-terminal domain. The dimer contains two active sites with residues 
contributed from each monomer and it is located in a cleft between the 2 nI  and 3 rd 
domains. The PLP cofactor is bound via lysine residue (K236) which is conserved 
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among all AONS enzymes studied to date. The structure of the product AON-bound 
form revealed the residues involved in catalysis (Webster et al. (54)). 
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Figure 1.7 - X-ray crystal structure of the monomeric E. co/i BioH (PDB 
accession code: 1 M33). The catalytic Rossman fold consists of seven strand 
0 sheets (blue) surrounded with a helices ( ) 
/ 
L •C ø!"A< 
Figure 1.8 - The x-ray crystal structure of internal aldimine of E. coil AONS 
(1 BSO). The dimer is shown, with a single chain coloured. Monomer contains 3 
domains the N-terminus wraps around the opposing monomer. The PLP co-factor 
is bound as an aldimine to lysine 236 shown in yellow (12). 
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L-Ala 	 Pimeloyl CoA 	 8-Amino-7-oxononanoate 
Figure 1.9 - Reaction catalysed by 8-Amino-7-oxoxnonanoate synthase. 
The carboxylate group of alanine is replaced by a pimeloyl moiety. 
AONS is a member of a family of enzymes which catalyse similar chemistry - the a-
oxoamine synthase family. Other members include SPT the first enzyme in the 
sphingolipid biosynthetic pathway, ALAS involved in heme biosynthesis and KBL 
which is involved in the metabolism of threonine. 
1.2.5 - E. coil 7,8-diaminononanoate synthase (DANS) 
After the formation of AON by AONS the next step in the biosynthetic 
pathway is a transamination reaction which is catalysed by 7,8-Diaminononanoate 
synthase (DANS) which leads to the formation of 7,8-diaminononanoate (DAN). 
This enzyme is the product of the bioA gene which encodes a 430 amino acid protein 
with monomer molecular weight of 47.4 kDa. The dimeric enzyme has a requirement 
for PLP, and unusually, the amino donor is S-adenosyl methionine (SAM). The 
DANS enzyme is unique in its requirement for SAM but resembles both AONS and 
other type II aminotransferase structures in that the homodimer is formed from 
monomers with three domains very similar to those described for AONS. The X-ray 
crystal structure has been determined by Lindquist (55) and Alexeev (2) and that 
solved by Alexeev is shown in Figure 1.10. Recent mutational studies have explored 
the residues involved in catalysis. Four residues were found to be important for the 
complete reaction, two tyrosine residues were suggested to be involved exclusively 
with the DAPA half reaction, an arginine residue which is involved in the SAM half 
reaction and an asparagine residue, the mutation of which inhibited both half 
reactions (56). However, the exact details of SAM binding are still unclear since a 
structure of the DANS-SAM external aldimine complex has remained elusive. 
Interestingly, recent work by Marquet and coworkers has revealed the 
structural details of the inhibition of DANS by the antibiotic amiclenomycin. 
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Figure 1.10 - The X-ray crystal structure of E. coil DANS dimer. 
Each monomer is coloured with 0 sheets blue and a helices 
and contains 3 domains the first of which wraps around the 
opposing monomer. The PLP co-factor is bound to lysine 274 (2). 
4 
Figure 1.11 - The X-Ray crystal structure of E. co/i DTBS (1 DAD). Dimer 
shown, with one monomer coloured 0 sheets blue and a helices 	.(15) 
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The inhibition of DANS with this antibiotic was found to be specific for the cis 
isomer and it is suggested by the authors that PLP forms a covalent bond with the 
inhibitor and is initiated by hydrogen abstraction from the cyclohexadiene ring of 
amiclenomycin by the sidechain of the lysine residue (1(274) lying in close proximity 
(56). 









Figure 1.11 b - Proposed mechanism of formation of the covalent aromatic 
adduct between amiclenomycin and PLP in the active site of DAPA synthase. 
1.2.6 - E. coil Dethiobiotin Synthase (DTBS) 
The penultimate step in the pathway is catalyzed by the dethiobiotin 
synthetase (DTBS) enzyme encoded by the bioD gene. The product of the bioD gene 
is a 224 amino acid protein, where the N-term methionine is cleaved after translation 
with monomer molecular mass of 23.8 kDa. The catalytically active, dimeric form of 
DTBS catalyses the insertion of carbon monoxide into DAN forming dethiobiotin 
and the reaction has a requirment for ATP and Mg  2+  (57). Interestingly this enzyme 
is unusual in that it does not use biotin as a CO2 carrier but instead uses ATP to drive 
the formation of the two C-N bonds of the ureido ring. The E. coli DTBS shows little 
sequence homology with other proteins except related DTBS proteins from Serratia 
marcescens and B. sphaericus (58, 59) with which it shares 70.2% and 49% 
sequence identity respectivly. The ligand-free crystal structure was determined to a 
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resolution 1.6A (I DAD) (15, 60) as shown in Figure 1.11. Each monomer of the 
dimer has seven stranded parallel 0 sheets surrounded by helices. These sheets 
contain the classic mononucleotide binding motif G-X5-G-K-T and the sequence of 
catalytic steps have been examined in depth and roles of these residues elucidated 
(61, 62, 63). The DuPont group have subsequently determined the structures of 
DTBS with a range of intermediates, substrate analogues and inhibitors which have 
provided insight into the catalytic cycle (64). 
1.2.7 - The Final Step: Dethiobiotin - Biotin conversion 
The final step in the biosynthetic pathway is chemically the most challenging 
and has been the subject of intensive research by a number of groups over the past 
decade. This step involves the insertion of a sulfur atom between the C-6 and C-9 
carbons of DTB, thus forming two carbon-sulfur bonds of the tetrahydrothiophene 
ring of biotin as shown in Figure 1.12. In absolute enzymological terms this step is 
the least well understood regardless of the large amount of work that has been 
undertaken. It is accepted that the bioB gene product, biotin synthase, is responsible 
for this conversion, however to date, enzymatic turnover of biotin synthase has not 
been achieved in vitro. Similarity searches have revealed a number of sequence 
homologs in bacteria and plants to that of the predicted E. co/i biotin synthase. The 
entire sequence from twenty six species are known of which only four species, B. 
sphaericus (65), A. thaliana (66), S. cerevisiae (67) and E. co/i (68) have been 
cloned, overexpressed and purified. Other work has been sufficient to verify that 
genes of the species Methylobacillus, B. flavum (69), B. subilis (70), E. herbi cola 
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Figure 1.12 - Conversion of dethiobiotin to biotin thought to be 
catalysed by biotin synthase forms two new carbon-sulfur bonds 
( ). 
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1.3- E. coil bloB gene product: Biotin synthase (BS) 
The E. co/i bioB gene encodes a biotin synthase (BS) polypeptide of 346 
amino acids with a predicted molecular weight of 38.6 kDa (72). The E. co/i gene 
was initially cloned and overexpressed by Sanyal et a/. and they were the first group 
to achieve the purification of native, un-tagged BS. They identified two species by 
native gel electrophoresis with masses of approximately 82kDa and 1 O4kDa as 
judged by SDS-PAGE which were shown to be homodimers. Iron and sulfur analysis 
revealed the BS:sulfur:iron stoichiometry in each species and suggested that they 
contained two [2Fe-2S] clusters and one [2Fe-2S] cluster respectively. The BS with 
apparent mass of approximately 1 O4kDa was converted to the 82kDa species upon 
incubation with Fe 31,  S2 and 3-mercaptoethanol. Both species were red/brown in 
colour and had UV-Vis maxima at 324nm and 419nm which is consistent with other 
[Fe-S] cluster proteins (68). One further species of biotin synthase has been reported 
with apparent molecular weight of 1 6OkDa which again showed similar UV-Vis 
maxima as before (67). 
1.3.1 Biotin synthase - a member of the Radical SAM superfamily 
Multiple sequence alignment of biotin synthase homologs reveals several 
regions of high identity and others of high conservation. The region between 
lysine49 and serine63 shows very high conservation with three cysteine residues 
being completely conserved within the motif -C-X3-C-X 2-C- which was originally 
known as the Cys box motif (67). In a seminal bioinformatic study in 2001, Sofia and 
colleagues discovered a protein superfamily with >600 members which contain this 
motif— named the "Radical SAM superfamily" (72). The proteins in this family bind 
SAM and generate a reactive species, the S'deoxyadenosine radical, which is then 
used in I electron radical chemistry in a number of diverse biochemical pathways 
(73). For example, the signature motif has been identified in anaerobic ribonucleotide 
reductase activating enzyme (ARR-AE, Swissprot acc number P39329) (74), 
benzylsuccinate synthase activating enzyme (CAA05050) (75), lipoic acid synthase 
(P25845) (76), lysine aminomutase LAM (77), the nitrogen fixation B gene product 
(P1 1067) (78), FNR protein (P03019) (79), 
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Figure 1.13 - Some reactions catalysed by some members of the SAM radical 
super family. Reproduced from uS.Adenosylmeth  ion  ine  radical enzymes" Marja S. 
Huhta (5). 
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pyrrolo-quinoline-quinone synthase (Q01060) (80), pyruvate formate lyase activating 
protein (PFL-AE) (P09374) (81), spore photoproduct lyase (P37956) (82), 
molybdenum cofactor synthase (MOAA) (027593) (83), NARA protein (P39757) 
(84) and the thiH gene product (P30140) (85). It was recognised that all these 
proteins bound [Fe-S] clusters which led to speculation that the conserved cysteine 
residues within the Cys box were the ligands for cluster binding. Evidence for this 
was shown by mutagenesis studies that indeed the Cys53, Cys57 and Cys60 of the E. 
co/i biotin synthase protein are involved in the coordination of an Fe-S cluster (86, 
87). 
1.3.2 - Biotin synthase - controversies of cofactor composition 
Since the initial purification of BS in 1994 seven groups have carried out 
extensive studies on E. co/i BS. Methods for the expression, purification, handling 
and characterisation vary between laboratories. Each laboratory produces BS with 
varying activity as well as differing Fe, S and cofactor content. No single method has 
been adopted within the field but there is general agreement that active BS contains 
two types of Fe-S cluster bound at different sites on the enzyme using conserved 
cysteine residues. The Fe-S clusters in biotin synthase are also labile which has also 
led to preparations varying in Fe and S content. While aerobic purification of the 
protein produces a dimer with two [2Fe-2S] 2 clusters (8, 88) the protein can be 
reconstituted anaerobically to contain mainly [4Fe-4S] 2 or [4Fe4S] clusters upon 
strong chemical reduction with dithionite with or without, respectively, 60% ethylene 
glycol (8, 88, 89, 90). Also reduction under milder conditions appeared to produce a 
1:1 ratio of [2Fe-2S] 2 :[4Fe4S] 2 clusters as judged by UV-Vis and chemical 
analysis (7) and comparisons of amounts of DTB to biotin conversion suggested that 
this last state provides highest activity however it is still unclear as to the processes 
involved in these conversions. A proposed mechanism for interconversions of 2 x 
[2Fe-2S] clusters to a single [4Fe-4S] cluster was proposed by Johnson et al. where a 
single [2Fe-2S] from each monomer of the biotin synthase dimer contributes to the 
final [4Fe-4S] cluster and is shown in Figure 1.15 below (8) 
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Figure 1.15 - Scheme proposed by Johnson et al. for conversion of 2[2Fe-
2S] clusters, one from each monomer, to a single [4Fe-4S] cluster. (8) 
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The field was further divided by the finding by Fontecave's laboratory that BS 
displays PLP-dependent cysteine desulfurase activity and a BS-bound persulfide was 
implicated in the sulfur transfer step (91, 92, 93). This paper has garnered little or no 
support from other groups in the field and as such is the subject of controversy (see 
below). This thesis describes efforts to clarify this area further. 
It was presumed that BS preparations containing [2Fe-2S] 2+ clusters are inactive 
forms of the protein produced as an artefact of overexpression under aerobic growth 
conditions and purification procedures. Recent groundbreaking in vivo Mössbauer 
studies which measured the spectra of whole cells expressing BS found that the main 
product of bioB overexpression was in fact the [2Fe-2S] 2 cluster. The appearance of 
this species within the cell before isolation led Johnson and colleagues to conclude 
that this BS form was the product of hyperexpression of the gene in E. co/i in the 
absence of Fe-S cluster enzymes which leads to an inactive form in vivo (94). 
Although extensive work has been carried out to ascertain the nature of the cluster(s) 
present in active biotin synthase it still remains a highly contentious issue and exact 
mechanistic roles for the cluster(s) have yet to be agreed between experts in this 
field. 
Although much has been discovered about biotin synthase in the last 20 years certain 
issues still remain unclear such as the exact source of sulfur, the mechanism of 
formation of each of the two C-S bonds and an explanation as to why there have 
been no preparations of BS capable of multiple turnovers in vitro. It is now accepted 
that biotin synthase is a SAM dependant enzyme that also requires NADPH, 
flavodoxin (FLAV) and flavodoxin reductase (FRED) to supply the electrons for 
cluster reduction, subsequent SAM cleavage and biotin formation (95, 96, 97, 98). 
This system provides maximum activity in vitro however it has also been shown that 
photoreduced deazaflavin can also be used (99). Whether the FLA V/FRED reducing 
system is indeed the true in vivo redox partner is also open to conjecture since 
addition of these enzymes still does not produce the desired in vitro catalytic DTB to 
biotin activity. 
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1.3.3 - Radical SAM-dependent mechanism of BS 
The binding of SAM to BS has been investigated by MOssbauer and Raman 
spectroscopy by examining spectral changes observed upon addition of SAM to BS 
(94). This led to the development of some insightful models which suggested that 
SAM was bound directly to the [4Fe-4S] cluster, later this was confirmed by X-Ray 
crystallography (see Section 1.3.4). It is suggested that one electron reduction occurs 
after SAM binding resulting formation of a deoxyadenosyl radical. This DOA radical 
is then proposed to abstract the hydrogen from C6 and/or C9 and the resultant carbon 
radical is then used to form the first of the C-S bonds. Since a [4Fe-4S] cluster 
requires four thiol ligands it was thought that three of the ligands were provided by 
the conserved cysteine residues in the 'cys-box' —C-X3-C-X2-C- motif and that the 
fourth iron ligand in the cluster is provided by an atom from SAM. It also follows 
that for every SAM molecular turned over an equivalent amount of methionine and 
5 '-deoxyadenosine are produced. In two separate studies a 1:1 ratio of methionine: 
5'-deoxyadenosine were observed but this was 3 times as much with respect to the 
amount of biotin produced (100, 101, 102). This discrepancy was put down to 
abortive SAM cleavage, without biotin production. Both studies concluded that these 
results were consistent with consumption of 2 SAM molecules per DTB to biotin 
conversion and therefore formation of one 5'-deoxy adenosine radical per C-S bond. 
Calculations of SAM consumption are difficult and prone to error due to the assays 
being performed using crude cell extracts or having extremely low turnover activities 
compared with previously reported values (100, 101, 102). 
In contrast to these earlier studies, it has recently been reported that only one SAM is 
required for biotin formation when an assay was performed using a biotin synthase 
preparation containing PLP and a single [4Fe-4S] cluster (91, 92). This work showed 
that an in vitro assay system containing purified BS, PLP, DTB, DTT, SAM, FLAy, 
FRED, NADPH and cysteine had biotin production activity equivalent to the 
reported maximum of one biotin molecule per molecule of BS. This single turnover 
was achieved when PLP was included in the assay system compared to 0.25 biotin 
molecule per molecule of BS without PLP (92). Fontecave and colleagues also 
measured a biotin to methionine ratio of 1:1 suggesting that only one SAM radical 
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conclusions drawn from this study were that biotin synthase is capable of liberating 
sulfur from cysteine by a NifS-like, PLP-dependent cysteine desulfurase activity. 
The conversion of cysteine to alanine was confirmed by isolation of the alanine as a 
ninhydrin derivative and comparison with amino acid standards on HPLC. This 
cysteine desulfurase activity of biotin synthase was also shown to exhibit multiple 
turnovers albeit at slow rates in the region of 1 per hour. This system also supported 
a second DTB to biotin conversion if the proteins were rigorously washed of any low 
molecular weight products. The reasoning behind this wash step was that the 5'-
deoxyadenosine (DOAH) produced after a single turnover is a potent inhibitor of the 
BS reaction and its removal is essential for multiple turnovers (91). Again, the role of 






Figure 1.16— Reductive cleavage of S-adenosylmethionine to the 5'-
deoxyadenosine radical facilitated by the reduced [4Fe-4S] cluster of the radical 
SAM superfamily (5). 
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1.3.4 - Source of sulfur incorporated into biotin 
Cysteine is accepted as the source of the sulfur atom in biotin but the details 
of the pathway involved in the breaking of the cysteine C-S bond and the subsequent 
intermediates involved during its transfer to DTB have been the subject of numerous 
studies. This has led two theories of sulfur incorporation; the first proposes that the 
cysteine sulfur is incorporated into the [2Fe-2S] cluster and it is a sulfur from this 
species that is the direct source of the sulfur in biotin (7, 103). The second theory is 
that the cysteine is incorporated in a PLP-dependent mechanism into a cysteine-
bound persulfide (S-S) (93, 91, 92). 
The background which led to these two hypotheses is as follows; crude bacterial 
extracts containing 35  cysteine were shown to yield biotin with 35 S label but with 
significantly lower levels than expected indicating other sources of sulfur are used in 
this system (102, 65). Several others have reported that in a more controlled system 
containing purified biotin synthase no transfer of the 35S label into biotin was 
observed unless a cysteine desulfurase enzyme (NifS, IscS) is included in the system 
(95, 104, 105). As well as this it has been demonstrated that 34  or 35 S has been 
transferred from labelled Na 2S suggesting that 2  can be used as the source of 
sulfide in vitro. In an attempt to show the source of '5' inserted into biotin originates 
from the protein bound clusters, preparations of apo-biotin synthase were 
reconstituted with Fe 2+/34S2-  or with Fe2 7(35 S)-cysteine and cysteine desulfurase 
(NifS) however incorporation of the labelled S was found to be only 62% and 56% 
respectively (106, 104) suggesting that large portions of 32 S remain within the protein 
as sulfane type species which are clearly distinct from the bound cluster(s). 
The hypothesis initially proposed by Flint and colleagues and then enhanced by the 
labelling experiments from the Marquet laboratory states that the sulfur atom inserted 
into biotin originates from the cluster itself and is derived from one of the cluster 
bridging sulfur atoms (106, 68). However other sulfur sources could not be excluded 
as treatment of BS with labelled sulfur could affect other sulfur containing species 
within the protein. This theory was later revised by Jarrett and co-workers who 
suggested that a second cluster within each monomer of biotin synthase was required 
(7, 107, 108). 
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Figure 1.17 - Hypothetical mechanism of sulfur insertion to form biotin 
where two SAM molecules are consumed and the second [2Fe-2S] cluster is 
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Figure 1.18 - Proposed mechanism of PLP dependant 
cysteine desulfurase activity of biotin synthase. Reproduced 
from Fontecave et al. (9). 
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This hypothesis was based on the already recognised reduced [4Fe-4S]' cluster 
acting as the electron source to cleave SAM and also a second [2Fe-2S] cluster 
which is responsible for donation of the sulfur species to form biotin via the 
mechanism proposed in Figure 1.17. The mechanism suggests initial abstraction of a 
hydrogen atom from C9 to form a radical which couples to sulfur in the cluster. Ring 
closure occurs after generation of a second radical intermediate formed from another 
SAM radical cleavage thus resulting in formation of biotin. This mechanism suggests 
that the [2Fe-2S] cluster is destroyed during the formation of biotin and 
spectroscopic evidence for this was obtained by Jarrett and colleagues. 
In contrast, Fontecave and colleagues have proposed a [2Fe-2S] cluster-independent 
mechanism. They have suggested that biotin synthase can liberate S 2 by a similar 
mechanism to other PLP-dependent cysteine desulfurase enzymes (fig. 1.18). This 
multi-step mechanism involves the formation of a substrate cysteine-PLP quinonoid 
adduct and subsequent nucelophilic attack by a thiolate anion of protein bound 
cysteine (91). The exact PLP-binding residue is postulated to be lysine 49 but the 
exact role of this residue is the subject of this present study. This generates a PLP 
bound enamine which is subsequently hydrolysed to alanine and a 2  species (fig. 
1.18). 
The resultant 2  is then proposed to form a protein bound persulfide which is the 
direct sulfur donor to the activated DTB radical produced by the [4Fe-4S]/SAM 
radical (fig. 1.19). 
The PLP-dependent mechanism involves the formation of unprecedented persulfo-
metal complex as no examples have been observed in other metallo-proteins. The 
mechanism consists of the coupling of the C9-radical and the terminal sulfur of the 
persulfide giving rise to a thiyl radical and the iron bound dehydrogenated 9-
mercaptodethiobiotin. The thiyl radical is postulated to abstract the hydrogen at C6 
and ring closure occurs with a one-electron reduction of the cluster (9). 
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Figure  1.19 - Proposed mechanism of protein bound persulfide as 
donor to convert activated DTB radical to biotin (9). 
This biotin production mechanism involving the PLP-dependant cysteine desulfurase 
activity is still highly debated in the literature as a direct alternative to the [2Fe-2S] 
cluster mechanism discussed previously. However it is interesting to note several 
similarities between them. Firstly, both have suggested that the final acceptor of the 
electron that results from the formation of biotin is ferric iron. Secondly, the authors 
of both mechanisms implicate the same conserved cysteine residues within the biotin 
synthase sequence as being essential for activity but provide differing explanations. 
Jarrett and colleagues proposed that the conserved cysteine residues, Cys97, Cys 128 
and Cys 188 which have been shown to be catalytically important (109) are involved 
in the binding of the second cluster, namely the [2Fe-2S] sulfur donating cluster. 
However, the same conserved residues (Cys97, Cys128 and Cys188) have been 
shown to be extremely important (C188 less so) for the PLP-dependent cysteine 
desulfurase activity (92). 
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Given the complexity of the biotin synthase system and despite the determination of 
the crystal structure of reconstituted BS (see Section 1.3.5) it is still difficult to 
discount the published work in favour of one mechanism or the other. The fact that 
two different preparations of biotin synthase, one with [4Fe-4S] and [2Fe-2S] 
clusters and the other with a single [4Fe-4S] cluster and PLP bound, seem to produce 
very similar biotin production rates, suggests that a number of possibly similar, but 
hitherto uncharacterised, intermediates have still to be revealed in the sulfur insertion 
reaction. 
1.3.5 - X-ray crystal structure of E. coil biotin synthase 
Until recently no 3D structures had been determined of any member of the 
radical-SAM superfamily of enzymes presumably because it had been tremendously 
difficult to obtain a solution of the protein in a suitably homogeneous state to enable 
crystallisation. However, a milestone was reached in this field by the publication of 
the x-ray crystal structure of a reconstituted E. coli BS at 3.4A resolution through the 
collaborative efforts of the Jarrett and Drennan groups (16). The structure of BS was 
determined using a single crystal of a reconstituted protein preparation via the 
hanging drop method in an Argon atmosphere. Biotin synthase is a homo-dimer 
(Figure 1.20) and the BS monomer tertiary fold was not found to be unique but is in 
fact a common triosephosphate isomerase (TIM) type (a/0)8 barrel with two 
additional a-helices at the N-terminus and a disordered region at the C-terminus 
(16). It is interesting to note that BS shares the same fold as three AdoCbl-dependant 
enzymes that also utilise radical-chemistry mechanisms (110) but it is unusual to find 
[Fe-S] clusters bound in this type of fold. As shown in Figure 1.21b the authors 
identified two clusters bound —16A apart (a single [4Fe-4S] and a single [2Fe-2S]). 
The [4Fe4S] cluster is found toward the C-terminal end of the TIM barrel at least 
30A from the dimer interface whereas the [2Fe-2S] cluster is located deep within the 
barrel 25A from the C-terminus. The authors were also delighted to find not only 
SAM bound directly to the [4Fe4S] cluster but also DTB within a few angstroms of 
the cluster, poised for hydrogen abstraction. They found no evidence of PLP bound 
to BS, however no PLP was 
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Figure 1.20 - X-Ray crystal dimeric structure of E. co/i biotin synthase (1 R30) as 
solved by Drennan and co workers. Monomer A is shown with a-helicies in 	and 
sheets in in blue. The relative positions of [4Fe-4S] and [2Fe-2S] clusters (yellow 
spacefill) are shown with relatively exposed [4Fe-4S] cluster and buried [2Fe-2S] 
cluster. Monomer B is viewed as indicated by arrow (X) [4Fe-4S] in spacefill and yellow 
with [2Fe-2S] cluster omitted for clarity. Also shown is SAM (black) and DIB (blue) 
.(16) 
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added during the reconstitution process in contrast to the 5mM concentration of 
SAM and DTB in the reconstitution buffer (I 11). Although the authors do mention 
the only conserved lysine residue in biotin synthase (K49) as a putative site of PLP 
modification they disregard this theory due to its solvent exposed position. The 
discovery that BS has a very common 3D topology, rather than a unique tertiary fold 
was slightly disappointing. However, it is not surprising since such a common 
scaffold is used in a diverse range of enzymatic reactions. The crystal structure has 
finally revealed details of important residues involved in the mechanism, the binding 
sites of the Fe-S clusters, SAM and DTB substrates and their spatial positions 
relative to each other. Figure 1.21b shows both the [4Fe-4S] and the [2Fe-2S] 
clusters and their corresponding interacting residues. The major binding interactions 
within the active site are summarised in Figure 1.2a. The [4Fe4S] cluster is bound 
by Cys53, 57 and 60 as previously postulated by mutational studies (87, 86) and the 
final iron is bound via a N/O bidentate contact with the amino-group nitrogen and 
carboxyl-group oxygen of SAM predicted by spectroscopic studies (16). The 
remainder of the SAM molecule interacts with Arg173, Asn153, Asp155, 1le192 and 
Tyr59 as shown. The second cluster, [2Fe-2S], is bound by Cys97, 128 and 188 
which have all been implicated as vital for biotin synthase activity (109) and for the 
putative cysteine desulfurase activity (91). A final unusual arginine ligand (Arg260) 
is shown to interact with the [2Fe-2S] cluster and this Arg260 also is in contact with 
residues Ser43, Ser218, Ser283 and Arg95 as shown. The DTB substrate is shown to 
interact with the conserved residues Asn222, AsnlSl and Asn153 in the active site 
and also the carboxylate tail of DTB stacking with the adenine ring of SAM. The 
carboxylate tail also appears to interact with residues Thr292 and Thr293. 
The binding of substrates SAM and DTB is of a cooperative fashion both displaying 
significant interactions with each other as well as the protein chain. SAM is suitably 
positioned in this structure to accept the electron from the [4Fe-4S] cluster directly 
through the N/O coordination of the bridging Fe. The close proximity of the cluster 
to the surface of the protein, within 7A, suggests that a system like NADPH, FLAV 
and FRED could directly supply an electron for this one electron reduction. The 
formation of the DOA' radical within this active site would result in the radical being 
3.9A and 4IA from the C9 and C6 positions respectively of DTB and so it is 
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possible that abstraction of hydrogen from either position could be achieved by the 
DOA radical. 
The final controversial step of the mechanism is the insertion of S, and with respect 
to the second cluster the bridging Fe is within 4.6A of C9 of DTB and as such could 
act as donor. If the second cluster is indeed found to be the donor two possibilities 
remain. Firstly biotin synthase acts as a suicide enzyme as suggested by Drennan and 
co-workers (16) or the cluster can be rebuilt either by a recognised system such as 
ISC or perhaps by biotin synthase itself in which case this would implicate the PLP 
dependant cysteine desulfurase activity reported (92, 91) as vital to this rebuilding 
process. Although this cluster is buried within the barrel movement of Arg95 and/or 
Tyr 149 would open an access route to this region allowing possible interactions 
between a sulfur containing moiety and the [2Fe-2S] binding region. 
Unit 	Binding interactions 
[4Fe-4S] 	Cys53, 57 and 60 
NIO bidentate with amino tail of 
SAM 
[2Fe-2S] 	Cys97, 128, 188 
- Previous evidence 
Mutational studies. Cluster 
binding (84, 85) 
Spectroscopic studies (15) 
Mutational studies. Vital for 
BS activity (89, 107) 
Arg260 
SAM 	[4Fe-4S], Arg173, Asn153, 
- ____ 	Asp155, 11e192, Tyr59  
DTB 	Asn222, 151 and 153, Thr292 
and 293 ?  Adenine ring? 
Arg260 	Ser43, 218, 283 and Arg95 
Figure 1.21a - Major binding interactions within the active site of BS crystal 
structure (15). 
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Figure 1.21 b - X-Ray crystal structure of active site of E. co/i biotin synthase (PDB ID - 1 R30) 
showing clusters as spacefill, iron in red and sulfur in yellow. SAM is shown in purple and DTB 
in yellow. A - Displays both clusters and ligands thought to contact these. [4Fe4S] cluster 
ligands shown in red (C53,57,60), final ligand is N/O chelate from SAM. [2Fe-2S] cluster 
ligands shown in blue (C97,128,188 and R260), residues contacting R260 (S43,218,283 and 
R95) omitted for clarity. Also shown is proposed PLP modified residue K49 (olive green). B - 
Shows ligands contacting SAM in dark blue (Y59, A100, N153, 0155, R173,1192 and V225) 
with hydrogen bonds dotted green. Both clusters are also shown. C - Shows ligands thought to 
contact DTB and displayed in light green (N151,153,222 and 1292,293) with hydrogen bonds 
in dotted green. The [2Fe-2S] cluster has been omitted for clarity (16). 
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1.4— [Fe-S] cluster utilizing enzymes 
Biotin synthase is the best characterised member of the growing family of 
radical-SAM, [Fe-S] cluster-dependent enzymes which catalyse diverse chemistry. 
Four other members which have been the subject of numerous studies are lysine 2,3-
aminomutase (LAM), pyruvate formate lyase activating enzyme (PFL-AE), 
anaerobic nbonucleotide reductase activating enzyme (ARR-AE) and lipoic acid 
synthase (LIPA). Although all of these enzymes share in common with biotin 
synthase the requirement for [Fe-S] clusters and SAM subtle differences are apparent 
in their specific mechanism and less subtle differences in function as described 
below. 
The enzyme lysine 2,3-aminomutase (LAM) has been purified from Clostridium 
substerminale and has been implicated in the inter-conversion of L-lysine and L-l-
lysine. The active form of LAM has an absolute requirement for an [Fe-S] cluster, 
SAM and PLP. The protein forms a homohexamer with subunit weight of 47kDa 
producing an active complex of 285 kDa. The [Fe-S] cluster of LAM can be bound 
in the complex in three possible formations, but only one is thought to interact with 
SAM (112). It has been proposed that LAM and biotin synthase share a similar 
mechanistic pathway in which SAM binds directly to the cluster and is cleaved to 
form methionine and the 5'-deoxyadonosine radical (DOA). In the case of LAM the 
resultant DOA' radical is thought to abstract a hydrogen from L-lysine resulting in 
the formation of a lysine radical. This proposed lysine radical could isomerise, with 
addition of a hydrogen atom, to form the L-3-lysine product (112). 
Pyruvate formate lyase (PFL) is a homodimer with monomer molecular weight of 
85kDa the tertiary structure of which (113, 114) reveals a single stable glycyl radical 
(Gly734) which has been shown to be required for catalytic activity (115). The PFL 
dimer forms a (X2P complex with a second monomeric protein, pyruvate formate 
lyase activating enzyme (PFL-AE) a 38kDa enzyme containing a [4Fe-4S] cluster. In 
common with biotin synthase the [(PFL) 2 :PFL-AE] complex also requires SAM, 
DT-F, NADPH and the FLA V/FRED electron transfer complex to exhibit enzymatic 
activity (116, 117). The activation of this a20 complex is thought to be initiated via a 
similar reduction cascade described for biotin synthase (NADPH -+ Flay -* Fred -* 
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[Fe-S]). The bound SAM molecule is cleaved to form the DOA' radical which is then 
available to abstract a hydrogen atom from the a-carbon of the conserved Gly734 
forming the glycyl radical required (118, 119). Three conserved cysteine residues 
(Cys 29, 33 and 36) have been proved to be essential for activity and also the site of 
cluster binding corresponding to the cys-box motif -C-X3-C-X2-C- (118). 
Anaerobic ribonucleotide reductase (ARR) also forms a complex with its activation 
enzyme, anaerobic ribonucleotide reductase-activation enzyme (ARR-AE). ARR 
itself was found to be a homodimer and upon complexation with ARR-AE forms a 
a22 complex which demonstrates enzymatic activity. Anaerobic ribonucleotide 
reductase activating enzyme (ARR-AE) contains a [4Fe-4S] cluster which is located 
in the interface between the P monomers (120). The equimolar binding of SAM to 
this cluster initiates the cleavage to form methionine and the DOA radical. In a 
mechanism similar to PFL the DOA radical abstracts a hydrogen atom from a 
conserved glycine residue (G1y68 1) forming the activated ARR enzyme. 
The lipoate synthase (LIPA) enzyme catalyses the insertion of 2 sulfur atoms into an 
octanoic acid group during the final step of lipoic acid synthesis as laid out in Figure 
1.22. This insertion reaction catalysed by LIPA is comparable to the conversion of 
DTB to biotin by biotin synthase as both involve the production of two new C-S 
bonds (76, 121, 122). The LIPA protein has approximately 36% identity with BS and 
both proteins have a requirement of an [Fe-S] cluster and the mechanisms are SAM 
dependent. Exogenous lipoate is transferred to apo proteins by lipoate protein ligase 
(LplA) (123). In the 2-oxoacid dehydrogenases, the lipoyl modified domains are 
found at the termini of the E2 subunit. Two distinct pathways exist in E. coli for the 
formation of lipoyl modified dehydrogenase E2 domains, so forming lipoyl-E2. Both 
involve the formation of an octanoylated-E2 before its conversion to the lipoyl-E2 by 
LIPA. The first pathway uses octanoic acid as the substrate (derived from the fatty 
acid synthetic pathway) and this is covalently linked to a dehydrogenase enzyme 
subunit by the LpIA protein (123). This second pathway requires the lipB gene 
product and this utilises the lipoyl(octanoyl)-ACP as the substrate to form the 
octanoylated-E2, which again is converted to lipoyl-E2 by LIPA (124, 125). A recent 
study on the thermostable lipoyl synthase for Sulfolobus solfataricus by Roach et al. 
has discovered that the LIPA protein is quite promiscuous with regard to its substrate 
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and they developed an assay for activity based on octanoylated tetra peptides (126). 
Although the exact mechanism for the activity of LIPA is not known, a study by 
Booker el al. has shown that both sulphur atoms are provided from a single LIPA 




LipA 	 :- H 
8- 'cOO H 
Figure 1.22 - Reaction catalysed by the lipA gene product, lipoic acid 
synthase, a [Fe-S) cluster containing member of the SAM-radical 
family. Reproduced from Fontecave et.aI. (9). 
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1.5 - 3D Structures of Radical-SAM enzymes 
Structures of three distinct SAM radical enzymes from the family of >600 
representatives have been elucidated to date namely BS, HemeN and MoaA and a 
structural comparison is shown in Figure 1.23. 
The HemeN enzyme catalyses the oxidative decarboxylation of two propionate 
groups of the A and B rings of coproporphyrinogen III to form coproporphynnogen 
IX under anaerobic conditions in E. coli. In analogy with other members of the 
Radical SAM super family a mechanism has been proposed where initial abstraction 
of hydrogen from the beta position of the propionate side chain forms a radical, 
which is further oxidised by as yet unknown partner yields an allylic carbocation that 
facilitates the formation of the vinyl group (5). 
The first step in Moco biosynthesis is catalysed by the SAM dependant [4Fe-4S] 
cluster MoaA and MoaC. This reaction involves the conversion of a guanosine 
derivative to a precursor Z which is an oxygen sensitive 6-alkyl pterin with a cyclic 
phosphate. As with other members of this family the reaction pathway involves a 
reductive cleavage of SAM by the [4Fe4S] cluster(s) (14,128). 
An interesting comparison of these 3 members of the SAM radical family was made 
by Schindelin et al. when they obtained the structure of MoaA as shown in Figure 
1.23. All three structures show high structural similarity in the N-terminal domain of 
the protein which is responsible for [Fe-S] cluster and SAM binding but differ in the 
C-terminal domain of the protein, presumably to facilitate the binding of structurally 








4 	 riJ 
1l\ 
'. 	 .,'.' 	 '... 
WH 
RO1 . NW 
Dethioblotin 	 Biotin 	





Coproporphy- 	 Protoporphy- 
rinogen rinogen IX 
Figure 1.23 - A structural comparison of SAM-dependent enzymes BloB, MoaA and HemN and the reactions catalysed. The a-
helicies and shown in red, 13-sheets in blue and loops in grey. Structurally diverse regions are shown transparent. Reproduced from 
"Crystal structure of the S-adenosylmethionine dependant enzyme MoaA and its implications for molybdenum cofactor deficiency in 
humans" Petra Hanzelmann and Hermann Schindelin, PNAS vol 101, no. 35(14). 
Chapter One: Introduction 
1.6— Bacterial Iron-Sulfur Cluster Formation 
Identification of bacterial iron-sulfur clusters ("[Fe-S]" generic form) 
occurred over 40 years ago within the ferredoxin class of electron carrier proteins 
(129). Over 100 proteins are now known to contain [Fe-S] clusters and their 
structural, functional and mechanistic diversity is remarkable having influences in 
controlling protein structure, environmental sensing, modulation of gene expression 
and formation of reaction intermediates (130, 131). This diversity is almost certainly 
due to the chemical versatility of both iron and sulfur which in turn has led to 
suggestions that prebiotic iron-sulfur complexes may have played an influential role 
in the emergence of life (131, 132, 3). Although the most common forms known in 
biology are [2Fe-2S] and [4Fe4S] many others have been identified with much 
higher nucleanty such as the [7Fe-9S-Mo] core of the nitrogenase MoFe protein 
(133). Studies by Holm and colleagues have shown that all clusters can be formed 
from reductive coupling of [2Fe-2S] units (134). This work demonstrated that 
clusters can self assemble, however it is unlikely that this spontaneous assembly 
occurs within the intracellular environment. The required components for this self 
assembly, Fe 2+13+  and S2- , are metabolic poisons and are therefore likely to be 
metabolised or detoxified before larger clusters can form. More likely is the use of 
protein scaffolds to form the [2Fe-2S] unit building blocks. Analysis of the 
Azotobacter vinelandii genome revealed a region of [Fe-S] cluster biosynthetic 
genes. The genes within this region became known as the iron sulfur cluster (isc) 
gene cluster and the predicted biological functions of gene products are shown in 
Figure 1.24. They include proteins with cysteine desulfurase activity, DNA binding 
motifs, electron transfer activity and chaperone function. 
Subsequently, regions showing high sequence conservation to this isc gene cluster 
were found throughout numerous bacterial genomes. Their general involvement in 
synthesis of [Fe-S] clusters has been well established using genetic experiments in E. 
coli(135, 136). 
Although it is generally accepted that the role of the isc proteins is to mobilise Fe and 
S in the cell, as yet, the specific function of every individual gene and their dynamic 
interactions as a whole are unclear. 
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0-acetylsenne 	desulfurase alteiflveiFSI 	I 12F2SI synthase 	 scaffold? cluster assembly ferredoxin I2Fe-2S] negative 
regulator 	[Fe-S] cluster 	 Molecular 
assembly scaffold 	chaperones 
Figure 1.24— Region of A. vinelandil genome encoding the iron sulfur 
cluster biosynthetic genes, isc operon (3). 
The CysE2 gene product is an O-acetylserine synthase and this activity is known to 
be the rate limiting step in cysteine biosynthesis. It is assumed that the CysE2 protein 
facilitates the build up of the cysteine pool for downstream desulfurase activity 
(137). The iscR gene product is recognised as the protein responsible for regulation 
of the transcription of the isc machinery within bacterial cells. The mature iscR 
protein contains a weakly bound [2Fe-2S] cluster which can initiate a negative 
feedback on the operon. The weak cluster binding ensures that little or no 
competition for the products occurs (138). The product of iscS gene has been shown 
to be necessary for the mobilisation of sulfur for biotin, thiamine, thiolated tRNA and 
Mo cofactor maturation (139) and shows high sequence similarity to the cysteine 
desulfurase NifS from the nitrogen fixation pathway. The NiIS gene product is 
located in a Nif-specific region of the genome and is involved in formation of [Fe-S] 
clusters specifically for the nitrogen fixation machinery (discussed in detail, Section 
1.6). The mechanism of NifS is thought to proceed from the PLP dependant 
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desulfurisation of cysteine and formation of a NifS bound persulfide. The persufide 
is presumed to be the activated form of sulfur required by the scaffold protein NifU 
for [Fe-S] cluster assembly (140). General consensus suggests that the IscS and IscU 
proteins have similar functions to there equivalent Nif-specific genes (NifS and 
NifU) and although no unambiguous function has been identified for the iscA gene 
product it is accepted that it may function as the alternative scaffold protein (141, 
142). The presence of the HscA and HscB molecular chaperones within this cluster 
was unexpected however it has been shown by Hoff et al. that these well studied 
chaperone proteins interact with the IscU protein (143). These chaperones have been 
implicated in either cluster assembly on the IscU or in the transfer of an assembled 
cluster to the target bio-molecule (3). The final gene in the cluster is the fdx gene 
encoding the ferredoxin protein that contains a permanent [2Fe-2S] cluster whose 
role within the isc machinery is not fully understood. Suggested functions include a 
site for transient [2Fe-2S] unit assembly into higher nuclearity clusters and a more 
recognisable role of involvement in the acquisition of Fe (3). The full understanding 
of exactly how the clusters are formed is of great interest throughout biochemistry 
because of the variety of cellular mechanisms that are implicitly linked to the [Fe-S] 
cluster reduction-oxidation cycle and therefore the formation of these within the cell 
needs to be better understood. 
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1.7— Cysteine Desulfurase Enzymes 
Studies by Dean et al. have greatly enhanced the understanding of sulfur trafficking 
within bacteria. It has been shown that the nf gene cluster in A. vinelandii is 
responsible for the construction of iron-sulfur clusters specifically for the nitrogen 
fixation machinery (144). The purified ni/S gene product has been found to be a PLP 
dependant cysteine desulfurase, catalysing the conversion of L-cysteine into L-
alanine and a protein bound persulfide. The persulfide is subsequently used in [Fe-S] 
cluster assembly (145, 6). The E. co/i homolog of the nifS protein is IscS which 
demonstrates 40% amino acid sequence identity to A. vinelandii NifS. 
Two other proteins have been identified in E. coli which display significant 
homology to NiIS, cysteine sulfinate desulfinase (CSD) and CsdB or SufS, with 
sequence identity of 24%. These are presumed to represent a different class of 
cysteine desulfurase enzymes (146). All three identified NifS like proteins from E. 
co/i (IscS, CSD and CsdB) have been shown to catalyse the desulfuration of cysteine 
and deselenation of selenocysteine with widely varying efficiency (147, 148). CSD 
shows wide specificity for a number of cysteine analogs such as L-cysteine, sulfinic 
acid, L-selenocysteine and L-cysteine. In contrast IscS and CsdB show high 
specificity towards one reagent, L-cysteine and L-selenocysteine respectively. The 
mechanism of activity for both cysteine desulfurase and selenocysteine deselenation, 
shown in Figure 1.25, is initiated by the conversion of the protein-PLP species, 
bound via a conserved lysine residue, to a substrate-PLP Schiff base upon 
introduction of substrate. Within the active site the conserved lysine residue which 
binds PLP could act as base to abstract a hydrogen and then turn H-donor for the 
subsequent step. The sulfur is thought to be abstracted by a conserved cysteine 
residue, thus forming the protein bound persulfide and L-alanine, with the 
reformation of the protein-PLP species (6). Recently, the crystal structure of E. co/i 
IscS protein has been solved by Vickery et al. to a resolution of 2.1A. The structure 
displays a homodimeric form with specific residues from the adjacent monomer 
protruding into its partner, shown in Figure 1.26. The conserved cysteine residue 
which is required for catalysis is Cys328 and it may have a dual role, where it also 
acts as the "arm" to deliver the persulfide to a partner scaffold protein, 
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Figure 1.25 - Proposed mechanism of desulfuration of cysteine by N1fS like enzymes, lscS, CSD and CsdBISufS (6). 
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Figure 1.26 - The X-Ray crystal structure of E. co/i lscS (1P3W). Dimer shown, 
with monomerA coloured P sheets blue and a helices 	. MonomerB (grey) shows 
residues A1a237 and G1u334 highlighted in 	showing location of ends of 
disordered loop containing conserved Cys328 (13). 
which is presumed to be lscU/A (6, 149). The flexible nature of this "arm" 
containing Cys328 is emphasised by the location of the residue on a surface exposed 
disordered loop in the crystal structure. The termini of this disordered region lie at 
A1a327 and G1u334 (A 327 and E334 residues highlighted in Figure 1.26). The 
assumption is that although this essential residue is not resolved in the structure its 
N-terminal neighbour is, A1a327, thus Cys328 must lie approximatlyl7A from the 
active site and bound PLP. Modelling studies have shown that the extended loop 
could rotate to bring the y-sulfur atom of Cys328 to within 3A of the PLP, suggesting 
that large conformational changes occur during the catalysis process (13). 
The binding pocket of E. coli IscS shows a large similarity to the NifS. The PLP 
molecule sits at the base of a binding pocket which in turn is near the surface of the 
protein molecule (see Figure 1.26 and 1.27). The pocket is highly solvated and lined 
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with several charged or polar amino acids including His104, LyslO5, Asn155, 
Asp156, Tyr337 and Arg354. These residues are shown as space fill in Figure 1.27 
and it is important to note the imidazole ring of His 104 which is positioned directly 
below the pyridine ring of PLP. The PLP molecule is anchored into site via the 
conserved lysine residue, Lys206, via an internal aldimine Schiff base linkage as 
well as a number of polar and non-polar interactions. Hydrogen bonds (dashed green 
in Figure 1.27) are formed between phosphate oxygen's of PLP and the side chains 
of Thr76, Ser203 and His205 of that subunit one and Thr243 of the adjacent subunit 
(shown in italics). Additional hydrogen bonding occurs between the phenolate 
oxygen of PLP and G1n183 and between the pyridine N  of PLP and Asp 180. The 
structure is further stabilised by the hydrogen bonding of Asp 180 to side chains of 
Asp79, Thr182 and Ser201 (not shown) (13). 
One criticism of the proposal that BS is a PLP-dependant cysteine desulferase is that 
it lacks this typical PLP binding fold and that the lysine is surface exposed. However, 
all PLP-dependent enzymes undergo large conformational changes during their 
catalytic cycle and we must be careful not to rely on a single structure of [4Fe-4S], 
[2Fe-2S], DTB, SAM bound to BS. It is clear that more crystal structures of the 
protein in various stages of its reaction cycle (e.g. in the apo-form, and with 
methionine and biotin bound) will be required to fully understand the mechanism of 
DTB to biotin conversion. Certainly addition of PLP during the crystallisation 
process may provide important insight. 
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2111 
Figure 1.27 - Structure of the active site of E. co/i lscS (1P3W). PLP linked 
via Schiff base to the Lys206 anchor and hydrogen bonding residues shown 
as labelled. Atoms coded - CarbonGrey, Oxygen=Blue, Nitrogen= 
Phosphorous= 	. Charged and polar residues at bottom of binding 
pocket shown as space fill in dark yellow Hisl04, Lysl05, Asn155, Asp156, 
Tyr337 and Arg354. Termini of missing dis-ordered loop containing Cys327 
shown as ribbon in 
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1.8 - Mass Spectrometry based proteomics 
1.8.1 - Introduction 
Over the last 10 years the term proteomics has become synonymous with 
mass spectrometry based analysis of biological samples. In general the proteomics 
discipline can be described as " ...dealing with the large scale determination of gene 
and cellular function directly, at the protein level (150)." And encompasses a diverse 
range of techniques such as cell imaging, gene array technologies, genetic readout 
experiments such as the Yeast two-hybrid assay as well as mass spectrometry. 
The development of new 'soft' ionisation techniques in the late 1980's, 
namely electrospray ionisation (ESI) (151) and Matrix assisted laser desorption 
ionisation (MALDI) (152), led directly to further application of mass spectrometry. 
Previous to these new ionisation techniques analysis was limited to small 
themostable compounds only. ESI and MALDI enabled a much greater diversity of 
compounds, and pertinently for this thesis, led to the ability to generate gas phase 
biomolecules without excessive source fragmentation (153). These developments 
were rightly acknowledged with the 2002 Nobel prize for chemistry. 
These developments rapidly increased the power of mass spectrometry for 
research scientists and subsequently led to the development of new mass analysers 
and then to novel multistage MS/MS instruments (e.g. Q-ToF, ToF-ToF, QQQ etc). 
Mass spectrometry based proteomics is most commonly used as a technique 
for the characterisation and/or identification of proteins and peptides derived from a 
biological source, regardless of the biological question being asked. 
1.8.2 - Mass spectrometer basics 
In the simplest terms a mass spectrometer consists of 3 portions, a source 
region where the ions are generated, an analyser region where ions can be 
sorted/filtered based on the mass to charge ratio (m/z) and a detector which can 
detect an arrival of an ion (150). The range of analysers currently on the market is 
huge and diverse. Here we will briefly describe the three instruments used during this 
PhD work and explain the analyser configurations. 
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Waters-Micromass Platform I 
The Micromass Platform instrument is a mass spectrometer that contains an 
ESI source with a single quadrupole analyser. A schematic is shown in figure 1.28. 
The ions are generated in the ESI source region and passed to a quadrupole analyser 
before detection on the detector. 
The quadrupole consists of four parallel rods. The rods have a circular cross-
section and are equidistant from a central axis. A combination of DC and RF 
voltages are applied to the rods. Opposing rods have the same polarity (positive or 
negative); adjacent rods have opposite polarity. The combination of voltages 
separates ions on the basis of their mass-to-charge ratios (m!z). At a given set of 
voltages, only a single mlz value has a stable trajectory along the length of the rods 
allowing transmission to the detector (154). During data acquisition the DC voltage 
is continuously 'scanned' across voltages which allow the transfer of ions with in the 
required m/z range. At any given moment only an ion of a particular m/z will be 
passed through and thus detected, correlation between the time the ion was detected 
and the DC voltage applied provides the m!z and over the course of an experiment a 
picture is constructed of the component ions and there observed relative abundance. 
Applied Biosystems Voyager-DETM STR 
The ABI Voyager-DETM STR BiospectrometryTM Workstation is a MALDI-
TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometer 
that includes a reflector analyzer (TOF). A schematic is shown in Figure 1.28 
Time-of-flight mass spectrometry works on the principle that if ions are 
accelerated with the same potential from a fixed point and time and are allowed to 
drift, the ions will separate according to their mass-to-charge ratios. Lighter ions drift 
more quickly to the detector and heavier ions drift more slowly. Ions are formed in a 
field-free region, and a high voltage pulse is applied after a predetermined time delay 
to accelerate the ions into the TOF region. A reflector acts as an electrostatic mirror 
and in principle, ions with higher kinetic energy penetrate further into the reflector 
and therefore take longer to emerge, thus decreasing the spread of ion velocities as 
they reach the detector (154). The reflector improves resolution by narrowing the 
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spread of velocities for ions of the same m/z. All generated ions are pushed into the 
TOF region at once and the time of arrival at the detector after the push correlates to 
the mlz. 
Waters-Micromass QTOF 
The QTOF (quadrupole time-of-flight) instrument is a hybrid instrument and 
contains both a quadrupole and a time of flight analyser, as shown in Figure 1.28, 
and is equipped with an electrospray source. 
The instrument can be used in both MS mode (RF voltage only to quadrupole 
allowing passage of all ions) where m/z is measured in the TOF analyser and in what 
is known as MS/MS mode. In MS/MS the quadrupole DC voltage is set to allow 
transfer of only a specific mlz through, after this the filtered ion(s) are passed into the 
argon containing collision cell before mlz analysis in the TOF region. By increasing 
the energy supplied to the ions before entry into the collision cell the ions can be 
fragmented by a process called collision induced dissociation (CID) (154). 
With this process it is possible to select an ion from a mixture, a single 
peptide ion from a digestion for example, and obtain not only the m/z of the peptide 
but m/z of fragments which may allow structural information to be elucidated. In the 
case of peptides specific fragmentation pathways are favoured, predominantly at the 
amine bond, allowing a subset of the peptide sequence to be elucidated. 
B 
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Figure 1.28 . - General layout diagrams of mass spectrometry analysers. 
A - general MS; B - Micromass Platform I; C - Applied Biosystems 
Voyager DETMSTR;  D - Micromass Q-TOF 
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1.8.3 - Mass spectrometry of biomolecules 
The basic approaches to most proteomic applications can be separated into 2 
catagories. The analysis of 'intact' and the analysis of 'proteolytically digested' 
proteins, both of which can be extremely valuable in addressing specific problems. 
The application of the correct analysis can be both complementary and also provide 
specific information which is exclusive to that method. 
The analysis of intact proteins has been used to simply measure the mass of a 
protein, in the case of recombinant proteins confirm global amino acid composition, 
and more recently to look for possible post-translational modifications such as 
phosphorylation and glycosylations. In this instance single stage mass spectrometers 
are used such as single quadrupoles and TOF instruments (153, 155). However 
given the nature of protein ionisation the analysis using an electrospray source, 
compared to MALDI, provides much more convincing and accurate mass 
measurement. This is mainly due to the multiple charges that typically are observed 
when a protein is ionised by electrospray (151, 11). In this thesis all intact protein 
mass spectrometry analysis has been done on the Waters-Micromass Platform I 
instrument coupled to a Waters 2795 HPLC and the results are discussed in Section 
3.4. 
In contrast, the analysis of digested proteins can be performed using a variety 
of instrumentation, separation methods and sample preparation. Two-dimensional 
gel electrophoresis (2DE), itself a common technique for comparative studies for 
over 25 years was the first common entry point to MS analysis (150). The traditional 
method for protein regulation analysis done using 2DE gives quantative information 
based on changing protein spot patterns within the gel. However the subsequent 
identification was extremely time consuming until mass spectrometry provided a 
quick and reasonably reliable resolution. 
The general approach is to excise protein spot of interest, perform an 
enzymatic in-gel digestion of the protein before extraction of resultant peptides. 
These peptides are analysed using MALDI-TOF to produce a list of m/z ions which 
are characteristic of the protein (154, 150). The subsequent identification is achieved 
by a matching these ions with those predicted from an in-silico digestion of each 
protein from a database or subset. This method is known as peptide mass 
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fingerprinting (PMF) and is still the most common place method for protein 
identification (see Figure 1.29) (156). This technique has developed and now 
purification of proteins by other means (HPLC, CE etc.) are now commonplace as 
sample preparation for MALDI-TOF PMF analysis for protein identification. 
Identification by PMF is based on m/z only and the technique is mainly 
applicable to purified proteins only. Extra confidence in protein identification can be 
gained by using MS/MS capable instruments (e.g. QTOF) to obtain not only peptide 
masses but also a partial or full peptide sequence. This enables database 
searching/matching based not only on m/z of peptides but also on their sequence. 
This can greatly enhance the confidence in protein identification even when only one 
or two peptides are observed (see Figure 1.29). 
The need to identify proteins from only a few peptides is becoming more 
important as the desire to investigate increasingly complex samples is growing and 
integrated separations technologies are enhancing separation and hence increasing 
the ability to identify more components from highly complex samples. Identification 
of a protein based on a few peptides can also allow more information to be extracted 
from the analysis. For example, a peptide may have a post translational modification 
which alters the m/z and so will not be recognised from the database during a 
standard PMF search. However, the MS/MS spectra may provide the amino acid 
sequence of the peptide and hence the identity. Given the mass difference of 
expected to the observed it may be possible to putatively identify not only the 
modification but also the site of modification (see Figure 1.29) (155). 
The field of proteomics is constantly developing and further advances in 
sample preparation, instrumentation and informatics, all of which are an integral part 
of proteomics, continue to push forward what it is possible to routinely achieve. 
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Mass Spectrometry 
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- Identify Protein A 	 - Idntify Protein A 
Mass and seq. for pep. 1 
	
Mass for pep. 1 and 2. 
and 2. 
No match for mass 1498 
- Phos. of pep. 3. 
based on mass increase 
of 98 + peptide sequence 
Figure 1.29 - General proteomics workflow showing both mass 
spectrometry and informatics input. Highlights the difference inceased 
confidence (peptide sequence information) and additional information 
(possible modifications) gained from MS/MS acquisitions. 
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2.1 - General Reagents 
All chemicals were purchased from Sigma-Aldrich, Amersham Pharmacia, 
Gibco BRL, New England Biolabs, Waters, or Invitrogen unless specifically stated. 
All reagents purchased were of appropriate quality for their use. 
2.2 - Solutions and Buffers 
Ampicillin - Stock solution of 100 mg/mi which was sterile filtered (0.45 rim) and 
was used at a final concentration of 100 .tg/ml and stored at 4°C. 
Kanamycin - Stock solution of 30 mg/ml which was sterile filtered (0.45 tm) and 
was used at final concentration of 30 .tg/ml and stored at 4°C 
Ethidium Bromide - A 10 mg/ml stock was made and used at final concentration of 
5 .tg/ml, stored at 4°C in a dark bottle. 
IPTG - A 100 mM stock solution of Isopropyl J3, D - thiogalactopyranoside was 
made and used at final concentration of 1 mM, filter sterilised and stored at 4°C. 
Buffer A - Imidazole (5 mM), sodium chloride (500 mM), Tris-HCI (20 mM, pH 
7.9) 
Buffer B - Imidazole (1 M), sodium chloride (500 mM), Tris-HC1 (20 mM, pH 7.9) 
Buffer C - Tns-HCI (50 mM, pH 7.5) 
Buffer D - Tris-HCI (50 mM, pH 7.5) +2 M NaC1 
SIDS sample buffer - Tris-HC1 (0.5 M, pH 6.8, 1 ml), Glycerol (2.0 ml), SDS (10% 
w/v, 1.6 ml), 2-3-mercaptoethanol (0.4 ml), bromophenol blue (0.05% w/v, 2.0 ml) 
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TAE - Tris-HC1 (40 mM, pH 8.0), acetic acid (57.1 ml), EDTA (0.5 M, pH 8.0, 100 
ml) 
2D electrophoresis solutions and buffers 
Cell lysis solution (stock)— 8 M Urea (19.2 g), 4% (w/v) CHAPS (1.6 g), 40 m Tris 
base (0.194 g), double distilled water to 40 ml. Stored in I ml aliquots at minus 
20°C. 5 .tl of appropriate IPG buffer (Amersham Pharmacia) and 2 mg of DTT is 
added prior to use. 
IPG strip rehydration buffer - 8 M Urea (12 g), 2% (w/v) CHAPS (0.5 g), 
Bromophenol blue trace (a few grams), Double distilled water to 25 ml. Stored in 2.5 
ml aliquots at -20°C. 7 mg DTT and 50 j.tl of appropriate IPG buffer (from 
Amersham Pharmacia) are added prior to use. 
SDS equilibration buffer - 50 mM Tris HC1 (1.21 g) pH 8.8, 6 M Urea (72.07 g), 
30% (v/v) Glycerol (69 ml), 2% (w/v) SDS (4.0 g), Bromophenol blue trace (a few 
grains), double distilled water to 200 ml. Stored in 10 ml aliquots at -20°C. Either 
100 mg of DTT or 800 mg iodoacetamide is added to 10 ml prior to use. 
Solutions for In-Gel digestion of protein- 
100 mM ammonium bicarbonate 
50 mM ammonium bicarbonate 
20 mM ammonium bicarbonate 
50% acetonitrile 
5% formic acid in 50% acetonitrile 
200 tg trypsin in 200 jil 50 mM ammonium bicarbonate 
2 .ig AspN in 200 p.1 50 mM ammonium bicarbonate 
10 mM DTT, 0.02% EDTA in 100 mM ammonium bicarbonate 
50 mM iodoacetamide in 100 mM ammonium bicarbonate 
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Solutions of ZipTip procedure - 
Wash - H20 + 0.1% trifluroacetic acid 
Wet! Elution - Acetonitrile : H20 (1:1) + 0.1% trifluroacetic acid 
Matrix solutions for MALDI-MS - 
CHCA - Saturated solution of a-cyano-4-hydroxycinnamic acid in Acetonitrile 
H20(1:1) + 0.1% trifluroacetjc acid. 
Sinapinic - Saturated solution of sinapinic acid in Acetonitrile : H20 (1:1) + 0.1% 
trifluroacetic acid. 
Dithionite / EDTA for [Fe-Si cluster reduction - 100 times stock, 50 mM Tris-
HC1, pH7.5, 5% glycerol, EDTA (480 mM). Degassed with N 2 for >2h, dithionite 
added to final concentration of 480 mM in anaerobic glovebox. Buffer used within 
30 min of addition of dithionite. 
2.3 - Media 
Agar Plates - 15 g agar per litre was added to specified media, 1000 times' stock 
antibiotic of choice added and approximately 25 ml poured into sterile Petri dish, 
stored at 4°C. X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) was 
added to agar at 1 j.ig!ml final concentration. 
2YT - bacto-tryptone (16 g), bacto-yeast extract (10 g), sodium chloride (5 g) were 
dissolved in one litre of water and pH adjusted to 7.5, autoclaved (121°C, 15 mm, 15 
psi). 
Luria Bertani (LB) - Tryptone (10 g), yeast extract (5 g), sodium chloride (10 g), in 
one litre of distilled water and pH adjusted to 7.5 with sodium hydroxide. 
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2.4 - Bacterial Cell Lines 
Cell Line Genotype Reference 
F'; traD36; 	A(lacZ); proKB / supE thi; A(Iac- (157) 
JM101 
proAB) 
F'; traD36; Jac;  A(lacZ); proAB I e14- (McrA-);A  
JM109 (lac-proAB); Thi gyrA96 Na,'); endAl; hsdR17 (rk 
mk), relAl; supE44; recAl 
(F; mcrA; A(mrr-hsdRMS-mcrBC) ct80IacZAM15;  
ToplO 
(Invitrogen) 
A/ac X74; deoR; recAl; araD 139; A(ara-Ieu)7697; 
gaIU; ga/K; rpsL; endAl; nupG. 
HMS174 (DE3) F; recAl (rk12 	rkl2); Rif (DE3), a X prophage  
(Novogen) carrying the 17 RNA polymerase gene 
BL2I (DE3) F; ompT LSdSB (rB MB- ) gal dcm(DE3)  
(Novogen) 
2.5 - DNA Vectors and Plasmids 
Vector used for initial cloning and storage of genes was pCR2.1 
TOPO cloning vector, which contains a precut TA overhang for direct cloning 
of PCR products, an ampicillin and kanamycin resistance gene. 
Plasmids used for expression of proteins were, pET16b (Phenotype : amp'; 
T7 promotor; Factor Xa protease cleavage site), pET6H (Phenotype: amp'; 
17 promotor: Factor Xa protease cleavage site; N-terminal 61-lis sequence), 
pHisBS (H is6-biotin synthase), pC53/57S, pC53I60S, pC57/60S, 
pC53/57/60S, pK49Q, pK49R, pBSN tem,, (N twm His6-tagged BS mutants, 
Amp selection) and pBS-C, (deletion mutant BS with Kan selection). 
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2.6 - Oligonucleotide primers 
The following oligonucleotide primers were custom made by Sigma-Genosys, 
restriction sites in bold, codon changes underlined, stop codon highlighted in grey, 
methionine start highlighted in green. 
BioBfor - 5'-GGTAAAACC 	GCTCACCGCCCA-3' 
BioBrev - 5 '-GGATCCTCATAATGCTGCCGC-3' 
C53S - 5'-AAGACCGGAGCTTCCCCGGAA-3' 
C57S - 5'-CCGGAAGATTCTAAATACTGCCCG-3' 
C60S - 5'-AAATACCGCAAACGTCGCGC-3' 
MI3for - 5'- GTTGTGTGGAATTGTGAGCGG -3' 
MI3rev - 5'- CGCCAGGGTTYFCCCAGTCACG -3' 
BSNterm_rev - 5 '-GGATCCTCAATCATCGTTATCGGCAAG-3' 
BSCterm_for - 5'-CC 	GTCGATGCCTFTGATTVFATT-3' 
BioBfor contains NcoI restriction site for cloning and Met start codon, BioBrev 
contains BamHI restriction site for cloning and TCA stop codon. BioBrev contains a 
BamHI restriction site for cloning and a stop codon. C53S, C57S and C60S all 
contain 3 base pair mutations encoding a cysteine to serine amino acid sequence 
change. M13for and Ml3rev were using for sequencing of genes from PCR2.1 
vector. 
2.7 - Equipment 
Denley BR401, Micro centrifuge Spectrofuge 16M and Sorvall RC-5B 
centrifuges were used for all centnfugations. Unicam UV/Vis spectrometer UV4, 
Labnet Thermolyne G 1 gyrorotory shaker used for cell culture. Horizontal running 
frame (Berthesda Research Labs, Model H5) for Agarose Gel electrophoresis, 
vertical running frame (Bio Rad Labs), power packs (Machem PSU 400/200, Bio 
Rad Power pac300), precast Nu-PAGE gel running apparatus (Invitrogen) for gel 
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based ID protein electrophoresis. IPGphor (Amersham Pharmacia), Mutiphor II 
(Amersham Pharmacia) used for 2D gel based protein electrophoresis. Mass 
Spectrometry was performed on Micromass Platform 1 equipped with online waters 
HPLC-2690, Voyager DETm SIR Mass Spectrometer (ABI) and Micromass Q-ToF1 
with Nanospray and ESI sources. 
2.8 - Transformation of Competent Cells 
Competent cells are stored at -80°C, 25 tl aliquot of required cells are 
defrosted on ice. 2 tl of plasmid DNA is added to cells and incubated on ice for 10 
min to 30 mm, cells heat shocked at 42°C for 30 sec and returned to ice for 2 mm. 
250 tI of SOC media is added and shaken at 250 rpm and 37°C for 1 hour. 25-250 l.tl 
of cells are spread to dryness on selected agar plate (161). 
2.9 - Plasmid DNA preparation 
Cells transformed with required DNA, were grown up in 10 ml of 2YT broth 
with appropriate selective antibiotic. Cells harvested by centrifugation and DNA 
purified with Qiagen plasmid DNA Mini Prep Kit. The plasmid DNA stored in 
ddH20 at -20°C. 
2.10- Restriction endonuclease digestion of DNA 
Typically, the required amount of DNA (0.5 .tg to I tg) was treated with 
required restriction endonuclease in appropriate buffer for 1 to 3 hours at 37°C 
(amount of enzyme and buffer as advised by manufacture). Blue/orange loading dye 
(10 times stock) added to incubation mixture prior to agarose gel electrophoresis 
(161). 
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2.11 —Agarose Gel Electrophoresis 
The required amount of molecular biology grade agarose was added to 100 
ml of TAE buffer and heated to 100°C for the agarose to dissolve (typically 1 g per 
100 ml buffer produces a 1.0% Gel). The solution was cooled to -50°C before 5 .t1 
of stock ethidium bromide was added (final concentration of 5 gg/ml) and poured 
into mould and allowed to set at RT. The DNA fragments were visualized under UV 
light, and sizes gauged using standard markers Hyperladder I and IV (Bio-Line) 
(161). 
After visualisation excised DNA bands were purified from gel using Qiaprep gel 
extraction kit (Qiagen). 
2.12 - PCR amplification and mutagenesis of DNA 
All PCR and sequencing reactions were performed in Perkin Elmer 480 
thermal cycler. PCR reactions set up in 0.5 p.1 PCR tube as follows. 
1 p.1 template DNA, 
1 p.1 forward primer, 
1 p.1 reverse primer, 
39 p.1 ddl-120, 
2 Ready-to-Go PCR beads (Taq Polymerase; Amersham Biosciences). 
The reaction was overlaid with mineral oil and cycled 30 times for Imin at 
95°C, required extension time (lkbase/min) at 54°C. The PCR product subjected to 
Agarose gel Electrophoresis and purification as in Section 2.11. In mutagenic PCR 
reactions, the first PCR used as reverse Mega primer in subsequent PCR reaction 
(162). 
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2.13— Automated DNA sequencing 
Automated DNA sequencing was carried out on an ABI prism 377 DNA 
sequencer using the Sanger dideoxy chain termination method. The following was 
combined in a 0.5 ml PCR tube, 
template DNA (2 tl), 
primer (1 j.il), 
ddH20 (13 .tl), 
BigDye sequencing mix (4 tl, PE Biosystems). 
The reaction was overlaid with mineral oil and incubated at 95°C for 30 sec, 54°C 
for 15 sec and 72°C for 4 min which was cycled 30 times. Sequencing 
chromatograms were analysed with Vector NTi - Contig Xpress software. 
2.14 - Cloning into Plasmid Vectors 
PCR products were cloned into pCR2. 1 vector (Invitrogen) and then 
restriction endonuclease-digested DNA was cloned into complementary cut 
expression plasmid DNA such as pET plasmids (see Section 2.10). PCR products 
were purified by Agarose Gel Electrophoresis (see Section 2.11) and the following 
were combined in a 1 ml Eppendorf tube; purified insert DNA (3 p1), Salt solution (1 
j.il), pCR2.1 vector (1 tl). The ligation reaction was incubated at room temperature 
for 10 to 30 mm, and 2-4 p1 of the reaction used to transform Top 10 E. coli cells and 
the transformation mixture spread on an X-Gal-LB-amp plate. Positive colonies were 
identified by Blue/White screening. 
Restricted DNA (vector and insert) were combined in 1 ml tube as follows, 
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Insert DNA (14 ml), 
vector DNA (2 ml), 
T4 DNA ligase (2 ml), 
10 times T4 DNA ligase buffer. 
The ligation reaction was incubated at RT for > 16 hours and used to transform 
Top 10 E. co/i cells. Positive clones were identified by restriction digest analysis and 
agarose gel electrophoresis. 
2.15- ID SIDS Poly Acrylamide Gel Electrophoresis 
The discontinuous buffer system of Laemmeli (163) was used to analyse proteins on 
a molecular weight basis via SDS poly acrylamide gel electrophoresis. 
The NuPAGE system (Invitrogen) of precast gels were also used where appropriate. 
2.16 - Small Scale Induction of Protein Expression 
A freshly transformed single colony from agar plate was used to inoculate 2 
ml of 2YT broth with appropriate selective antibiotic in a 25 ml universal tube. The 
culture was grown (37°C, 250 rpm shaking) to an 0D 600 = 1.0 (4 to 5 hours), 1 ml 
aliquot removed as control and placed in fresh tube and protein expression induced in 
remaining aliquot with the addition of 1 mM final concentration IPTG and grown for 
a further 3 hours. 250 .tl of each were centrifuged (13k rpm, 2 mm) and the 
supernatant was discarded, the pellet resuspended in SDS-sample buffer (250 PI), 
boiled for 5 min and 15 to 25 .tl loaded onto SDS-PAGE (see Section 2.15). 
2.17- Preparative Induction of Protein Expression 
Routinely 4 litre growths were performed in 8 one litre shake flasks as 
follows. A freshly transformed single colony from an agar plate was used to 
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inoculate 500 ml of 2YT broth with appropriate selective antibiotic in a I litre shake 
flask. The culture was incubated (37 °C, 250 rpm shaking) for approximately 16 
hours. A I ml aliquot was removed as control, and protein expression was induced 
with the addition of 1 mM final concentration of IPTG and incubated (37 °C, 250 
rpm shaking) for a further 3 hours. The cell pellet was harvested by multiple 
centrifugation steps (5k rpm, 10 mm) and the final wet cell paste weight calculated 
(typically 25 g from 4 litre growth). 
2.18— Preparation of Cell Free Extracts 
The wet cell pellet was fully re-suspended in 3 times wet weight of 
appropriate chromatographic binding buffer and cell lysis performed by sonication at 
4 °C for 15mm (power on for 30 sec off for 30 sec). A Cell Free Extract (CFE) was 
obtained by two subsequent centrifugation steps (2 times 25 min at 20k rpm). CFE 
was 0.45 .tm sterile filtered before addition to any chromatographic column. 
2.19 - Purification of 6His-BS and histidine tagged BS 
mutants 
Large scale preparation of 6His-BS was done using BL21(DE3) or 
EMS 1 74(DE3) pHisBS transformants according to procedure set out in Section 2.17. 
6HisBS CFE was prepared in BufferA (Section 2.2) ready for binding to HiTrap ® 
chelating affinity column (Amersham-Pharmacia). The HiTrap®  column was pre-
charged with Ni 2 (Flow rate 2 ml/min at 4 °C, 3 CV ddH20, 5 CV 100 mM NiSO4 , 
3 CV Buffer A) and CFE loaded onto the column at 4 °C with a flow rate of I 
ml/min. The column was washed with 5 CV of Buffer A and protein eluted with a 50 
CV gradient from 100% Buffer A to 100% Buffer B. Fractions containing 6HisBS 
protein typically eluted in the region of 200 mM imidazole and purity was judged by 
SDS-PAGE and concentration by 0D280. Fractions containing pure 6His tagged 
protein were immediately dialysed vs. Buffer C and aliquots stored at -20 °C. 
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6HisBS mutants were also produced and purified using the same method as 
described above. 
2.20 - Anaerobic preparation of apo-6HisBS 
Approximately 40 mg of purified 6HisBS was concentrated to 400 tM using 
a 30kDa c.o. centrifugal concentrator (Vivascience). The concentrated protein and 2 
aliquots (25 ml and 3.5 ml) of Buffer C (50 mM Tris-HC1, pH7.5) were 
deoxygenated by bubbling with N2 for> 2 hours. EDTA!Dithionite buffer was also 
prepared in parallel (See Section 2.2). All buffers were transferred to N2 glovebox 
and 25 p.1 of 100 times EDlAfDithionite buffer added and incubated in glovebox at 
RT for 16-20 hours. 
Reduced apo6HisBS was desalted and buffer exchanged using a PD1O gelfiltration 
column (Amersham-Pharmacia), 25 ml deoxygenated Buffer C used to equilibrate 
column, 2.5 ml protein sample loaded and eluted with 2.5 ml deoxygenated Buffer C. 
Sample removed from Glovebox and stored at -20°C (68, 164). 
2.21 - PLP loading of 6H1sBS and reduction of internal 
aldimine 
Aliquots of 6HisBs (2.5 ml protein, approx 25 p.M) were freshly loaded with 
PLP by dialysis verses two changes of 3 litres of Buffer C + 100 p.M PLP for 2 hours 
each. Unbound PLP was removed by gelfiltration using disposable PD1O GF column 
(Amersham-Pharmacia, 25 ml equilibration, 2.5 ml sample and eluted with 3.5 ml) 
using Buffer C without PLP. If required, reduction of the protein-PLP internal 
aldimine was performed with DTT, final concentration 10 mM. 
2.22 - Analytical Native Protein Chromatography 
All native protein chromatography experiments (Gel Filtration and Ion 
Exchange) were run on AKTA Basic (Amersham-Pharmacia) at RI and concurrently 
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monitored at 280 rim, 330 nm and 425 nm wavelengths. Identity of elution species 
were confirmed by SDS-PAGE mass spectrometry. Columns used were MonoQ 
(anion exchange) and Superdex 200 (gel filtration) and were purchased from 
Amersham-Pharmacia. 
2.23 - Two Dimensional SDS-Poly Acrylamide Gel 
Electrophoresis 
2.23.1 - Cell Extract preparation 
Typically 108  cells (1 ml of culture 0D 600 = 1.0) were pelleted by 
centrifugation (13k rpm, 5 mm) and were resuspended in 1 ml of Cell Lysis buffer 
(see Section 2.2) vortexed vigorously for 20 min followed by sonication in bath for 5 
mm. The Cell Extract was cleared by centrifugation (14k rpm, 30 mm) and the 
supernatant removed and stored at -20 °C or -80 °C. 
2.23.2 - Immobilized pH Gradient Isoelectric Focusing (ID) 
The cell extract defrosted on ice and 20 j.il added to 180 t1 of IPG strip 
rehydration solution (See Section 2.2, with appropriate IPG ampholyte mix and DTT 
added) and mixed by inversion. The entire 200 lii  was loaded to IEF running coffin 
and dehydrated strip placed gel side down on top ensuring no air bubbles are present 
and gel is in contact with electrodes. Sample and strip are covered with Dry Strip 
cover fluid and rehydration/JEF protocol performed using IPGphore at 20 °C. 
Step Time - h 	Voltage - V 
Rehydration 12 30 
IEF — stepi 1 	 150 
— step 2 1 300 
— step 3 1 	 600 
— step 4 1 1200 
— step 5 I 	 2400 
— step 6 4 8000 
Total= 	37,000Vh 
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Strips were equilibrated for SDS-PAGE immediately or stored at -20°C for 
subsequent use. 
2.23.3 - SDS-PAGE of Isoelectric Focused Cell Extract (213) 
Focused IPG strips were incubated in 25 ml SDS equilibration buffer firstly 
with DTT added, secondly with iodoacetamide and finally with no addition for 10 
min each. Equilibrated strips were placed gel side down onto precast, 0.5 mm Excel 
Gel on MultiPhore (Amersham-Pharmacia) with gel-buffer strips and run for 15 mm 
at 30 mA and 600 V (constant 20 °C) until the coomassie dye front had fully entered 
SDS gel. The strip was removed and gel run for approximately 2 hours at 50 mA, 
600 V until coomassie dye front had run from bottom of gel. Backed gel removed 
from MultiPhore and fixed immediately with 10% acetic acid, 40% Ethanol, 50% 
ddl-{20 to allow subsequent staining. 
2.23.4 - Staining of 213imensional Gels 
All gels were equilibrated for staining with 70% methanol 7% acetic acid 
23% H20 for 30 mm. Colloidal coomassie staining was performed with GelCode 
(Pierce) as per manufacturers' instructions. When required silver staining was 
achieved using the Plus-One Silver Stain kit (Amersham-Pharmacia) utilising Mass 
Spec compatible modified protocol (No glutaraldehyde of formaldehyde). 
2.23.5 - Analysis of 2D Gels 
Gels were scanned and analysed using the Genomic Solutions "Analyzer HT 
Investigator" software and target protein spots identified. 
2.24 - Enzymatic Digestion of Protein 
2.24.1 - In Gel Digestion 
The area of interest from the gel (ID band or 2D spot) was excised with a 
clean scalpel, placed in a clean sterile 1 .5m1 tube and dried in a GyroVap for 30 mm. 
Gel pieces were treated as follows, solutions described in Section 2.2. Gel pieces 
were washed twice with 50% acetonitrile for 5 min followed by 30 min drying in 
S. 
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GyroVap. Samples were reduced with DTTIEDTA solution for 30 min at 56 °C 
followed by alkylation of cysteines with iodoacetamide solution for 30 min in dark. 
Samples were dried in GryoVap before addition of 5-10 j.tl of required 
endoproteinase (e.g. trypsin). After 15 min 50 il 50 mM ammonium bicarbonate 
added and incubated for 16 hours at 37 °C. Digestion liquid was removed and dried 
in GyroVap and stored at -20 °C. 
2.24.2 - Solution Digestion 
Large scale total enzymatic digestion of protein samples was performed by 
precipitation of protein with 50% acetone 10% trichloroaceticacid (TCA) for 30 mm 
at 4 °C; sample was centrifuged for 30min at 14k rpm and supernatant removed. The 
protein pellet was washed 4 times with -20 °C acetone and resuspended in 50 mM 
ammonium bicarbonate. Samples were reduced and cysteines alkylated with DTT 
and iodoacetamide if required followed by addition of endoproteinase at final 
concentration suggested by manufacturer. The digested protein solution stored at -20 
OC. 
2.25 - Limited Digestion of Native Protein 
A protein solution (typically Tris-HC1, pH7.5) was incubated with 
endoproteinase for required amount of time and reaction stopped by addition of SDS-
PAGE sample buffer and boiling for 5 min or protein precipitation by addition of 
50% acetone + 10% TCA at 4°C for 1 hour. Samples were analysed by SDS-PAGE, 
HPLC RP chromatography and Mass Spectrometry. 
2.26 - UV-Visible Spectroscopy 
UV-Visible spectra were measured on a Unicam UV/Vis spectrometer UV4 fitted 
with diode array using 0.5 ml quartz cuvettes and scans were performed between 250 
nm and 600 run. 
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2.27 - HPLC Reverse Phase Chromatography 
All reverse phase chromatography was performed on Gilson 306 HPLC, mobile 
phase was suitable grade H20 + 0.1% trifluroacetic acid (Buffer X) and acetonitrile 
(AcN) + 0.1% trifluroacetic acid (Buffer Y) at a flow rate of 0.5 mllmin. Columns 
were equilibrated with Buffer X and after sample loading 2.5 ml Buffer X used to 
wash unbound species from column before a 5 to 95% Buffer Y gradient. Columns 
used were Luna 5 j.im C 18(2) 250 mm x 4.6 mm, Luna 5 tm C8(2) 150 mm x 5 mm 
and Jupiter 5 tm 300 A C5 150 mm x 2mm and purchased from Phenomenex. 
2.28 - Liquid Chromatography Mass Spectrometry (LC-
MS) 
Electrospray mass spectrometry (ESI-MS) was performed on a Micromass Platform I 
single quadrupole mass spectrometer equipped with an electrospray ion source. The 
system conditions were first optimised with Horse Heart Myoglobin a further 
optimised with repeat injections of protein under analysis. The spectrometer cone 
voltage was set to 70 volts and source temperature to 65°C. Protein samples were 
separated on a Waters HPLC 2690 with Phenomenex CS reverse phase column 
directly connected to the spectrometer. The proteins were eluted from column with 
0.01% TFA and a 5% to 95% acetonitrile gradient at a flow rate of 0.2 ml/min and 
0D280 measured. Total ion current was measured from 500 to 3000 mlz. The protein 
peak scans were combined and average molecular mass was determined from the 
protein ion envelope by the MaxEnti and Transform algorithms of the Mass Lynx 
software (Waters-Micromass). 
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2.29 - MALDI-T0F Mass Spectrometry 
Samples for MALDI-ToF analysis were co-crystallised with Matrix solution (Alpha-
Cyano-4-hydroxy cinnamic acid (CHCA) or Sinapinic acid (see Section 2.2), directly 
on MALDI plate. MALDI-ToF peptide mass fingerprinting (PMF) was performed on 
an Applied Biosystems Voyager DE-STR. 
Peptide spectra were acquired using CHCA matrix and instrument in reflectron mode 
with delayed extraction and positive polarity. Spectra were acquired in the range of 
500-3500 Da with the low mass gate set at 500 Da. Other variables were set as 
follows, Accelerating voltage = 20,000V, Grid voltage = 65%, Mirror voltage ratio = 
1.12, Extraction delay time = 170 nsec. Typically 500 shots per spectra were taken 
and a minimum 1000 shots were taken for each sample combined an analysed using 
the DataExplorer software from Applied Biosystems. 
Protein spectra were acquired using Sinapinic acid Matrix and instrument in linear 
mode with delayed extraction and positive polarity. Spectra were acquired in the 
range of 500-45,000 Da with the low mass gate set at 500 Da. Other variables were 
set as follows, Accelerating voltage = 25,000 V, Grid voltage = 96%, Guide wire = 
0.15%, Extraction delay time = 800 nsec. Typically 100 shots per spectra were taken 
and a minimum 400 shots were taken for each sample combined an analysed using 
the DataExplorer software from Applied Biosystems. 
2.30 - Q-ToF Mass Spectrometry and Collision Induced 
Fragmentation MS/MS 
2.30.1 - Nanospray Q-ToF MS 
Samples were desalted prior to analysis using ZipTip (Millipore) according to 
manufacturers' instructions. Micromass Q-ToF I mass spectrometer was fitted with 
nanospray source and samples were sprayed in 50% acetonitrile + 0.1% TFA from 
Ag coated borosilicate capillary needles (Proxeon). Capillary voltage optimized for 
maximum signal intensity between 1000 and 2000 V with cone voltage set at 65 V. 
Argon was used as fragmentation gas which was set at 4 kV for all MS' acquisitions 
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and data was acquired from 500 to 3000 rnlz with. When CID MS 2 was required the 
quadrupole RF set to transmit monoisotopic mass and 3 isotope peaks of species 
under study, fragmentation energy was increased to give optimum fragmentation 
pattern (up to 40 kV) and data acquired from 50-3000 mlz. 
2.30.2 - Electrospray Q-ToF MS 
The Micromass Q-T0F I mass spectrometer was fitted with ESI standard 
source and samples from HPLC were directly infused with a flow rate of 5 Al/min, 
capillary voltage was set to 3000 V and cone voltage to 65 V. Argon was used as 
fragmentation gas which was set at 4 kV for all MS' acquisitions and data was 
acquired from 500 to 3500 mlz. When CID MS 2 was required the quadrupole RF set 
to transmit monoisotopic and 3 isotope peaks of species under study, fragmentation 
gas increased to give optimum fragmentation pattern (up to 40kV) and data acquired 
from 50-3000 m/z. 
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3.1 - Production of Biotin Synthase Mutant DNA 
Previous work done by McIver et al. (87) has yielded a variety of vectors 
containing the E. coil bloB gene and the pET16b/BioB was chosen as template DNA 
for the site directed mutagenesis performed using the mega primer method (165). 
The BioB gene contains a natural NcoI (CCATGG) site at the 5' end incorporating 
the methionine start codon ATG. A BamHI (GGATCC) site was engineered at the 3' 
end of the gene during the initial amplification and cloning reactions thus all 
subsequent cloning was done using NcoI and BamHl restriction sites. 
Previous work has demonstrated that the highly conserved 'cys box' motif, 
CX3CX2C, is the site of [Fe-S] cluster binding and single mutations at these 
conserved cysteine residues to serine significantly reduced the ability of the protein 





















Figure 3.1 - Representation of the plasmid pETl6b/bioB (6681 bp) 
containing the 1041bp bioB gene cloned using the NcoI/BamI-ll cloning 
sites 
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QVQVSTLLSITGACPED KY: PQSSRYKTGL 
QVQVSTLLSITGASPEDtKY :PQSSRYKTGL 
QVQVSTLLSITGA PEDSKYPQSSRYKTGL 
QVQVSTLLSI TGA PEDCKYSPQSSRYKTGL 
QVQVSTLLSI TGASPEDSKY:PQSSRYKTGL 
QVQVSTLLSI- TGASPED KYSPQSSRYKTGL 
QVQVSTLLSI:TGA PEDSKYSPQSSRYKTGL 
QVQVSTLLSIYTGASPEDSKYSPQSSRYKTGL 
QVQVSTLLSIQTGA PED KY IPQSSRYKTGL 
QVQVSTLLSIRTGA PED KYPQSSRYKTGL 
Figure 3.2 - Alignment of wild type biotin synthase with all constructed mutants. 
Residues as wild-type shown in and mutated residues in blue. Residues mutated 
are lysine 49 (K49), cysteine residues 53, 57 and 60 (C53, C57 and C60). 
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Figure 3.3 - Representation of the two possible products, forward and reverse 
configurations, of the PCR2.1 TA-TOPO cloning reaction to produce PCR2.1/bioB. 
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The residues in E. co/i biotin synthase demonstrated to bind [Fe-S] clusters are 
cys53, cys57 and cys60 and this study complements the mutagenesis of these 
residues by mutatation of the gene to include multiple Cysteine to Serine mutations 
within the 'cys box' attempting to further disrupt the cluster binding capacity of the 
subsequent protein. 
A complete complement of double and the triple mutants genes were constructed as 
shown in Figure 3.2 using the mega-primer method (165). The resultant PCR 
amplified mutant bioB genes were successfully ligated into the pCR2.1 TA-TOPO 
cloning vector (Invitrogen) as shown in Figure 3.3. 
Other mutants constructed were lysine 49 mutations to glutamine and arginine for 
analysis of the cysteine desulfurase activity of biotin synthase as described in Section 
3.3. These were constructed in the same manner as the cysteine mutants and are also 
shown in Figure 3.2. 
The pCR2. 1 vector containing the BS WT and mutant genes were subjected to 
restriction digest analysis with BamHI to ascertain the direction of cloning and 
subsequently was successfully sequenced by automated DNA sequencing as 
described in Section 2.13 and the mutant sequence confirmed as those described in 
Figure 3.2, thus taken forward to expression and purification. 
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3.2 - Expression and Purification of 6HisBS WT and 
Mutants 
The wild type and mutant genes as described in Figure 3.2 were excised using 
restriction enzymes from their corresponding pCR2. 1/bioB plasmids and cloned in to 
pET6His, cut with the same enzyme, using the NcoL/BamHI restriction site to 
produce pET6His/bioB and corresponding mutants as shown in Figure 3.4.The 
pET6His plasmid contains an ampicillin resistance gene (Apr)  for selection and the 
bioB gene is under the control of the strong bacteriophage T7 transcription and 
translation signals and expression is induced with addition of IPTG. When cloning 
with 5'-terminus NcoI site the plasmid also yields a protein with an 8 residue 
extension at the N-terminus, namely MHHHHHHA, containing the 6 histidine tag 
which enables quick one step purification of protein via Immobilised Metal Affinity 
Chromatography (IMAC) on a Ni 2 resin.. 
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pET6His / bioB WT 
pET6I-Iis / bioB C53/57S 
pET6His / bioB C53/60S 
pET6His / bioB C57/60S 
pET6His / bioB C53/57/60S 
pET6His / bioB K49Q 
pET6His / bioB K49R 
Figure 3.4 - Representation of expression plasmid used for biotin synthase and mutants. 
Contains an ampicillin resistance gene and 17 promotor controlling the protein 
expression and yields protein with N-terminal Histidine tag. 
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Production of wild-type and mutant proteins were performed in BL2 I (DE3) and 
HMSI74(DE3) cells which both yeilded high expression levels. However, 
HMS 1 74(DE3) cells were used routinely. Optimum expression levels were found 
using 2YT and ampicillin (100 tgIm1) broth at 37°C and when protein expression 
was induced using 1 mM IPTG as described in Section 2.17. Proteins were purified 
via IMAC as previously described (87) and eluted at approximately 200 mM 
imidazole. 
The purity of the protein was judged by SDS-PAGE (Figure 3.5) and this showed 
that biotin synthase eluted greater than 95% pure in this single step and so for a 
majority of applications no further purification was performed. Routinely we were 
able to purify 30-40 mg of wild-type biotin synthase per litre of cell culture within a 
single day and the purified protein was stored in 10 mg aliquots at -20 °C. 
M 9 10 11 12 13 14 15 16 17 18 19 
U w • -- 
Figure 3.5 - SDS-PAGE of elution fractions from purification of 6HisBS from 
Hilrap column. Fractyions 14 to 17 combined and dialysed to remove 
imidazole.. Lane M shows SeeBlue2 molecular weight marker (Invitrogen) 
[200kDa = Myosin, I l6kDa = 13-galactosidase, 97kDa = Phosphorylase b, 66kDa = BSA, 55kDa = 
Giutamic dehydrogenase, 36kDa = Lactate dehydrogenase, 31kDa = Carbonic anhydrase, 21kDa 
= Trypsin inhibitor, 14kDa = Lysosyme, 6kDa = Aprotinin, 3,5kDa = unresolved insulin] 
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M A B C D E F  
In 
Label Protein Typical yields per litre culture (mg) 
A WT 20 
B C53/57S 15 
C C53/60S 20 
D C57/60S 10 
E C53/57/60S 10 
F K49Q 15 
G K49R 15 
Figure 3.6 - SDS-PAGE of purified biotin synthase and mutants A to G 
and yields shown in table for 1 litre of culture. Lane M shows SeeBlue2 
molecular weight marker (Invitrogen) [200kDa = Myosin, 116kDa = 3-gaIactoside, 
97kDa = Phosphorytase b, 66kDa = BSA, 55kDa = Glutamic dehydrogenase, 36kDa = 
Lactate dehydrogenase, 31 kDa = Carbonic anhydrase, 21 kDa = Trypsin inhibitor, 14kDa = 
Lysosyme, 6kDa = Aprotinin, 3,5kDa = unresolved Insulin] 
All biotin synthase mutants were purified using the same method and elution profiles 
were comparable to wild-type biotin synthase however total protein yield generally 
decreased between wild-type and mutant expression and varied from 15-30 mg per 
litre of cell culture depending on mutant (inset Figure 3.6). All proteins were again 
judged for purity by SDS-PAGE (See Figure 3.6) and concentrations estimated by 
Bradford assay (166) using BSA as a standard. 
After purification all proteins were dialysed against Buffer C (50 mM Tris, 
pH7.5) at 4 °C over night. Mutant proteins BS C57/60S and BS C53/57/60S became 
unstable when NaCI and imidazole concentrations were reduced and completely 
precipitated within 2 hours of dialysis so these mutants were not subjected to further 
analysis. We believe these mutations may affect the tertiary or quaternary structure 
of the protein causing protein instability through aberrant, misfolding and/or 
denaturation followed by precipitation. 
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3.3 - UV-Vis characteristics of biotin synthase and 
mutants 
After purification and dialysis against 50 mM Tris-pH7.5, UV-Vis 
absorbance spectra were measured for wild-type biotin synthase and mutants 
C53/57S, C53/60S, K49Q and K49R. The scan was performed using the same 
concentrations of the proteins between 250 rim and 600 nm and the spectrometer 
blanked with a portion of the used dialysis buffer. Figure 3.7 shows the UV-Vis 
spectra for each soluble mutant and also shows an overlay of all spectra which was 
corrected to 280 rim. This clearly enables visual comparison of the protein UV-Vis 
absorbance characteristics of the purified biotin synthase proteins. The observed 
absorbance between 420-500 nm is responsible for the observed deep red colour of 
biotin synthase. The spectral characteristics associated with aerobically purified 
6HisBS are observed in all mutants however they are significantly reduced in the 
C53/57S mutant. The spectra show absorbance maxima at 280 nm, 330 rim, 460 rim a 
distinct plateau leading from 400nm to 450nm. The maxima have been compared as 
shown in Figure 3.7 highlighting ratios of 330'/280nm, 460flm/280nm and 460/330m.  The 
comparison of the absorbance at 330nm and 280nm shows a marked decrease in the 
330nm maxima for the BS C53/57S and a smaller decrease for BS C53/60S whereas 
little difference is observed between wild-type and K49 mutants. As the C53,57 and 
60 have been shown to be involved in the binding of the redox active [4Fe-4S] 
cluster (87, 86) we propose that this spectral feature is primarily derived from the 
formation of this or an intermediate cluster, for example the [2Fe-2S] present when 
biotin synthase is prepared aerobically. In contrast the 460 rim to 280 nm ratio shows 
little variation throughout the wild-type and mutants. The ratios of 460 nm to 330 rim 
seem to be maintain constant between all the mutants with exception again being the 
C53/57S mutant which shows an increase in this absorbance ratio of the 460 rim and 
330 rim maxima. In conclusion these mutations have had little effect on the UV-Vis 
characteristics of the purifed protein excepting the C53S/C60S mutant. Thus we must 
conclude that the mutations made to the protein, C53S/C57S, K49Q and K49R have 
not greatly effected the [Fe-S] cluster characteristics compared to WT in this aerobic 
environment. In contrast the C53SIC60S mutant shows deviation from this 
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characteristic UV-Vis profile suggesting that the binding of the aerobic [2Fe-2S] 
cluster is greatly hampered by this double mutation. 
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3.4 - Mass Spectroscopy of Biotin Synthase and 
Mutants 
Purified proteins were all subjected to LC-MS analysis to confirm their 
theoretical mass as calculated using VectorNti software. Proteins were loaded (30 il) 
from an approximately 1 mg/ml solution and run using a standard LC-MS run using 
a 20 min reverse phase gradient optimised using Myoglobin, as described in Section 
2.28. The resultant ion-envelope spectra were deconvoluted by MassLynx algorithms 
Transform and MaxEnt, the results spectra for the MaxEnt deconvolution are shown 
in Figure 3.9. The table imbedded in Figure 3.9 shows the obtained average 
molecular weight for all proteins using both deconvolution algorithms. 
The major mass species of all proteins were within 0.01 % of the calculated 
theoretical masses from VectorNti. Un-resolvable higher mass species were observed 
as high mass tailing up to approximately 500 Da above the calculated mass. The high 
mass tail observed in all spectra can be attributed to specific and non specific protein 
adducts maintained during the LC-MS process. Non specific adducts such as sodium 
and potassium could account for some of this poorly defined peak shape. However, 
the ion-envelope topology is intriguing and some closer analysis reveals some 
interesting qualitative information. 
Over the last 10 years the analysis of entire proteins by mass spectrometry 
has developed from a 'molecular weight conformation tool' into one where 
qualitative structural information can be elucidated from the over topology of 
observed ion envelopes. Several important studies have been conducted looking at 
overall protein folds and how they relate to observed ion-envelopes (167, 168, 169, 
170, 171). In many of these studies well characterised proteins have been analysed 
varying buffers incubation time etc. These studies show that the more structured the 
protein chain, the less projected area is available for accommodation of charge (11). 
Experimentally, a protein with 3-dimensional structure (compared to the same 
protein in a random coil) display an ion envelope biased toward the high m!z region 
due to the few charges being maintained on the protein surface. This is shown in 
Figure 3.8. 
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rA 
I Ji £. 
Figure 3.8 - Diagram showing general topology of theoretical ion-envelope 
of a random coil protein compared to the same protein with 3-
dimensional structure maintained (blue). The less random coil like the 
protein chain the more likely it is to observe the lower charge states at 
higher m/z values. Based on Kaltashov et. al. (11) 
A simple visual comparison of the acquired ion-envelopes of BS and its 
mutants shows that several differences are observed between them. Both double 
cysteine mutants C53/57S and C53/60S (B and C respectively in Figure 3.9) show a 
predominance for the lower m/z range, maximum at approximately 1000 m/z which 
is a charge state in the region of +40. In contrast, the BS wild type and BS_K49R (A 
and D respectively in Figure 3.9) proteins show envelope maxima in the region of 
1600 m/z which would equate to charge states of approximately +25. Clearly, even 
though the protein chain as not altered considerably between these species their 
behaviour during ionisation and MS analysis differs greatly. If we apply the ideas 
discussed above we can conclude that in comparison to the double cysteine mutants 
the wild type and K49R proteins have more structural integrity during the LC-MS 
experiment. The observed masses for all the proteins show no evidence for major 
modifications on the majority of protein analysed. However, we can easily conclude 
that the conserved cysteine residues in BS (C53, C57 and C60) may play an 
important structural role whether a cluster is bound to them or not. This is 
particularly interesting as the crystal structure seems to show that they are present on 
a loop region and the authors suggest that structure in this region is maintained by the 
cluster (16). The observed ion-envelope for the last species analysed, K49Q, seems 
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to show a combination of the topologies described abovem where it has 2 maxima 
regions, one around 1000 m/z and one around the 1600 mlz region. We must 
conclude that this preparation contains at least 2 major structures, one which is like 
the WT and one which displays the more random coil like structure which may 
interchange in solution. 
Although it is impossible to conclude real structural/conformational 
information from these simple observations it is valuable to compare how these 
simple amino acid changes within the BS sequence at sites recognised as important 
can affect the gas phase structure in such a obvious manner. 
-83- 











Transform Error MaxEnt Error 
39,673.00 +2.37 39,671.00 +1.37 
39,641.00 +2.51 	1 39,640.00 +1.51 
39,642.00 +3.51 39,639.00 +0.51 
39,664.00 -6.63 39,670.00 -0.63 
39,704.00 +5.36 39,703.00 +446 
Figure 3.9 - LC-MS spectra of wild-type and mutant biotin synthase purified proteins. Traces 
shown are deconvoluted from ion-envelope (inset) using the Transform algorithm. Theoretical 
and calculated masses, Transform and MaxEnt algorithms, and Da errors are shown in table. 
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3.5 - Identification of the Pyridoxal-Phosphate Binding 
Residue of E. coil Biotin Synthase 
3.5.1 - Introduction 
Prior to publication Prof. Marc Fontecave visited our laboratory in 2001 and 
presented data that suggested BS had PLP-dependant cysteine desulferase activity. 
His data clearly shows that their biotin synthase preparations did convert free 
cysteine to alanine and sulphide in the presence of PLP albeit at a low rate. After a 
discussion on the possible experiments we could do to further investigate the 
hypothesis he agreed to supply some protein from his laboratory. 
The initial aims of this study were, firstly, to unambiguously identify any covalent 
link between BS and PLP and secondly, to explore if the conserved Lys49 residue of 
biotin synthase is involved in PLP binding. We intended to utilise a variety of mass 
spectrometry instrumentation available for this purpose. We also wanted to exploit 
our experience with PLP enzymes gained during analysis of other members of the 
biotin biosynthetic pathway (AONS and DANS) to study the UV-Vis characteristics 
of the PLP modified biotin synthase species in the presence of cysteine. 
3.5.2 - PAWS digestion analysis 
The theoretical sequence of biotin synthase was modified to contain the 
histidine tag at the N-terminus (MHHHHI-IHA) and this was used for theoretical 
enzymatic digestion with endoproteinases. Trypsin and Asp-N enzymes were chosen 
to facilitate the further study of the PLP modification of biotin synthase. This 
analysis produced a list of M' ions corresponding to enzymatically derived peptides 
from biotin synthase (156, 154). Experimentally only specific peptides are 
observable due to mlz limits of the analysis. Specifically peptides of m/z less than 
500 would be hard to observe in the MALDI-ToF spectra as they are likely to be 
indistinguishable in this highly populated region of the spectra a major constituent of 
which will be the abundant matrix ions observable in the 50-500 mlz region. 
Similarly ions of mlz greater that 3000 would be difficult to observe in the usual 
peptide mass fingerprint (PMF) spectra as ionisation tends to requires higher laser 
energies. Use of high laser energies tends to cause peptide fragmentation and as such 
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produces additional ambiguous peptide species in the fingerprint spectrum. During 
the nanoESl-Q-Tof analysis ions with m!z less than 500 were found to be hard to 
observe due to formation of high intensity H20 clusters, chemical noise and abundant 
small molecular contaminants. Although nanoESl-Q-Tof would tend to allow 
observation of larger species due to multiple charging of peptides, observation of 
>+I 
	identification . 	impossible 	>+3 M species, definitive identif cation was impos ible for M 	due to a resolution 
limit and as such distinguishing +4 and +5 charge states from each other was 
unreliable. 
Shown in figure 3.10a and 3.10b are tables showing all theoretical peptides derived 
from digestion of E. coli biotin synthase with the endoproteinase trypsin and AspN 
respectively and their related m/z value for different charge states. 
3.5.3 - In Gel Digestion of Biotin Synthase and Preparation for 
Mass Spectrometry 
Two sources of biotin synthase were used at this stage our own 6His-BS and 
a wild-type BS obtained from Prof. Marc Fontecave which had been purified and the 
iron-sulfur cluster(s) reconstituted anaerobically in the presence of Fe(N}{ 4)2(SO4)2 
and Na2S in 6 molar excess (in this thesis termed BS_MF). This procedure has been 
previously described (89, 86, 109). The samples were then anaerobically incubated 
for 4 hours with 5 molar excess of PLP and excess PLP removed by 2 x 1 litre 
dialysis against 100 mM Tris-HC1 pH 7.5 and finally treated with 1 mM NaBH4 for 5 
min at 25 °C. (92, 91). Aliquots were analysed by electrophoresis using Nu-PAGE 
gel (Invitrogen) as described in Section 2.15 and Mark12 molecular weight marker 
used to estimate protein MW (see Figure 3.11). Bands were excised and subjected to 
in-gel enzymatic digestion as described in Section 2.24.1. The resultant protein 
digest was dried to a pellet of peptides and salts visible in eppendorf tube. For all 
analysis samples were reconstituted in 20 tl of H20 + 0.1 % TFA and desalting 
carried out using C18 Reverse Phase ZipTips (Millipore) as manufacturers protocol 
and peptides eluted using 5t1 of 50% acetonitrile, 0.1% TFA in ddH20 (154). 
mlz mlz mlz mlz mlz Sequence Peptide No.. 
(M+1) (M+2) (M+3) (M+4) (M+5) 
I .. MAHRPRWTLSQVTELFEKPLL 
2 1768.970 884.985 590.323 993 354.5 DLLFEAQQVHRQHF 
3 2200.510 1100.755 734.170 878 440.9 DPRQVQVSTLLSIKTGACPE 
DCKYCPQSSRYKTGLEEARLMEVEQVLESARKAK.AAGSTR 
FCMAAWKNPHER 
5 950 1405 1 1054.475 43.7 DMPYLEQMVQGVKAMGLEACMTLGTLSESQAQRLANAGL 
6 938.970 78.5 DYYNHNL 
7 2405.620 1203.310 802.540 71.9. DTSPEFYGNIITFR1YQERL 
8 860.980 DTLEKVR 
9 1861.160 931.080 621.053 DAGIKVCSGGIVGLGETVK 
10 3468.180 1156.727 867.795 1)4 • 4 DRAGLLLQLANLPTPPESVPNMLVKVKGTPLA 
11 1' DO.4L DN 
12 34.110 67.555 '1 27.65 D 
13 33.240 117.120 16.413 59.060 47.4i DV 
14 1'(.685 118.123 88.843 71.27 DAF 
15 -. . .80 1.04.;. 
DFLIRTIAVARIMMPTSYVRLSAGREQMNEQTQAMCFMAGANSIF 
YGCKLLTTPNPEE 
16 262.290* 123 53.2 OK 
17 2183.550 1092.275 728.517 638 437± DLQLFRKLGLNPQQTAVLAG 
18 1801.970 243 361.1 DNEQQQRLEQALMTP 
19 235.220 55 4T8-1 DT 
20 1030.080 515.540 DEYYNAML 
Figure 3.10a - Table of theoretical peptides derived from a complete digestion of E. coli 6H1sBS by endoproteinase Asp-N. 
Compiled using PAWS software and sequence manipulated using VectorNti. Masses observed during MALDI analysis in Bold 
and peptides observed during QTOF analysis underlined. Non observed theoretical peptide masses in • * observed in 
combination with peptide 17 as miss cleavage. ** observed in combination with peptide 18 as miss cleavage. 
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Peptide mlz mlz m/z Sequence 
No.. (M+1) (M+2) (M+3) 
1 MAHRPR 
2 R 1. 1048.207 WTLSQVTELFEPLLDLLFEAQQVHR 
3 799.860 QHFDPR 
4 1216.460 608.730 QVQVSTLLSIK 
5 ut TGACPEDCK 
6 840.930 u u.97 YCPQSSR 
7 310.370 85 104.12 YK 
8 775.840 .28: TGLEAER 
9 1404.620 702.810 .87 LMEVEQVLESAR 
10 73 K 
11 j,42 AK 
12 562.600 9nn 188.201 AAGSTR 
13 914.130 305.37 FCMGAAWK 
14 652.690 NPHER 
15 1538.820 769.910 DMPYLEQMVQGVK 
16 2098.420 700.140 AMGLEACMTLGTLSESQAQR 
17 3074.330 1025.443 LANAGLDYYNHNLDTSPEFYGNUTTR 
18 696.740 TYQER 
19 718.820 .910 LDTLEK 
20 670 92.11 VR 
21 503.570 16991) - DAGIK 
22 VCSGGIVGLGETVK 
23 DR 
24 1265.540 844.027 AGLLLQLANLPTPPESVPINMLVK 
25 246.330 VK 
26 1881 .990 941.495 GTPLADNDDVDAFDFIR 
27 630.760 92 TIAVAR 
28 1098.370 549.685 IMMPTSYVR 
29 LSAGR 
30 . 902.037 EQMNEQTQAMCFMAGANSIFYGCK 
31 1257.380 1° 419.793 LLTTPNPEEDK 
32 791.920 264.640* DLQLFR 
33 147.200 K 
34 2181.370 1091.185 727.790 LGLNPQQTAVLAGDNEQOQR 
35 1065.665 LEQALMTPDTDEYYNAAAL 
Figure 3.1 Ob - Table of theoretical peptides derived from a complete digestion of E. coil 
6HisBS by endoproteinase trypsin. Compiled using PAWS software and sequence 
manipulated using VectorNti. Masses observed during MALDI analysis in Bold and 
peptides observed during QTOF analysis underlined. Non observed theoretical peptide 
masses in r1' * observed in combination with peptide 32 as miss cleavage. 
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M A B 
Figure 3.11 - Nu-PAGE gel showing purified biotin synthase bands excised for subsequent 
in-gel digestion and Mass Spectrometry analysis, bands halfed and one half digested with 
Trypsin and other with AspN. 	A - 6His_BS, B - BS_MF. M - molecular weight marker 
(Markl 2, Invitrogen) [200kDa = Myosin, 1 l6kDa = -galactoside, 97kDa = Phosphorylase b, 66kDa = BSA, 
55kDa = Glutamic dehydrogenase, 36kDa = Lactate dehydrogenase, 31kDa = Carbonic anhydrase, 21kDa = 
Trypsin inhibitor, 14kDa = Lysosyme, 6kDa = Aprotinin, 3,5kDa = unresolved Insulin] 
3.5.4 - MALDI MS Peptide Fingerprint of Biotin Synthase 
Desalted enzymatically derived peptide mixures of biotin synthase were 
analysed with the Applied Biosystems DETMSTR  MALDI-ToF as described in 2.29 
to obtain a fingerprint spectra for direct comparison with the theoretical PAWS 
derived peptides. The in-gel digestion process should theoretically yield a complete 
complement of peptides, fully reduced with no intra-molecular disulfides. It is in 
practice very rare to observe all theoretical peptides due to experimental factors 
described above as well as multiple miss cleavages instrument limits of detection and 
non ionisable peptide chains. 
Trypsin Digest 
The detected fingerprint spectra of an in-gel trypsin digestion of biotin synthase is 
shown in Figure 3.13. Peaks are labelled with the chronological peptide number N-
terminus to C-terminus as described. The total residue coverage was 207 residues of 
346 total (>60%), this corresponding to 22 of the 35 theoretical cleavage peptides 
9 M-62 
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(>65%) which demonstrated extremely high coverage of the entire protein sequence 
from N to C terminus (See Figure 3.12). Six of the 13 peptides not observed in the 
spectra were not practically observable due to their mass being 500 Da. During 
analysis a 500 mlz gate was set with the instrument to increase sensitivity of species 
in the range 500 to 3500 m/z, the area which tends to provide the most significant 
and specific data. The remaining 7 theoretical peptides not observed have predicted 
m/z values within the range 500 to 3500 m./z. An explanation could be due to post-
translational modifications, which will alter the mass of the peptide and thus shift the 
m/z resulting in a non recognisable peptide species. Secondly a certain number may 
not ionise easily using MALDI or they may require a different matrix. 
In addition 4 species were observed in this analysis which originate from a single 
miss cleavage of a lysine (K) or arginine (R) residues. These miss-cleaved species 
observed at mlz 1066. 1002 corresponding to peptide 7 and 8 and deriving from a 
miss cleavage at lysine67 and a species at m/z 2108.050 is derived from a miss 
cleavage at residue lysine228 and combines peptides 25 and 26. The species 
observed at 2029.703 rnlz contains peptides 31 and 32 and is similarly derived from a 
miss cleavage, in this case at lysine300. The final miss-cleaved species observed at 
2308.923 mlz derives from a miss cleavage at lysine307 and combines peptides 33 
and 34. 
Residue Number 
N 	 50 	 100 	 150 	200 	250 	300 
1 	 - 
3 	 - 
5 	 - 
7 	 - 
9 	 - 
11 	 - 
13 	 - 
15 
17 	 - 
19 	 - 
21 
Figure 3.12 - Coverage map of peptides observed during in-gel trypsin 
digestion MALDI-ToF of biotin synthase. Miss cleavages shown in 
K49 containing peptide shown in 
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As shown in Figure 3.13 two species are observed that corresponds to peptide 4 
(Tryp4-WT) and peptide 4 plus the addition of 231 Da (Tryp4-WT+PLP) which is 
consistent with the hypothesis of 011agnier-de-Choudens et al. (91, 92) of PLP 
modification of K49. This observation strongly supports the modification of this 
highly conserved lysine residue (lysine49 in E. coli biotin synthase) by PLP 
implicated in the proposed cysteine desulfurase activity reported by 011agnier-de-
Choudens et al. 
Tryp4-WT - 	QVQVSTLLSIK 	M+1 = 1216.460 mlz 
Tryp4+PLP- QVQVSTLLSlK-j 	M+1 = 1445.489 m/z 
The low relative intensity of the species at 1216 m/z and 1445 mlz (Tryp4-WT and 
Tryp4-WT+PLP respectively) compared to other biotin synthase derived peptides 
during this analysis was seen as a minor issue and as such a further study using 
MS/MS techniques was used to confirm this initial identification of the PLP 
modified residue as lysine 49. 






































Figure 3.13 - MALDI-ToF spectra of in-gel trypsin digested biotin synthase, Peptides matched 
with theoretical (See Figure 3.10) shown in green, peptide containing lysine 49 and 
corresponding +231 Da species shown in burgundy. 
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AspN Digest 
The peptide fingerprint spectra shown in Figure 3.15 shows all observed peptides N 
to C-terminus when wild-type biotin synthase was in-gel digested with 
endoproteinase AspN. The total residue coverage observed was 195 of 346 residues 
(>56%) which correlates to 12 out of 22 (>54%) theoretical peptides derived from a 
biotin synthase digestion with AspN. The observed peptides show fairly high linear 
coverage of the protein sequence as shown in Figure 3.14. 
The much of the unobserved portions of the protein sequence was due to the small 
peptides with mlz of less than 500 therefore lie outside the observable region of the 
MALDI-TOF analysis. However 2 large peptides are unobserved and correspond to 
the major uncovered regions in the coverage map (Figure 3.14, shown in grey). 
Residue Number 
N 	 50 	 100 	 150 	 200 	 250 	 300 
1 	 - 
3 
5 	 - 
7 - 
9 
11 	 - 
Figure 3.14 - Coverage map of peptides observed during in-gel AspN digestion 
MALDI-T0F of biotin synthase. Miss cleavages shown in 	. K49 containing 
peptide shown in 	Peptides (>6kDa) observed using Sinapinic acid matrix in 
separate spectra shown in 
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The digest mixture was analysed using sinapinic acid as the Matrix and the laser 
intensity increased correspondingly. This analysis allowed observation of these two 
>50 residue peptides however many of the other peptides in the mixture were not 
observed in this analysis (data not shown). Two relatively low intensity species were 
observed corresponding to single miss cleavages. The species at 2443 mlz derives 
from a miss cleavage at Aspartic acid 301 and constitutes peptide 16 and 17 and the 
species at 2015 mlz is derived from a miss cleavage at Aspartic acid 335 and 
contains peptides 18 and 19. 
In concurrence with the trypsin digested biotin synthase MALDI-ToF fingerprint we 
observed a low intensity species that corresponds to the peptide containing the highly 
conserved lysine49 (AspN3-WT), as well as a species corresponding to this peptide 
with the addition of 231Da (AspN3-WT+PLP) as shown in Figure 3.15. This 
observation is again consistent with the hypothesis that this Lys49 residue is 
modified by PLP as shown. 
AspN3-WT - 	DPRQVQVSTLLSIKTGACPE 	M+1 = 2200.510 m/z 





























Figure 3.15 - MALDI-ToF spectra of in-gel AspN digested biotin synthase, Peptides 
matched with theoretical (See Figure 3.10) shown in green, peptide containing lysine 
49 and corresponding +231 Da species shown in burgundy. 
-95- 
Chapter Three: Results and Discussion 
3.5.5 - Q-ToF Peptide Fingerprint of Biotin Synthase 
To complement the analysis of the protease fragments with MALDI we 
performed analysis of the peptides using a Q-Tof instrument. We hoped that this 
further analysis would generate a range of multiply charged species that would 
complement the MALDI analysis as well as providing enhanced sequence coverage. 
This analysis would also enable optimisation of the instrument for the further 
MS/MS analysis shown in section 3.57. 
The samples used for Q-ToF mass spectrometry were prepared from the same gel-
digestion as those used for MALDI-ToF analysis. Due to intolerance of salts in ESI 
ionisation, extra sample washing during the micro reverse phase desalting step was 
performed (C 18, ZipTip (Millipore) washed with 6 column volumes). 
The mass spectra observed of trypsin-digested biotin synthase using the Q-T0F in 
ToF-MS mode is shown in Figure 3.19a. All observed peptides are annotated and 
labels are used to describe the charge state at which they were observed correlating 
to the trypsin fragments in Figure 3.1 Ob. The total amino acid coverage observed was 
230 of 346 residues (>66%) which correlates to 16 out of 35 (>45%) theoretical 
peptides derived from a biotin synthase digestion with trypsin. The observed peptides 
show good linear coverage of the protein sequence (See Figure 3.16) and the mass of 
the unobserved peptides tends toward the lower masses (100 to 1000 Da). Due to 
instrument parameters used no species with mlz less than 500 were observed, as most 
trypsin peptides are doubly or more charged, we unlikely to observe fragments below 
1000 Da. Seven peptides were observed as singly charged, three of which could not 
be observed as multiply charged species. 
Importantly for the confirmation of the site of PLP modification, the peptide 
containing the theoretical binding lysine residue, Tryp4-WT containing K49, is 
clearly visible as a doubly charged species at 608.73 m/z and a species is also 











724.029 m/z (M 2) 
3902 
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The observation of these species is further evidence that lysine 49 is modified by 
PLP and further corroborates observations made during the MALDI analysis of the 
trypsin digest. Multiply charged peptides typically allow observation of both halves 
of the peptide chain after a single bond cleavage and as such the +2 charge state 
makes these species ideal for Collision Induced Dissociation (CID) MS/MS 
sequencing. This should allow further confirmation of the identity of this modified 
species and therefore verify the site of PLP modification as Lysine 49. The Q-Tof 
MS/MS data is shown in Section 3.5.7. 
Q-ToF-MS analysis was also performed using the Asp-N digestion and the 
result of this is shown in the spectra shown in Figure 3.19b. The MS spectra 
observed again highlights observed peptides and their apparent charge state based on 
C 13 isotope distribution. The total residue coverage observed was 181 of 346 residues 
(>52%) which equates to 9 out of 20 (45%) theoretical peptides derived from a biotin 
synthase digestion with AspN. The observed peptides show acceptable linear 
coverage of the protein sequencc 8). 
N 	 50 	 100 	150 	200 	250 	 300 
3 
5 	 - 
7 
9 	 - 
11 	 - 
13 	 - 
15 	 - 
Figure 3.16 - Coverage map of peptides observed (blue) during in-gel 
trypsin digestion Q-ToF MS of biotin synthase. Miss cleavages shown in 
K49 containing peptide shown in 
Residue Number 
N 	 50 	 100 	 150 	200 	250 	300 
Figure 3.18 - Coverage map of peptides observed during in-gel AspN 






















Figure 3.19a - Q-ToF MS spectra of in-gel trypsin digested biotin synthase , Peptides 
matched with theoretical (See Figure 3.10) labelled and colour coded as to charge state 
as follows, M 1 in green, M 2 in blue, M 3 in 	and peptide containing lysine 49 and 
orresnondina +231 Da snecies shown in buraundv. 
2 
1 
Figure 3.19b - Q-ToF MS spectra of in-gel AspN digested biotin synthase, Peptides 
matched with theoretical (See Figure 3.10) labelled and colour coded as to charge state 
as follows, M 1 in green, M 2 in blue, M 3 in 	and M+4 in black. Peptide 
rontainina lvine 49 and cnrrRsnnndina +231 Da snprips shown in buraundv 
IDIOM 
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The MALDI analysis displayed two large proteolytic fragments 4 and 15 of 
mass 618613a and 651 51)a respectively which were not observed under electrospray 
conditions. As in the previous analyses we clearly observed a species which would 
correspond to the peptide containing lysine 49, (AspN3-WT) and again a species 
matching the PLP-modified species (AspN3-WT+PLP). In this case both peptides 
were observed in their triply-charged state at 734.17. m/z and 811.18 m/z 
respectively as shown in Figure 3.19b. 
AspN3-WT 	DPRQVQVSTLLSIKTGACPE 	743.17 m/z (M 3 ) 
AspN3-WT+PLP 	DPRQVQVSTLLSIKTGACPE-[PLP] 811.18 m/z (M 3 ) 
These species were not as ideally suited for CID MS/MS sequence analysis as 
dissociation of a M 3 charge state species yields a complex dissociation spectra with 
M', M 2 and M+' fragment ions observed. Spectrum deconvolution software 
reduces complexity of acquired ESI continuum spectra by examining spectra, 
assigning charge state and finally displaying all species as singly charged. However 
we had no access to this software therefore assignment of a peptide with a mixture of 
charge states sequence manually is cumbersome. These species were of relatively 
high mass, 2200Da and 2431 Da respectively, and were found to be difficult to 
fragment successfully in our instrument and therefore sequencing was found not to 
be possible. A degree of fragmentation was observed at high collision energies 
however the signal significantly reduced on the ToF detector and therefore 
insufficient ion statistics were obtained for the fragment species to enable 
interpretation. 
For these reasons we concentrated on the MS/MS sequencing of the Lysine 
49 containing peptide of interest, (Tryp4-WT), and the postulated PLP modified 
derivative (Tryp4-WT+PLP). MS/MS fragmentation was performed using the doubly 
charged peptides derived from biotin synthase digestion with trypsin with peaks 
observed at 608.73 m/z and 724.24 m/z respectively and is shown in Section 3.5.7. 
_100- 
Chapter Three: Results and Discussion 
3.5.6 - Q-ToF-MS Comparison of Residue 49 Containing Peptides 
of WT, K49Q and K49R Biotin Synthase. 
Thus far we have investigated the possible PLP binding site of biotin 
synthase, lysine 49, by peptide mass fingerprinting and observation of a species that 
could correspond to a PLP modification. The assumption that this Lysine 49 residue 
is modified was further investigated by site-directed mutagenesis at this residue. The 
proposed PLP binding lysine was mutated to both arginine and glutamine to disrupt 
the proposed binding site and remove possible internal aldimine formation. These 
mutants should not be modified by PLP and enzymatically-derived peptides should 
provide diagnostic mass shifts for identification of the peptide containing the 
modified lysine residue. For this analysis mutant proteins were provided by Dr. 
011agnier-de Choudens prepared identically to the wild-type enzyme i.e. all samples 
had been purified and treated with PLP followed by NaBH 4 using the published 
method (92, 91). 
These samples were in-gel digested and treated in the same way as the wild-
type enzyme and digestion mixture was desalted for nanospray Q-T0E-MS analysis 
(as described in Section 3.5.3). Samples were analysed under equivalent conditions 
with mutant samples and wild-type analysed in parallel and wild type spectra were 






608.7 mz 	 724.5 m/z 
BS-WT 	 - 
MID 
60 
Figure 3.20 - Pile up 550 to 765 mlz region of Q-ToF spectra observed using WT (lower in 
), K49Q (centre in green) and K49R (upper in purple) proteins digested with trypsin. 
Showing Tryp4-WT and Tryp4-WT+PLP species present in WT and absent in both mutants. 
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The lower trace (in ) in Figure 3.20 shows the region 500 to 800 mlz of the Q-
ToF fingerprint spectra (Figure 3.19a) of trypsin digested WT BS containing the M 2 
(Tryp4-WT at 608.73 m/z ) species of the unmodified peptide containing K49 and its 
corresponding modified species Tryp4-WT+PLP, seen at 724.245 mlz. The 
additional 231Da modification is observed as a +115.5 m/z shift due to the double 
charge state of the species. The centre trace is the same region of the K49Q BS 
fingerprint spectra (in green) which shows an absence of any species at 608 m/z, due 
to the lack of a trypsin cleavable residue, lysine or arginine, at position 49. Trypsin 
digest of mutant BS K49Q should now result in a peptide of mass 2234.5 Da 
(combination of trypsin peptides 4 and 5) which we have thus far been unable to 
observe via ESI or MALDI MS. However DNA sequencing shows the mutation has 
been successful. More importantly, the Tiyp4-WT and Tryp4-WT+PLP peptides 
observed at 608.73 and 724.5 m/z in the wild-type digest are absent from the mutant 
spectrum. This provides greater confidence in the assignment of these peptides in the 
wild-type digest. 
The upper trace (in purple) displays the region 500 to 800 m!z also and was acquired 
using the trypsin digested K49R mutant. The absence of a species at 608.73 m/z was 
as expected as the lysine to arginine mutation results in a 28 Da mass increase of 
peptide 4. This mutation is confirmed by the appearance of a new species with a m/z 
increase of 14 m/z at 622.m/z as indicated. To rule out the possibility that Arg could 
somehow be modified in a similar fashion to Lys we examined the spectra for an 
additional species. If Arg was modified with PLP a species would be observed at 
737.5 m/z (Tryp4-K49R+PLP (622 +115.5 mlz)) and no evidence to suggest that this 
or another species is present in any of the acquired data. 
A similar comparison using AspN digested biotin synthase analysed with Q-ToF-MS 
is shown in Figure 3.21. The lower trace is Asp-N digested WT biotin synthase 
(shown in ) and the region 700 to 850 m/z of the spectra is shown. The M 3 
unmodified species (at 734.17 mlz) of AspN3-WT contains the proposed PLP 
modification site K49 (See Figure 3.10a). A species corresponding to AspN3-
WT+PLP is observed in the +3 charge state at 811.18 mlz. The difference between 
the species is shown as +77 m/z shift consistent with the triple charged nature and 
equates to the +231 Da increase expected from an addition of a PLP moiety to a 
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peptide. The centre trace in Figure 3.21 shows the 700 to 850 m/z region of the AspN 
digested K49Q BS mutant spectra (in green). Since lysine and glutamine differ in 
mass by only 0.03638 Da the mutation of lysine 49 to a glutamine results in a mass 
change to the derived peptide too small to identify unambiguously. This results in the 
appearance of a peptide with the same nominal mass of 2200 Da that is visible in the 
spectra of the K49Q mutant peptide which is equivalent to the WT. This peptide is 
observed as a triply-charged species at 743.17 mlz and indistinguishable from the 
WT in this analysis. 
However the AspN3-WT+PLP observed in the WT BS at 811.18 mlz is absent in 
K49Q digest which again gave us confidence that we had assigned the identity of this 
peptide species correctly. The upper trace shows the 700 to 860 mlz region of the 
Asp-N digested K49R BS spectra (in purple). Peptide 3 shows a species with the 
expected mass increase of 28 Da associated with a lysine to arginine mutation as 
shown and is demonstrated by a m/z shift of 9 due to the +3 charge state of the 
species. 
743 mlz 	 820 mlz 














1'm 	 I inz 
710 	720 	130 	740 	750 	760 	770 	780 	780 	800 	810 	820 	630 	840 	850 660 
Figure 3.21 - Pile up 700 to 860 m/z region of Q-ToF spectra observed using WT (lower in 
), K49Q (centre in green) and K49R (upper in purple) proteins digested with AspN. 
Showing Peptide3 and Peptide3+231 Da species present in WT and absent in K49Q and K49R 
mutants. 
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Similarly to the trypsin-digested K49R BS mutant no species was observed with a 
mass shift of 231 Da relative to the unmodified peptide, indicating that the K49Q 
mutant did not contain a PLP-modified lysine. Combining all of the mutagenic and 
MS data leads us to conclude that the initially observed species that was assigned as 
the K49-containing fragment in the trypsin digest of WT BS is the site of PLP 
modification. 
3.5.7 - Q-ToF based MSIMS peptide sequencing of modified and 
unmodified Iysine49 containing peptide. 
The Q-Tof MS/MS analysis was performed using identical conditions and 
sample preparation as for the MS fingerprint spectra. The species isolated for 
sequencing were the doubly charged 608.8 m/z unmodified species and the 724.2 
m/z species, Tryp4-WT and Tryp4-WT+PLP respectively, of the BS wild-type 
tryptic digest (See figure 3.10b). These species have been subjected to CID MS/MS 
sequencing specifically due to the suitability of these species with regard to apparent 
mass, abundance and their double charge which provides a clear dissociation spectra 
for de-novo sequence interpretation. 
The species under study was isolated in the mass spectrometer with the quadrupole 
of the Q-T0F set at 0.5 Da above the monoisotopic mass to enable transfer of 
monoisitopic 1st , 2nd and 3id  isotope peaks. Dissociation was induced using Argon as 
the collision gas and the voltage in the collision cell was optimised between 15V and 
30V to yield maximum dissociation peak intensity and fragmentation data. When 
optimised for dissociation data was acquired for up to 30min or until the sample was 
consumed. 
Figure 3.22 shows an expansion of the region containing both the unmodified species 
(Tryp4-WT labelled A) and +231 modified species (Tryp4-WT+PLP labelled B) of 
Peptide 4 and the insets are expansions of each individual species when isolated with 
the quadrupole before application of the Argon collision gas and collision energy 
(shown in Figure 3.22 - A*/B*). When collision energy was applied to the 
unmodified 608.8 m/z species and data acquired the spectra shown in Figure 3.22, 
(A**) was obtained. The spectra shows a single y-ion series consisting of fragments 
yio to y (indicated with - 0) which when compared to the Biemann diagram (1) 
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(Figure 3.23) of the theoretical peptide sequence shows a complete complement of 
the dissociation fragments providing conclusive evidence for the sequence of this 
species being Q V Q V S T /L /L S /L  K from N-term to C-term. It also contains a 
single b-ion series consisting of fragments b2 to b10 (indicated with - .) and when this 
data is compared to the Biemann diagram (Figure 3.23) all theoretical fragments, 
excluding the b1 ion at 129 m/z, were observed. In the low mass range below 130 
m/z, species were observed which correspond to the immonium ions of 
glutamine(Q), leucine/isoleucine (Lu) and valine (V) observed at 72 m/z, 86 m/z and 
101 m/z respectively. This data adds further confidence to the identification of the 
peptide as the theoretical Tryp4-WT derived from trypsin digestion of WT BS. 
The spectra acquired when the Argon collision gas was introduced and collision 
energy applied to the isolated Tryp4-WT+PLP (at 724.2 m/z) species, thought to be 
derived from a +231 Da modification of 608.8 m/z peptide of BS, is shown in Figure 
3.22 (B**)  however the acquired MS/MS spectra in this case is significantly more 
complex. The Spectra B**  shown in Figure 3.23 includes the complimentary 
immonium 	 2+ ions also seen in the 608.8 MS/MS spectra in the low mass range and 3 
distinct y series as described below. A partial b-ion series is seen (indicated with -.) 
consisting of the ions b1 to b7 but excluding the b5 ion thus providing a sequence tag 
of Q-V-Q running N to C terminus from ions b1 to b4. Ions b6 and b7 provide 
evidence of a single L or I residue. Also observed is the partial y-ion series 
consisting of y2  to Y6  and provides an N to C terminus sequence tag of TL/1L/1_S 
which also corresponds to the theoretical amino acid sequence composition. A 
related y-ion series is observed with the addition of a Y8  ion (therefore y2 - y6 plus Y8) 
which is consistent with the unmodified species already sequenced from the 608.8 
m/z species. This data suggests that the +231 Da moiety is cleaved from the lysine 
during the collision induced dissociation thus yielding an unmodified species which 
is subsequently further dissociated to provide these fragment ions. Despite numerous 
attempts to affect the cleavage of PLP we were unable to cause the loss of this 
modification without significant backbone fragmentation. 
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Figure 3.22 - Q-ToF MS' spectra showing unmodified (Tryp4-WT = A) and modified (Tryp4-WT+PLP = 
B) peptide containing lysine49. The inset shows the isolated peaks before introduction of collision gas 
(AJB*). Q-ToF-MS 2  sequencing of the unmodified species (A) showing both y-ion and b-ion series and 
Q-ToF-MS2 sequencing of +231 modified species (B)showing partial b-ion and y-ion series, partial y -
ion series with loss of 231 Da, partial y-ion series with loss of 287 Da. 
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The final series we observed displayed the highest relative intensity and yielded the 
most complete set of y-ions as y 10 to y5 and y2  and  Yi  were observed. Initial 
examination of the data very quickly provided evidence for the N to C terminal 
sequence consisting of Q-V-Q-V-S-T, which perfectly matches the sequence of 
Tryp4-WT+PLP. However under further investigation all the species from this series 
exhibited a delta mass of+ 287 Da from the unmodified Tryp4-WT sequence. 
The appearance of a single charged species C, an apparent molecular ion at 1157, is 
consistent with the parent ion minus 28713a. From this species C, a fragment series 
was observed from which the sequence Q-V-Q-V-S-T could be read. Importantly, we 
also observed a single charged species at 287 m/z which is not assigned as a 
sequence fragment ion and originates from a single cleavage of Tryp4-WT+PLP. We 
wanted to determine the structure of this 287 Da ion and explain a mechanism for its 
formation during collision induced dissociation but did not have access to MS 3 
instrumentation which may have enabled this. However, the appearance of the 287 
mlz peak shows that this species must originate from a single cleavage and not as a 
multiple cleavage event, the cleavage of PLP and a valine sidechain (C41-18 = 56) for 
example could provide this apparent molecular ion but as we observe the 2871+  m/z 
species this must be a single fragment. One plausable explanation is that the cleavage 
of the PLP moiety is occurring along the site of attachment, namely the lysine 
sidechain and corresponds to cleavage of the beta-gamma C—C bond of the lysine 
side chain as shown in Figure 3.24. This cleavage, although energetically 
unfavourable, may be promoted due to the nature of the gas phase structure of the 
peptide with the PLP bound at the C-terminus. Cleavage may be aided by 
interactions with the backbone and C-terminus of the peptide in an electrostatic 
cyclisation, so stabilising the peptide bond. Another effect could be due to 
polarisation of the side chain and a subsequent decrease in the bond energy favouring 
the cleavage of the C3-Cy bond over N-N linkage between K and PLP. After the 
cleavage of the CO-Cy bond the resulting dissociation species would correspond to a 
species with mass 288 Da and the apparent molecular ion with mass which we do in 
fact observe in the MS/MS spectra. This unusual cleavage provides little or no 
opposition to the identification of the observed 724.2 nilz species indeed being the 
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enzymatically derived Tryp4-WT+PLP peptide of BS but is an intriguing observation 
as to the nature of this species in the gas phase. 
3.5.8 - Conclusions 
Through a combination of site-directed mutagenesis and mass spectrometric 
analysis we have been able to further investigate the proposed presence of a protein 
bound PLP moiety. The observation that biotin synthase had pyridoxal phosphate-
dependent cysteine desulfurase activity by 011agnier-de-Choudens et al., implicates a 
highly conserved lysine 49 residue in E. coli biotin synthase. We have characterised 
enzymatically derived peptides with masses corresponding to the addition of PLP to 
this conserved residue. No PLP-derived peptides were observed when we mutated 
the lysine side-chain. Moreover, we successfully isolated and sequenced both the 
unmodified and PLP-modified peptides by gas-phase collision-induced methods. 
Final conclusions from this study strongly confirms the proposal that biotin synthase 
can be covalently modified by PLP and that this occurs specifically at the conserved 
lysine residue found on a loop only 7.5A from the [4Fe-4S] cluster of the holo-
protein as shown by the recently published crystal structure. Although this residue is 
not within a known PLP binding site observed in other PLP-dependent enzymes, the 
solution phase dynamic structure of biotin synthase is significantly more complex 
than the single 'snap shot' crystal structure elucidated by Drennan and co workers 
(16) as discussed in Section 1.3.5. 
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3.6 - E. coil Biotin Synthase as a Pyridoxal-Phosphate 
Dependant Cysteine Desulfurase 
3.6.1 - Preparation of Pyridoxal-Phosphate loaded Biotin 
Synthase 
The 6HisBS protein and mutants were prepared in a 100 tM PLP cell lysis 
solution for subsequent analysis fresh PLP was added to protein solution by dialysis 
of protein solution against 100 AM. Protein solution was monitored during the 
process, (before dialysis, after dialysis and following gel filtration cleanup) by IJV -
Vis scan from 250nm to 600nm. The protein aliquot was defrosted on ice and 
dialysed against Buffer C with addition of 100 .tM PLP for 3 hours and unbound 
PLP removed by Gel Filtration using a PDIO disposable column from Pierce. The 
UV-Vis scans are shown in Figure 3.25 and maxima ratios shown in Figure 3.26. 
UV-Vis analysis performed prior to fresh PLP addition displays characteristics as 
described previously (Section 3.3) and scan performed directly after PLP dialysis 
clearly shows an increase in the observed maxima at 325nm and 400nm consistent 
with free PLP present at high concentration in solution. The most striking difference 
is observed after PD 10 column clean up, this clearly shows an increase in the 425nm 
region with respect to the 280nm region. In contrast little difference is observed in 
the 330nm region compared to 280nm region. These increases are highlighted in 
Figure 3.26 which shows the calculated ratios for 330nm!280nm, 425nm1280nm and 
425nm1330nm. 
These simple measurements suggest that the addition of fresh PLP to the protein 
solution dramatically shifts the absorbance characteristics of the solution which 
would lead to the conclusion that biotin synthase is effected by the presence of PLP 
and that this may have a structural or chemical role. 
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Figure 3.25 - UV-Vis scan of E.coli biotin synthase during PLP loading 
of protein. Before dialysis (blue), after dialysis against a PLP-containing 
buffer (100 .tM PLP) (green) and after re-purification using PDIO GF 
column ( ). 



























Figure 3.26 - Bar chart of UV-Vis maxima ratios of 280, 330 and 
425 nm before and during PLP loading. 
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3.6.2 - Incubation of PLP loaded BS with L-Cysteine Monitored by 
UV-Vis Spectroscopy 
The UV-Vis analysis of 6His-BS incubation with cysteine was optimised 
using protein at approximately 1 mg/mI and incubation at 37 °C. A maximum 
response was observed when cysteine was added to the protein sample at 3 mM final 
concentration. Incubation of the protein sample final concentration of cysteine 
greater than 3 mM resulted in the mixture immediately turning turbid and thus 
making UV-Vis analysis impossible. 
The spectrophotometer was blanked using buffer (50 mM Tris-HC1, pH7.5) 
and 3 mM cysteine final concentration. Identical conditions were used to assay the 
BS-containing sample. Addition of cysteine immediately caused absorbance of the 
sample to increase across the region between 250 nm and 600 nm. This initial 
absorbance increase could be caused by the initial mixing. After 30 sec the 
absorbance fell to approximately the initial values. As shown in Figure 3.27 after 
10min incubation at 37 °C the absorbance at 330 nm had increased () and 
absorbance at 425 rim had decreased (U). This trend showing an increase at 330 nm 
and a decrease at 425 nm is continued throughout the experiment until time 40 mm 
after which no measurable change was observed. The increase at 330 nm and 
decrease at 425 nm converge on an isosbestic point at approximately 360 nm, as 
shown in Figure 3.27, labelled ((:). The appearance of an isosbestic point in a UV-
Vis spectrally monitored time course is indicative of the chemical conversion of two 
species. A well characterised cysteine desulfurase, NifS, has been shown to respond 
to addition of L-cysteine with similar spectral characteristics and these observations 
were suggested to be indication of conversion of the NifS-PLP internal aldimine to 
the NifS PLP-L-cys external aldimine (145,172). 
When K49Q and K49R biotin synthase mutants were analysed in an identical 
experiment, the addition of L-cysteine affected the same initial increase from 250 nm 
to 600nm (with return to initial values within 30sec). However after a 40 mm 
incubation period at 37 °C no distinct absorbance changes were observed in the 
spectra. This result tends to suggest the involvement of the lysine residue 49 in our 
observed cysteine activated absorbance changes. As suggested a mutation at this site 
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would hinder incorporation of PLP into the protein structure and thus affect the 
proposed cysteine desulfurase activity of the protein. 
Incubation of the BS C53/57S and BS C53/60S mutants with 3 mM cysteine at 37°C 
caused the comparatively unstable mutants to precipitate thus making the analysis 
impossible. When these double mutants were incubated for the 40 min time course 
with L-cysteine, final concentration of 2 mM, they showed an absorbance profile 
much the same as for the wild type enzyme. The increase at 330 nm and decrease at 
425 nm were observed albeit much less pronounced. The reduced observed change 
caused by L-cysteine addition may be a direct result of the reduced cysteine 
concentration. However, as protein concentration is in the micro molar range 
compared to the milli molar range for PLP this seems unlikely. A more likely 
explanation is that the reduction is indicative of more fundamental changes to the 
protein structure caused by the mutation of the cysteine residues. 
I no L-cvs I 
5 I 
Figure 3.27 - Incubation of wild-type BS (26j.xM) re-loaded with PLP (excess 
PLP removed by gel filtration) with 3mM L-cysteine. A and B indicate the 
increase and decrease in absorption at 330nm and 425nm respectively during 
the 40min incubation period. The isobestic point produced by these spectral 
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3.6.3 - Conclusions 
We have shown that the addition of PLP has a marked effect on the UV-Vis 
characteristics of the protein which suggests the protein has the ability to bind PLP. 
This PLP-binding is entirely dependant on the presence of lysine49 in the protein. 
As-purified BS has a characteristic absorbance spectrum due to the presence of Fe-S 
clusters and incubation of PLP causes small changes in the small spectrum. 
Incubation of this PLP-reloaded BS with L-cysteine caused absorbance changes such 
that after prolonged incubation the BS resembles that of as-purified biotin synthase. 
The changes caused by addition of L-cysteine closely resemble those previously 
observed for cysteine desulfurase enzymes (e.g. NiIS) which have been attributed to 
the conversion of an enzyme-PLP internal aldimine to the corresponding PLP-
cysteine external aldimine (145,172). These observations lead us to conclude that our 
preparation of BS contains a species that is capable of binding PLP. In addition, this 
PLP binding species can subsequently be converted to a PLP-cysteine aldimine. The 
amount of the PLP-binding form of BS in the total BS sample is unknown and this 
would be difficult to determine. It is now accepted that turnover of BS destroys at 
least one of the Fe-S clusters, which then has to be regenerated. The role that the 
PLP-bound form of BS plays is the subject of controversy but we speculate that it 
could be involved in the delivery of sulfur to the partial cluster allowing regeneration 



























Figure 3.28 - Hypothetical mechanism of activity of a PLP dependant cysteine desulfurase enzyme (NifS, biotin synthase?). 
The mechanism is dependant on availability of PLP, L-cysteine, active site base (lysine) and a S acceptor. Modified from 
Zheng et.aI.(6) 
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3.7 - Differential Expression Analysis of Biotin Synthase 
by Two Dimensional Gel Electrophoresis 
3.7.1 - Introduction 
As discussed in Section 1.2.7 the in vitro biotin production from dethiobiotin 
(DTB) using the standard conditions results in only approximately one conversion of 
DTB to biotin. It has been postulated that an explanation for this could be that a 
important component or components (protein, small molecule, peptide etc) are missing 
from the in vitro assay, the addition of which may result in enzymatic turnover. The 
identification of these missing components is of great interest with the goal of producing 
a fully catalytic enzyme in vitro. This would help in our further understanding of the 
complex bio-reaction and possibly solve several of the mechanistic questions, which as 
yet are unanswered. Although several protein partners, such as flavadoxin (FLD), 
flavadoxin reductase (FLDR) and small molecules, such as SAM and NAPDH, have 
been shown to enable the single turnover of biotin synthase to convert DTB to biotin, it 
is still a contentious issue as to their in vivo role. The combination of these species 
certainly seem to provide a resource for activity in vitro, however thus far no hard 
evidence has been amassed to unequivocally prove they are the true partners in the 
cellular environment. Indeed, the lack of catalytic turnover points to two conclusions, 
they are true catalytic partners and we are missing an important component of the 
system or, the currently observed single turnover is an artefact of the assembled multi 
component system. 
The production of the 5'-deoxyadenosine radical (DOA) is vital to the activation of the 
carbon 6/9 of DTB. This radical is thought to derive from reductive cleavage of SAM by 
a reduced [Fe-S] cluster formed via a cascade reduction involving NADPH, FLDR and 
FLD, in this way the activity is dependant on the existence of the iron-sulfur cluster. We 
postulated that among other possible protein partners the cluster will have to be formed 
sequentially for each turnover by some means. 
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As the ISC operon and associated proteins have been shown to be vital for [Fe-S] cluster 
formations and purified biotin synthase contains a preformed [Fe-S] cluster and as over 
expression of biotin synthase has been shown to increase biotin production we hoped to 
observe that a forced over-expression of biotin synthase could up regulate cellular 
production of the in vivo protein partners involved in its cluster formation as well as 
those involved in DTB to biotin conversion. We attempted to analyse these up-
regulations by differential expression monitored using 213imensional Electrophoresis as 
described below. 
3.7.2 - Preparation of Extracts for 2Dimensional Electrophoresis 
The differential analysis cell growths were produced by small scale (lOmi) 
expression (Sections 2.16) using pETl6b/BioB and pETl6b as shown in Figure 3.29 and 
using BL2 I (DE3) competent cells. Cell extracts prepared by incubation of cell pellet in 
8M urea and CHAPS detergent to facilitate the solubilisation of the majority of the 
cellular proteins, full method is described in section 2.23.1. 











Figure 3.29 - Plasmids maps of pET16b and pET16b/bioB used for differential 
expression and extracts used for subsequent 2Dimensional Electrophoresis. 
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The cell extracts were first analysed by 1 D SDS-PAGE to gauge the extent of expression 
and concentration of total protein for subsequent 2D analysis as shown in Figure 3.30. 
The biotin synthase band is clearly observed in lane 2 at approximately 40kDa as judged 
by the low molecular weight marker (Amersham Pharmcia) shown in lane M. 








Figure 3.30 - Nu-PAGE gel showing urea solubilised cell extract for 
pET16b (lanel) and pET16b/bioB (lane2) expressing BL2I(DE3) 
cells. A - Biotin synthase at approx. 40kDa. 
M - molecular weight marker (LMW, Amersham Pharmacia) [96kDa = 
Phosphorylase b, 66kDa = BSA, 46kDa = ?????????, 30kDa = Carbonic 
anhydrase, 21kDa = Trypsin inhibitor, 14kDa = Lysosyme]. 
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3.7.3 - Analytical 213imensional Electrophoresis 
In the first instance to maximise coverage of the analysis we decided to perform 
a selection of analytical two dimensional gels which involved a wide pH range for the 
first dimensional separation from pH3 to pH 10. It is vitally important to optimise load 
amounts by using dilutions of the prepared cell extract to enable visualisation of the 
greatest dynamic range but also to minimise streaking caused by overloading the gel. 
The experiment was carried out in duplicate for cells expressing biotin synthase and 
cells transformed with the pET16b plasmid with no insert as described above. 
Visualisation of protein spots was done using the PlusOne Silver Stain Kit (Amersham 
Pharmacia) which is not compatible with enzymatic digestion and extraction, due to the 
inclusion of glutaraledhyde which crosslinks the embedded protein to the gel matrix. 
The inclusion of glutaraldehyde maximises the sensitivity of the stain to enabling 
visulisation of 0.2 ng of protein per spot. This high stain sensitivity coupled with the 
wide pH range allowed the greatest coverage of the protein mixture for this analytical 
stage. Figure 3.31 shows the acquired 2-Dimensional gel for the control cell extract of 
pET16b transformed cells only and Figure 3.32 shows the 213imensional gel for the 
biotin synthase expressing cell extract of pET 16b/bioB transformed cells. 
The expressed biotin synthase can clearly be observed at approximately 40kDa but 
shows significant streaking across the pH range 3 to 5. A significant proportion of this 
streaking is certainly due to the quantity of biotin synthase loaded but even with this 
relatively low resolving P1 strip several clearly defined biotin synthase spots are 
observed. 
Initial visual comparison can easily identity patterns of similarity between the 2 gels and 
so it was reasonable to believe that this data would be suitable of the more rigorous 
computer based differential mapping analysis as described below. 
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Figure 3.31 - Analytical 2 dimensional electrophoresis Gel of Urea extract from BL21(DE3) cells transformed with pET16b 
plasmid with no insert. 12cm pH3-10 IPG strips used as first dimension and 0.5mm 4-12% Excel Gel used for SIDS-PAGE 
second dimension. Non Mass Spectrometric compatible silver stain (PlusOne, Amersham Pharmacia) used to visualize protein 
bands. Image captured and manipulated with HT-Analyser (Genomics Solutions). 















Figure 3.32 - Analytical 2 dimensional electrophoresis Gel of Urea extract from BL21(DE3) cells transformed with the 
pET16b/bioB plasmid and expressing biotin synthase. 12cm pH3-10 IPG strips used as first dimension and 0.5mm 4-12% 
Excel Gel used for SIDS-PAGE second dimension. Non Mass Spectrometric compatible silver stain (PlusOne, Amersham 
Pharniacia) used to visualize protein bands. Image captured and manipulated with HT-Analyser (Genomics Solutions). 
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3.7.4 - Differential analysis of 2D Gels using HT-Analyser. 
The software used to analyse all 2D gels was the Investigator HT Analyser V.2.1 
which involves a combination of automatic and manual matching of spots from both the 
control and the experimental gel. Although all precautions are taken to ensure the gels 
are run under the same conditions minor dimensional differences inevitability occur. 
Because of this to facilitate matching gel warping is used. Similar spots from the 2 gels 
are matched manually which allows software to warp the gel dimensions and as such 
identify other species with significant overlap between the 2 conditions. Although the 
software allows fully automated spot identification and matching, we found that a large 
amount of manual correction was required to eliminate false matches. For this analysis 
the automated spot matching functions were disabled and spot identification and 
matching performed manually using 'gel warping'. Shown in Figure 3.33 and Figure 
3.34 is the biotin synthase expressing gel highlighting matched and unmatched spots 
respectively. 














36kDa 	 __ 




14k1):t selOW - 
6kDa 
Figure 3.33 - Spots matched (shown blue outline with pink vector) to control gel 
generated from comparison of Figure 3.31 and 3.32. Vector ( ) shows relative position 
shift of matched control spot. Image captured and manipulated with Investigator HT 
Analyser (Genomics Solutions). ID - sample of cell extract run 2 dimension only. 
Labelled regions referred to in discussion. M - molecular weight marker (Mark12, 
Invitrogen) [200kDa = Myosin, 1 l6kDa = a - galactoside. 97kDa = Phosphorylase b, 66kDa = BSA, 55kDa = 
Glutamic dehydrogenase, 36kDa = Lactate dehydrogenase. 31kDa = Carbonic anhydrase, 21kDa = Trypsin 
inhibitor, 14kDa = Lysosyme, 6kDa = Aprotinin, 3.5kDa = unresolved Insulin] 
ID 
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From this analysis we were able to identify an area of the gel which shows several 
species which are completely absent in the control gel. Our assumption is that these are 
directly associated with the over expression of biotin synthase within the cell. 
The majority of spots observed on the gel where the cell line is expressing biotin 
synthase were able to be matched directly to equivalent spots on the control gel as 
shown in Figure 3.33, however many of the matches showed significant intensity 
decreases which may have arisen due to the expression of biotin synthase but this proved 
difficult to ascertain due to general protein concentration reduction seen as a result of 
protein over expression. In a similar experiment this phenomenon was observed where 
the bioH gene product was over expressed and cell extract compared to control sample, 
both were analysed by 2D Electrophoresis. 
Figure 3.34 highlights spots and regions ( to ) which could not matched to any 
observed species on the control gel. Spot is observed at approximately 95-90 kDa and 
although not matched is of very low intensity. This particular species is not 
distinguishable in the control gel and this is most likely due to the streaking that 
occurred in this region resulting in the combination of two species. The large region 
clearly shows the biotin synthase protein species at approximately 40kDa as expected 
however this species shows a huge horizontal streak from approximately pH3 to pH6. 
Whereas a large majority of this streak is due to the quantity of expressed biotin 
synthase resulting in overloading of the strip in this region, several significant well 
defined species lie within the region of pH 5 to 6. 
This suggests that the in vivo expression of biotin synthase results in a number of 
different species with various defmed pt's. The theoretical p1 of biotin synthase as 
estimated examination of the primary sequence is 5.8. This gel suggests that this is a 
reasonably accurate it is clear that several distinct species are present in this preparation. 
Spot is of apparent molecular weight of approximately 5OkDa and is an irregular 
shape and is of very low intensity, it is likely that the identification of this area as a 
protein spot is incorrect and colour intensity in this region is due to irregularity of image 
while captured. Spots and seem to be have high intensity and regular shape 
consistent with regular protein species. Spot seems to be a single species whereas the 
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area highlighted in appears as if it consists of at least 3 species which have not been 
fully resolved in the gel. 
From this initial analysis it seems reasonable to focus on the identification of the species 
found in areas and as well as confirming the identity of the species in area 
assumed to be biotin synthase. 
With our targets clear we repeated the analysis to include the following variations, firstly 
we narrowed the pH range of the first dimension and the gels were silver stained using a 
modified protocol compatible with Mass Spectrometry. The Immobilized pH gradient 
strips were changed from the pH 3-10 range to pH 4-7 in an attempt to resolve the mixed 
species shown in area of Figure 3.34. The modified Silver Stain protocol excludes 
Glutaraldehyde and Formaledhyde which are used to fix protein to the gel matrix thus 
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Figure 3.34 - Spots unmatched (shown blue) to control gel generated from comparison of 
Figure 3.31 and 3.32. Image captured and manipulated with Investigator HI Analyser 
(Genomics Solutions). ID - sample of cell extract run 2n d dimension only. Labelled regions 
referred to in discussion. M - molecular weight marker (Markl2, Invitrogen) [200kDa = Myosin, 
1 16k0a = a :galactoside, 97kDa = Phosphorylase b, 66kDa = BSA, 55kDa = Glutan,ic dehydrogenase. 36kDa = 
Lactate dehydrogenase, 31kDa = Carbonic anhydrase, 21kDa = Trypsin inhibitor, 14kDa = Lysosyme, 6kDa = 
Aprotinin, 3,5kDa = unresolved Insulin] 
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3.7.5 - Spot Picking and Protein Identification by MALDI-ToF-MS and 
Database Querying 
As discussed the species outlined above were our initial targets for identification 
as our analysis suggests that these species are directly associated with the in vivo 
production of biotin synthase, in particular the region from Figure 3.34 which 
corresponds to species 5 to 13 in Figure 3.35. As well as these species we also attempted 
to identify some of the higher abundance proteins present in both control and biotin 
synthase expressing gels to act as internal corroboration of our experimental procedure. 
Shown in Figure 3.35 is the gel resulting from a biotin synthase expressing cells using 
the truncated pH gradient of pH 4-7, spots highlighted and labelled are gel regions 
excised for in-gel digestion with trypsin and subsequent MALDI-ToF-MS analysis and 
database searching. 
All excised gel portions were treated and digested with trypsin as described in Section 
2.24.1 samples were desalted using C18 ZipTips (Millipore) as manufacturers 
instructions and analysed by MALDI-ToF-MS as described in Section 2.29 using CHCA 
matrix (Section 2.2). Spectra were analysed by DataExplorer software (Applied 
Biosystems) resulting in a monoisotopic mass list internally calibrated with observed 
trypsin autolysis peaks which was used to query the SwissProt and OWL non-redundant 
databases (all species). Databases were queried using ProteinProspector 
(http://prospector.ucsf.edu )) and Mascot (http ://www. matri xscience.conif) search 
engines and results compared for consistency and to increase validity of identification. 
Excised areas of gel that produced valid database hits are highlighted in liht t , rccu and 
non-valid hits are highlighted in dark green in Figure 3.35 and table in Figure 3.36 
below shows all identified species and their corresponding database hits found from both 
ProteinProspector and Mascot search engines. 
Highlighted sections of the gel 5, 6 and 11 to 14 when analysed produced no significant 
hits corresponding to E. coli proteins with molecular weight within the region of the gel 
that the protein spot was visualized. These regions varied in spot intensity but the 
species of greatest intensity with which we failed to identify a protein was spot 14. MS 
fingerprint data from species I and 2 both showed extremely high statistical scores 
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Figure 3.35 — Spots excised (shown blue) for subsequent in-gel digestion with trypsin 
and MALDI-ToF-MS analysis. Identified and non identified spots labelled in light green 
and respectively. Labelled regions referred to in discussion. M — molecular weight 
marker (Markl2, Invitrogen) [200kDa = Myosin, 116kDa = a - galactoside, 97kDa = Phosphorylase 
b, 66kDa = BSA, 55kDa = Glutamic dehydrogenase, 36kDa = Lactate dehydrogenase, 31kDa = Carbonic 
anhydrase, 21kDa = Trypsin inhibitor, 14kDa = Lysosyme.] 
(4xl0 11 ) for the identity of these species both being Heat Shock Protein 70 (Hsp70, 
Ac# K01298) which suggests very low probability of random identification. Hsp70 has a 
mass of approximately 69kDa and p1 of 4.83 which both correspond to the mobility of 
this species we observe in this 2DE experiment adding further to the evidence of the 
correct identification. MS fingerprint data of species 3 shows even greater statistical 
probability for its top hit which in this case was GroEL with a score of 1.7x10 17, the 
GroEL protein has mass and p1 of 57kDa and 4.82 respectively which again shows good 
consistency with the mobility of the species 3 we observed. During the gel comparisons 
we identified that biotin synthase shows a huge amount of streaking across the pH range 
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between 4 and 5 which is again seen in this gel however the streaking is more 
pronounced but the section of this streak shown by section 4 in Figure 3.35 was analysed 
alongside the unknown species and this surprisingly produced a lower statistical score 
than the two previous samples of 2.63xl0 6 but this remains good conformation of the 
identity of biotin synthase. The lower statistical score could be directly due to the 
streaking which could cause a decrease in protein concentration in a specific area. the 
theoretical mass and p1 make this an unlikely candidate being the region is due to the 
degree of loading it was impossible to identify other species that may lie within this 
region but these could affect the resultant mass list and subsequent database search. Gel 
portion 7 shows a very strong statistical hit for a putative sidephore receptor (IreA) but 
was excised from a region approximately 30kDa and pH 4.25 suggesting an incorrect 
identification and may demonstrate the importance of initial arbitrary information from 
the 2 Dimensional Gel. The other hit for species 7 and hits for species 8, 9 and 10 are E. 
coli biotin synthase with statistical probabilities varying from 1890 down to 375. 
Although these hits are of fairly low probability upon further analysis it was clear that 
the peptides identified corresponding to biotin synthase were located within fairly 
restricted regions of the linear sequence. These species, are therefore assumed to be 
major breakdown products of biotin synthase and not a separate species up-regulated as 
hoped for. The final species identified was an outer membrane protein found from the 
spectra obtained from region 15 of the gel. This showed high statistical probability and 
theoretical mass and p1 correlation enhancing the identification. 
3.7.6 - Conclusions of Differential Expression Analysis of Biotin 
Synthase 
Our aim form the differential analysis was to identify possible in vivo protein 
partners of biotin synthase by means of up-regulation due to the over-expression. As 
discussed above the protein spots initially identified as the main targets of the analysis 
were eventually identified to be breakdown products of biotin synthase. Several species 
were identified easily from the gel proving the validity of the experimental conditions. 
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Unfortunately in this analysis, we were unable to demonstrate that the over-expression 
of biotin synthase results in the appearance or upregulation of cell protein component(s). 
Gel Protein ID Species Mass(kDa)/pI Accession # Mouse 
portion - Score 
I Hsp70 E.coli 69/4.83 K01298 4.7x10 1 ' 
2 Hsp70 E. co/i 69/ 4.83 K01298 3.6x10 ° 
3 GroEL E. co/i 57/4.82 AE000487 1.69x10 7 
Unknown E. co/i 58/4.85 X07850 1.7x10'7 
4 Biotin synthase E. coli 38.5/5.32 AE000I8O 2.63x10*6 
7 
Putative sidephore receptor 
E. co/i 75 /6.04 AF320691 1.34x10 3 
(IreA) 
Biotin synthase E. coli 38.5/5.32 AE000 180 658 
8 Biotin synthase E. co/i 38.5/5.32 AE000180 513 
9 Biotin synthase E. co/i 38.5/5.32 AE00018O 1.89x10 3 
10 Biotin synthase E. co/i 38.5/5.32 AE00018O 375 
15 Outer Membrane protein E. co/i 27/9.16 L37088 9.77x10 4 
Figure 3.36 - Table showing database hits for fingerprint spectra found for species 
highlighted in 2D-Gel in Figure 3,35. Species where no strong hits were found are 
excluded. 
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3.8 - Structural Analysis of purified 61-lis-Biotin Synthase 
3.8.1 - Anion Exchange Chromatography of purified Biotin Synthase 
Several distinct species of expressed protein were observed during the 2 
Dimensional Gel Electrophoresis analysis of expressed biotin synthase. Thus we 
concluded that several distinct and definable ionic species of the protein exist. These 
different species are normally unrecognised due to co-elution of these during low 
resolution anion exchange, Ni affinity chromatography and standard 1 D SDS-PAGE. To 
elucidate and differentiate these species we have performed high resolution analytical 
anion exchange chromatography on the purified 6His-BS protein using the Amersham-
Biosciences I ml MonoQ column. This column has a maximum binding capacity of 10 
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Figure 3.37 - Elution profile of 6His-BS from MonoQ anion exchange column, during a 0 to 
500mM NaCl gradient. Monitored wavelengths are I and 425nm are shown and 
3 major species indicated with arrows. Inset is UV-Vis 250-600nm scan of three major species 
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During this analysis approximately 10 mg of purified biotin synthase (as judged by 
Bradford Assay (166)) which was stored in 50 mM Tris-HCI, pH7.5, the sample was 
loaded at I ml/min. During loading the top of the column packing was visually red in 
colour. The mobile phases used were Buffer C and D as described in Section 2.2 and the 
elution profile was optimised using 6His-BS. A 0 to 500 mM NaCl gradient over 100 
CV was used to elute protein from the column and elution was monitored at 280 nm, 330 
nm and 425 nm wavelengths, 1 ml fractions collected. Column was cleaned with a 500 
mM to 2 M NaCl gradient and re-equilibrated with 0 mM NaCL for 30 mm. 
We identified several species in our purified 6His-BS and these produced a complex 
elution profile with the major peaks eluting at approximately 218 MM, 240 mM and 314 
mM NaCl. This profile from this high resolution analysis differs to the previously 
observed single peak for other chromatography profiles. A plot of the elution profile for 
6His-BS is shown if Figure 3.37 and a similar profile is observed for all the monitored 
wavelengths. 
0 	 10 	 20 
	
30 	 40 	 50 
Figure 3.38 - Pileup of elution profiles for 6His-13S, apoBS fresh PLP loaded 
BS and 6His-BS muants. Trace shows absorbance at 280nm of sample across 
0-500mM NaCl gradient. Profiles are offset by 200units to clarify diagram. 
Differences from 6His-BS are indicated. 
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The wavelengths 330 nm and 425 nm were monitored in addition to 280 nm, as these are 
typical maxima for [Fe-S] cluster containing species. These observations suggest that all 
species contain some form of (Fe-S] cluster and that the observed phenomenon is not the 
result of holo and apo forms of the protein. Inset in Figure 3.37 is the progressive IJV-
Vis scan of the 3 major peaks (1, 2 and 3), indicated with arrows. These all show 
identical absorbance characteristics which importantly display the maxima observed for 
the purified BS as described in Section 3.3. 
The experiment was repeated using the same conditions as described above with apo-BS 
BS freshly loaded with PLP and all biotin synthase mutants available to us as described 
in Section 3.2. The elution profiles for all BS mutants, 6His-BS and apo-BS are shown 
in Figure 3.38, this figure shows the absorbance measured at 280 nm only, for clarity 
and variations from 6His-BS are highlighted. All differences observed are reproduced in 
all 3 monitored wavelengths (280 nm, 330 nm and 425 nm). Biotin synthase freshly 
loaded with PLP shows little difference, however we do observe a small increase in the 
absorbance of the satellite peaks observed adjacent to the major peaks 2 and 3. The trace 
for apoBS shows a complete lack major species 3 but does display the other peaks, 
including the satellite peaks. The observed satellite peaks seem to be enhanced by 
loading fresh PLP. The BS-K49Q mutant demonstrates an enhancement of the first 
elution species to equivalent absorbance value of the major species observed for BS 
wild-type, however similarly to apoBS this protein shows an almost complete lack of the 
species 3. In comparison the BS-K49R mutant resembles the 6His-BS trace to a large 
degree however much peak broadening is observed for all 3 major peaks. Clearly the 
greatest difference in profiles was observed for the double cysteine mutants, C53/60S 
and C53/57S, which both display a complete lack the definition which is observed for 
the other protein samples. Both double mutants show a single broad peak which elutes 
with a front edge at approximately 250 mM NaCl, peaking at around 370 mM NaCI and 
trailing edge above the 500 mM limit. 
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3.8.2 - Size Exclusion Chromatography of Purified Biotin Synthase 
The analysis of the various biotin synthase proteins was also performed using the 
Superdex200 analytical, 36m1, Size Exclusion column from Amersham-Biosciences. 
The Superdex200 column has a dynamic separation range from 1 OkDa to 600kDa which 
would allow separation of monomer and up to and including a BS octomer. 
The protein samples were loaded, approximately I mg / sample / run, and a 40m1 
isocratic elution performed at 1 ml/min using 50mM Tris-HCI, pH7.5 + 100mM NaCI 
and elution monitored at 280, 330 and 425nm. As shown in Figure 3.40 BS wild-type 
showed similarly complex profile but displays this with apparently inverted topography 
to that observed for anion exchange analysis. The lowest abundant peak is observed first 
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Figure 3.40 - Elution profile of 6His-BS from Superdex 200 size exclusion column, 
during a 36m1 isocratic elution with 50mM Tris-HCI, pH7.5 + 100mM NaCl. Monitored 
wavelengths are 280nm, and are shown and 3 major species indicated 
with arrows. 
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The major species follows and this demonstrates a very sharp elution returning to 
baseline within 1-2 ml. As observed in the anion exchange analysis all of the observed 
species demonstrate absorbance at 280, 330 and 425 nm suggesting all contain some 
form of [Fe-S] cluster. As these species demonstrate similar profiles for all monitored 
wavelengths this comparison we focus on the 280 nm wavelength for clarity. Again 
large differences are observed between the BS mutants, 6His-BS and apoBS. The profile 
of apoBS is very similar to that of 6His-BS but absorbance at 330 nm and 425 nm are 
almost totally absent. The main difference lies in the lack of the shoulder present prior to 
the first elution species as indicated in Figure 3.41. The profile of the BS-K49Q protein 
displays significant differences to the 6His-BS in that a formation of a highly abundant 
species of higher mobility, however it the two major species observed for 6His-BS are 
still present but with lower relative abundance. Of all the mutant proteins the profile of 
BS-K49R resembles 6His-BS to the largest degree and the only observable difference is 
the resolution of the early eluting shoulder species into a peak, overlapping with the later 
higher abundant peak. Both double cysteine mutants show a long shallow elution profile 
from the high molecular weight range and this continues to around the 1 OOkDa range. 
BS C53/57S demonstrates a more pronounced higher mobility species similar to that 
seen for BS-K49R but BS-053/60S seems to be an even distribution across the range. 
The molecular weight of the observed species can be gauged from the elution of the 
three standard proteins, Alcohol Dehydrogenase (1 50kDa), holoTransferrin (81 kDa) and 
Ovalbumm (43kDa) and their theoretical masses, inset Figure 3.41. 
We observed no monomeric BS species based on the monomeric 43kDa Ovalbumin 
standard protein. The major species, in the case of 6His-BS, displays an elution time 
preceding the 81 kDa holoTransferrin standard and after the 15 8kDa Alcohol 
Dehydrogenase standard. This elution time would suggest a wide dimer configuration of 
BS. Previous experiments with native gel electrophoresis suggest predominantly a 
dimeric structure of 104kDa with a [2Fe-2S] cluster per monomer (68). A study by 
Hernandez et al. utilises native protein Mass Spectrometry to observe a variety of 
monomer and dimer species containing a variety of [Fe-S] clusters and other 
modifications (173). With these studies in mind our observations make it likely that the 
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elution times correspond to an 'open conformation' dimer with bound [Fe-S] cluster(s). 
The second major species, displaying higher mobility, could perhaps correspond to a 
tetramer with similar modifications. As described above the BS-K49Q and double 
cysteine mutant proteins show a variety of species of much higher apparent MW which 
could be due to the formation of a large multimeric compexes or chains with little 3 
dimensional structure which thread through the column packing. 















16 	17 	18 	18 	20 
Protein Monomer (Do) Dimer (Do) Trimer (Da) Tetramer (Do) 
6HisBS / BS-K49Q / apoBS 39,670 79,340 119,010 158,680 
BS-K49R 39,698 79,396 119,094 158,792 
BS-053/57S / BS-053/60S 39,638 79,276 118,914 158,552 
Figure 3.41 - Pileup of isocratic elution of biotin synthase and mutant proteins 
monitored at 280nm. Standard protein traces are inverted (Alcohol Dehydrogenase 
(1500a), holoTransferrin (81kDa) and Ovalbumin (43kDa). Theoretical apo-BS 
quaternary structure molecular weights are shown in table. 
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3.8.5 - Limited Digestion of as Purified and Prepared Apo Biotin 
Synthase Protein Samples 
Aerobically prepared BS in reported to contain one or two [2Fe-2S] (68, 90, 7, 
174). To investigate the effect of the presence of this cluster on protein structure a 
limited digestion experiment was performed. Samples of our purified 6His-BS and 
apoBS were subjected to a limited digestion experiment. The apoBS was prepared as 
described in Section 2.20 and as previously reported (164, 141, 86) anaerobically in N2 
with sodium dithionite and EDTA and apoBS was re-purified from reduction buffer with 
PD1O gel filtration column before removal to normal atmospheric conditions. 
Protein samples (1 mg) were incubated with 5 ng of the endoproteinase Asp-N for 
specific time periods and reactions stopped with addition of SDS-sample buffer and 
boiling for 5mm. All samples were run on SDS-PAGE gel as shown in Figure 3.42 and 
protein bands were visualized using GelCode reagent (Pierce). The band intensity can be 
used as a comparative protein concentration indicator with a good linear dynamic range 
as equal quantity was loaded in each lane. The gel was analysed with the Phoretics 2D 
software (NonLinear) to show band intensity along a single SDS-PAGE gel lane. Time 
course profiles for each sample are shown either side of gel and traces are shown in 
corresponding colours as lane label. The BS wild-type time course shows clear 
formation of several species of lower molecular weight than the monomer within 10 mm 
and the intensity of these species remains fairly constant throughout the 25min time 
period. The species observed at higher molecular weight are thought to be protein dimer 
and this is slowly reduced over the 25min incubation. The intensity of the "parent" 
monomer band appears to remain constant but as concentration of protein used was 10 
.tg/jtl it was in great excess and most likely above the upper limit of the protein stain. 
Clearly species with similar molecular weight are formed in the apoBS digestion 
however they are formed in a shorter time period and to much higher relative 
concentration. This suggests a greater lability of the protein to AspN proteinase 
digestion. However no species exclusive the apoBS are observed. Although the [Fe-S] 
cluster appears not to directly block an accessible AspN site, the structure is 
considerably more open or disordered allowing a much more rapid digestion of the 
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protein. In both cases we observe 6 major bands with apparent MW greater than 6 kDa 
which could correspond to a single cleavage at solvent exposed Asp residue. Subsequent 
cleavages resulted in the digestion of the protein into smaller species. To help in the 
characterisation of these species the gel was calibrated using the using the Phoretics 2D 
software and themolecular weight marker as standards. This allowed estimations of the 
molecular weight of each observed protein bands to be made. Figure 3.43 shows a single 
lane from the gel above and the molecular weight marker, the associated table shows the 
calibrated molecular weight for each species based on a First Order La Grange migration 
of the marker proteins. Inevitably this type of MW estimation of gel migrated species is 
inherently inaccurate and we believe that species A and B are likely to be the species 
observed by Sanyal et al. by native gel electrophoresis of 82kDa and I O4kDa. These are 
attributed to homodimers with one [2Fe-2S] per dimer and two [2Fe-25] per dimer 
respectively. The observation of these species under the denaturing and reducing 
conditions of SDS-PAGE suggests very tight complexation and binding of the clusters. 
The estimation of band C, presumed biotin synthase monomer shows good correlation 
with the calculated 39,670 Da molecular weight of the 6His-BS linear protein sequence. 
Observed species of calibrated molecular weight range from approximately 29 kDa to 8 

















Chapter Three: Results and Discussion 
E 	 I 
	
- © 	 = 
to — — — 	 sm 
,...w w.www 
1 
J 	 — 
As purified 6His- BS 	 apo 6His-BS 
Figure 3.42 - Profile analysis of Limited digestion of as purified and apo biotin 
synthase with endoproteinase Asp-N. Traces at side of gel are intensity plots for 
each lane in corresponding colour. Centre lane is SeeBlue2 molecular weight 
marker. [188kDa = Myosin, 98kDa = Phosphorylase b, 62kDa = BSA, 49kDa = Glutamic 
dehydrogenase, 38kDa = alcohol dehydrogenase, 28kDa = Carbonic anhydrase, 18kDa = 














Figure 3.43 - Calibrated molecular mass of species observed during the 
limited digestion of as purified biotin synthase protein with Asp-N. 
Calibration performed using the SeeBlue2 molecular weight marker as 
mass standards. [188kDa = Myosin, 98kDa = Phosphorylase b, 62kDa = BSA, 49kDa = 
Glutamic dehydrogenase, 38kDa = alcohol dehydrogenase, 28kDa = Carbonic anhydrase, 
lBkDa = Myoglobin, 14kDa = Lysosyrne, 6kDa = Aprotinin, 3,5kDa = unresolved Insulin] 
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3.8.6 - HPLC-RPC of Limited Digestion samples of Biotin Synthase 
For further analysis and purification of samples for mass spectrometry the 
limited digestions were repeated on large scale, small quantity of sample removed for 
SDS-PAGE and remaining sample incubated with or without DTT for 15min at room 
temperature. These samples were directly loaded on C5-RP-HPLC column. The HPLC 
elutions were monitored at 280 nm and I min fractions collected throughout the elution. 
As observable in Figure 3.44 the elution profiles differed greatly between apoBS and as 
purified 6His-BS as previously discussed. Interestingly differences were also observed 
between reduced and non reduced samples. All fractions were collected and stored at - 
20°C before further analysis. The reduction of the samples yields peaks just preceding 
the major species, undigested 6His-BS, the enhancement of these may due to the 
formation of enzymatic fragments, which remain linked to the main species until 
reduction. The 3 peaks of retention time in the region of 13 to 16 mm show increased 
intensity for apoBS compared to as purified which suggests the intensity is similarly 
affected by the presence of the [Fe-S] cluster as observed for some of the species in 
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Retention time (mm) 
Peak 
A B C D 
1 1.93 1.96 1.67 1.93 
2 12.46 2.97 12.50 304 
3 1340 12.57 13.34 12.43 
4 14.87 13.39 14.91 13.35 
5 19.00 14.98 19.10 14.95 
6 19.60 18.47 19.84 18.43 
7 19.06 21.25 18.99 
8 19.84 19.81 
9 21.25 
A B 	CD 
ik. 
0) 
Figure 3.44 - Traces of 280nm monitored C5-RP-H PLC purification of limited digestion of biotin synthase samples. A = 6His-BS, 
B = 6His-BS reduced, C = apo6His-BS, D = apo6His-BS reduced. Control sample trace is shown and all samples shown as run on 
SDS-PAGE with molecular weight marker (Sigma, 96kDa, 66kDa, 45kDa, 30kDa, 26kDa and 14kDa) 
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3.8.7 - Mass Spectrometry of HPLC Purified Limited Digestion 
Fragments of Biotin Synthase 
Each fraction from the HPLC purification described in Section 3.8.6 was 
spotted with Sinapinic acid Matrix directly onto MALDI target plate and analysed 
using the Applied Biosystems Voyager DEThSTR using a low and high lazer power 
to maximise observation of peptides from all mass ranges. Spectra were acquired for 
all fractions in samples A, B, C and D from Figure 4.44, species observed above 6 
kDa were used in the subsequent analyses. Spectra were analysed and each mass list 
used to search theoretical Asp-N digestion allowing identification of fragments in 
each fraction. 
Exclusion of peptides less than 6kDa was to filter the mass list the range observable 
by SDS-PAGE. The masses of observed species meeting these criteria were 
assembled and duplicates removed providing definitive list of observed 
protein/peptide species found for each sample (A to D). The final mass list was used 
to search the theoretical biotin synthase Asp-N map as previously described using 
PAWS software the results of which are shown in Figures 3.45 to 3.48. The Figures 
show all obtained masses and their identified section of the BS sequence identified 
according to measured mass. Identified regions are referenced and coverage map 
shows region of protein found for each species. Two abundant species are seen at 
mass 38,445Da and 38,66213a which correspond to the final 11 and 9 residues being 
cleaved from the protein resulting in a species which would be virtually 
indistinguishable from undigested protein by SDS-PAGE Ref # 5 and 6. Fragments 
of the protein are observed originating from a single cleavage at leaving the N-term 
intact (Ref # 1,2,3 and 7) suggesting the Asp sites 64, 117, 156, 189 and 242 are 
solvent exposed and available for digestion with the protease when the 6His-BS is in 
buffered solutions. 
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Al - 6His-BS non reduced 
Ref. # Mass Obs. (Da) Match 
1 7,450.52 M[1-63]E 
2 13,454.38 M[1-116]R 
3 17,593.20 M[1-155]L 
4 26,975.95 M[1-241]A 
5 38,445.97 M[1-343]P 
6 38,662.16 M[1-345]T 
7 21,665.88 M[1-189]R 
8 9,894.25 D[30-1 16]R 
9 8,305.35 D[1 17-189]R 
10 14,431.43 D[117-249]F 
11 9,400.76 D[156-241]A 
12 10,292.61 D[156-249]F 
13 8,480.82 D[163-241]A 
14 13,373.50 D[183-306]E 
15 7,540.56 D[242-308]K 
16 11,704.230 D[242-345]T 
17 12,486.09 D[244-354]L 
18 10,812.38 D[250-3451T 
Figure 3.45 - Table and PAWS map of peptides 01 
mass >6kDa found for limited digest of as purifiec 
61-lis-BS after purification on HPLC and MALDI-ToF 
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A significant number of the observed species seem to originate or terminate within 
the region of D242. All species containing peptides after this region originate from 
this narrow area of the protein sequence. With the exception of the almost entirely 
undigested protein only one species was observed that traversed this D242 region 
(Ref # 14) which suggests extremely high lability of this site/region for proteolysis 
and a therefore a possibly disordered linker/loop region. The reduced sample of 
6His-BS digestion (B - Figure 3.46) displays many similarities with the non reduced 
sample including the ladder of species consisting of residue ito 63, 116, 155, 162, 
182 and 241 (Ref # 1-6). However it does contain more species whose mass would 
correspond to species with 2 Asp sites cleaved. These are tend to be toward the N-
terminal end of sequence. 
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This results in species such as D[44-1 16]R shown as Ref# 8, 9 and 10. In this case 4 
species are observed that traverse the D242 region (Ref 16, 17, 18 and 19) which all 
suggests that the reduction of the protein with DTT has somehow destabilised the 
protein structure, and as such some further Asp sites are made available. 
The two samples of digested apoBS show very similar coverage and fragments to the 
reduced as purified 6His-BS as shown in Figures 3.47 and 3.48 but again it is clear 
that more species are observed when the sample is reduced after the limited 
digestion. Interestingly in the case of both reduced samples the final 26 amino acids 
are not observed whereas the whole sequence is covered when the digested sample is 
left unreduced. This may suggest that the C-term of the protein is linked via a 
reducible chemical bond which would be typically a disulfide. Although less 
pronounced, the region containing residues 242 to 250 seems to be a labile region 
and the existence of 5 Asp residues within this, results in a number of cleavages that 
yield a singly dissected protein chain. 
BI - 6His-BS reduced 
Ref. # Mass Obs. (Da) Match 
1 7,452.52 M[1-63]E 
2 13,454.38 M[1-116]R 
3 17,593.20 M[1_155]L 
4 18,513.15 M[1-162]L 
5 20,899.75 M[1-182]L 
6 26,975.95 M[1-2411A 
7 38,445.97 M[1-3431P 
8 9,894.25 D[30-1 16]R 
9 8,144.31 D[44-116]R 
10 10,158.69 D[64-155]L 
11 14,307.20 D[64-189]R 
12 8,305.35 D[117-189]R 
13 13,539.59 D[117-241]A 
14 9,629.96 D[156-243]N 
15 16,680.04 D[156-306]E 
16 16,938.47 D[156-308]K 
17 12,531.54 D[190-306]E 
18 10,746.45 D[209-306]E 
19 7,540.56 D[242-308]K 
20 11,704.23 D[242-345]T 
21 8,813.24 D[250-328]G 
Figure 3.46 - Table and PAWS map of 
peptides of mass >6kDa found for limited 
digest of reduced as purified 6His-BS after 
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IC - apo6His-BS non reduced 
Ref. # Mass Obs. (Da) Match 
1 13,454.38 M{1-116]R 
2 17,593.2 M[1-155]L 
3 18,513.15 M[1-162]L 
4 20,899.75 M[1-182]L 
5 26,975.95 M[1-241]A 
6 38,662.16 M[1-345]T 
7 9,894.24 D[30-1 16]R 
8 10,158.69 D[64-155]L 
9 27,063.98 D[64-308]K 
10 7,463.39 M[1-63]E 
11 10,090.44 D[117-208]K 
12 13,539.59 D[117-241]A 
13 9,745.04 D[156-306]D 
14 16,680.04 D[156-306]E 
15 6,094.22 D[183-241]A 
16 12,531.54 D[190-306]E 
17 7,540.56 D[242-308]K 
18 11,704.23 D[242-345]T 
19 12,715.28 D[242-354]L 
20 6,648.71 D[250-308]K 





Chapter Three: Results and Discussion 
This interesting data provides some convincing evidence as to some of the solvent 
exposed regions of the protein. However as the data is based on mass only 
identification and a further study utilising duel digestion was undertaken to produce 
some more convincing evidence that the observed masses have been correctly 
assigned to the protein chain. 
Figure 3.47 - Table and PAWS map of N# 
peptides of mass >6kDa found for limited 	
1 3 5 7 9 11 13 15 17 19 21 
digest of reduced as purified apo-BS after 
purification on HPLC and MALDI-ToF and 
PAWS analysis. 
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[D] - 6His-BS reduced 
Ref. # Mass Obs. (Da) Match 
1 13,454.38 M[1-63]E 
2 26,975.95 M[1-241]A 
3 17,593.2 M[1-155]L 
4 18,513.15 M[1-162]L 
5 20,899.75 M[1-182]L 
6 7,452.52 M[1-63]E 
7 23,974.33 D{30-246]V 
8 6,019.87 D[64-116]R 
9 19,541.44 D[64-241 ]A 
10 11,078.64 D[64-162]L 
11 27,063.98 D[64-3081K 
12 14,431.43 D[117-249]F 
13 10,090.44 D[117-208]K 
14 16,680.04 D[156-306]E 
15 8,480.82 D[163-241]A 
16 6,094.22 D[183-241]A 
17 12,531.54 D[190-306]E 
18 10,746.45 D[209-306]E 
19 13,154.24 D[209-328]G 
20 11,704.23 D[242-345]T 
21 6,738.79 D[247-306]E 
22 10,812.38 D[250-345]T 
23 8.813.24 D[250-328]G 
Figure 3.48 - Table and PAWS map of 	N 
peptides of mass >6kDa found for limited 
digest of reduced as purified apo-BS after 




1 	3 5 	7 9 	
11 13 15 17 19 21 23 
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3.8.8 - Dual digestion of Biotin Synthase for Structural Mapping 
To further substantiate that the limited digestion fragments of biotin synthase 
identified in Section 3.8.7 were correctly assigned a scheme was devised involving a 
dual endoproteinase digestion. This samples were analysed using MALDI-ToF and 
data compared using the PAWS maps of the protein. The scheme is outlined in 
Figure 3.49. Essentially the initial limited digestion was performed and SDS-PAGE 
used as a 1D separation technique. 
Bands were observed using coomassie stain (as shown in Figure 3.42/43). Bands 
were excised and in-gel digestion with trypsin performed on each. The doubly 
digested samples were prepared as previously described for MALDI-ToF and 
acquired peptide spectra deisotoped. The resultant mass lists were used to search the 
PAWS trypsin digestion map. The identified peptides were then super imposed onto 
the theoretical PAWS Asp-N digestion map. The observation of a trypsin peak from 
a specific Asp-N fragment was used as evidence of the presence of that Asp-N 
derived peptide in the band excised (see figure 3.49). 
Bands C and E to J (Figure 3.43) were excised from the gel and digested with trypsin 
as described above. The result of this analysis is shown in Figure 3.50 where 
identified Asp-N regions are shown compared to linear sequence. The of the 
linear sequence was not observed at any point and this could be due to these peptides 
not ionising or this region is very quickly digested. If this is the case species B and C, 
are the identified species Ref 5/6 from Figure 3.44. In this case the intact protein has 
had final 11 and 9 amino acids cleaved respectively. Similarly no evidence was 
found for the presence of Asp-N fragments 6, 7 and 8 in Band C, or any other bands, 
and this could again be due to a double cleavage causing a extraction of a region of 
the chain from the protein, however no species corresponding to this mass was 
observed. Band E shows a coverage matching the essentially intact protein up to the 
Asp rich region 242-249 exclusively and no evidence is found for any peptides 
toward the 
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Figure 3.49 - Scheme showing the protocol used for dual digestion to provide 
further evidence for previously identified Asp-N fragments of biotin synthase. An 
initial limited digestion was separated by SDS-PAGE and bands individually excised 
and in-gel digestion was performed with trypsin. Trypsin fragments were identified 
with MALDI-ToF and compared to theoretical Asp-N digestion map, thus showing 
existence of a specific Asp-N derived peptide in corresponding gel species. 
Residue Number 	






H. n d ( 
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Hand I 
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Figure 3.50 - Map of Asp-N derived peptides of biotin synthase found in bands 
C and E to J using dual digestion method. Species are shown offset and in 
correspondinci colours compared to linear seauence and theoretical diciestion. 
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As suggested (shown in Figure 3.43, Ref 4) this region, is cleaved quickly and 
efficiently, and thus resulting in two sections of biotin synthase. The CW,,n  portion of 
this single cleavage seems to be very labile compared to the as no evidence is 
found for this Cterm  fragment intact. However this is strong evidence that the section 
to the Nte side of this region is both soluble and resistant to digestion and so 
structurally distinct. The hypothesis of this region being a boundary between 
domains is strengthened by this evidence. The remaining bands produced a variety of 
identified regions of the protein which correspond to species with very similar 
molecular weight to others and so would be found with similar SIDS-PAGE mobility. 
Several species identified in Figure 3.43 can be paired with the equivalent region of 
the protein identified with the dual digestion methodology. As discussed above Band 
C shows constancy with species Ref 5 and 6 also Band E demonstrates good 
consistency with species Ref 4. All consistent data is summarized in Figure 3.51. 
Digestion and Calibration 
of SDS-PAGE (fig 3.46) 
HPLC purify and MALDI mass 
observation. (fig 3.48) 
Dual Dig region mapping 
(fig 3.53) 
Band ID Cal MW Obs. Mass Match region Region Obs. Consistent? 
C 39.6kDa 38,445Da [1-343] 
38,662Da [1-345] [1-345] 
E 29.1kDa 26,975Da [1-241] [1-241] 1 
[1-249] 
F 21.6kDa 21,665Da [1-189] (1-189] 1 
[209-343] 
G 18.3kDa 17,593Da [1-155] [30-155] 1 
H 13.1kDa 13,454Da [1-116] [30-116] 1 
14,431 Da [117-249] 
13,373Da [183-306] [250-306] 1 
11.4kDa 10,292Da (156-249] [209-244] 1 
11,704Da [242-345] [250-343] VI 
12,486Da [244-354] - - - 
1f' 
10,812Da (250-345] - - - 
I 





4gnn, 11..9&11 le 
Figure 3.51 - Table showing summary of limited digestion analysis by Gel calibration, 
HPLC purification and MALDI and Dual digestion protocol. Data found to be consistent in 
all 3 analyses shown ticked in table. Selected sequences are shown mapped to crystal 
structure in Figure 3.55. 
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As a crystal structure of E. co/i biotin synthase was published during the preparation 
of this manuscript a comparison of the identified fragments, and their associated 
cleavage sites was possible by mapping identified regions onto the crystal structure 
as shown in Figure 3.52 below. 
Firstly, it is interesting to note that of the major species identified during the analysis 
all display the cleaved residues at surface exposed regions of the protein. Closer 
inspection of the mapped structures reveals an intriguing structural feature. Almost 
all structures in Figure 3.52, with the exception of E, tend to separate the structure 
into 2 sections best described in structure A. Intriguingly when this is compared to 
the crystal structures of SAM dependant enzymes (Figure 1.17) this roughly 
corresponds to the structurally conserved region of these 3 crystal structures. This 
may suggest that it is this larger N terminal section that is the reproduced in these 
enzymes. Firstly the main body of the protein, red in this case, consists of 
approximately residues 4 to 240 and a second section (grey in A) of approximately 
240 to 354. An interesting structural feature is that the C-terminal section described 
seems to be sandwiched by the first 40 amino acids and the remaining protein folds. 
The first 40 amino acids seem to form a 'lid' of 2 helical sections linked to the main 
body by a flexible 8 residue loop. As most of the observed species originate from a 
cleavage releasing this C-term species from between this sandwich we hypothesise 
that this region may rotate around a backbone bond thus freeing the section. A 
theoretical example is shown in Figure 3.53. 
Figure 3.53 shows the 2 identified sections of biotin synthase in Green (Main N-
terminal 40 to 240 aa) and Red (C-terminal 240 to 354 aa), the 'lid' section in grey 
sitting on top of the C-terminal domain. A manipulation of the Q39-V40 peptide 
bond shows the shift of the whole 'lid' section from the surface of the proteins C-
terminal end. The Asp rich region between D242-D247 is shown in yellow and 
cleavage at any of these residues post or pre rotation would yield the fragments [1-
240] (See Figure 3.52 - A) and [241-354]. As the production of the [1-240] species 
was found consistently in all our analyses we proposed the production of a truncated 
gene encoding only this section of the protein and it complementary C-terminal 
partner to demonstrate the conformation of the distinct sections and flexibility of the 
first 40 amino acids. 
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Figure 3.52 - Identified limited digestion fragments of biotin synthase shown 
as part of the monomeric structure of published biotin synthase crystal 
structure. Observed fragment shown in red and cleaved Asp residue shown 
in yellow with side chain displayed. 
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Figure 3.53 - X-Ray crystal structure of E. co/i biotin synthase showing a rotation 
around G1n39—Va140 peptide bond that shifts the N-terminal 40 amino acids (grey) 
uncovering the C-terminal domain of the protein (red) for separation from 
remainder of protein (green) after cleavage at Asp rich loop shown in yellow. 




BamHl & TCA stop 	Ncol & ATG start 
Figure 3.54 - Representation of BioB wild type gene and the 
truncated genes BioB_N-term and BioB_Cterm. Shows cloning sites 
and start/stop codons. 
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3.8.9 - Cloning and Expression of Derived Domains of Biotin 
Synthase 
As in Section 3.1 pET16b/BioB was used as template DNA to produce the 
truncated biotin synthase genes. The gene was truncated removing the final 104 
amino acids and also the corresponding fragment containing the final section of the 
native protein sequence as shown in Figure 3.54. 
The truncated genes were amplified using standard PCR conditions and combination 
of the BioBfor, BioBrev, BSNterm rev and BSCterm_for primers were used as 
required. The forward primer used in both cases contained a NcoI restriction site at 
N-term, containing the ATG methionine start codon and the reverse primers contain 
a BamHI site as well as encoding a TCA stop codon. This allowed both genes to be 
restriction digested with NcoIIBamHI combination and subsequently cloned into 
complementary digested plasmids. The BS Nterm gene was cloned into pET6H to 
provide the N-term polyhis tag for purification and provides ampicillin resistance. 
The BS_C-term was cloned into the pET28a plasmid which provides the 
complementary kanamycin resistance, and no His tag, as represented in Figure 3.55. 
Both plasmids were used to transform HMSI74(DE3) E. coli cells and a single 
colony used to inoculate 2m1 2YT with appropriate antibiotic and protein production 
induced with addition of IPTG as standard conditions described in Section 2.16. 
After 3 hours of induction cells were harvested and analysed by SDS-PAGE. The 
calculated molecular weight of BS_N-term and BS-C-term are 27.5kDa and 12.3kDa 
respectively and band observed on SDS-PAGE was in agreement with the value of 
the BS_N-term as shown in Figure 3.56, however the band presumed to be BS_C-
term was observed at 20kDa almost twice the expected value however sequencing of 
the gene confirmed that no elongation of the gene was seen and so the observed 
SDS-PAGE migration was attributed to the protein chain characteristics. When large 
scale protein induction was performed and cells disrupted with sonication the 
expressed proteins were found to be insoluble and present exclusively in the pellet 
after centrifugation. The protein was solubilised with Urea in increasing 
concentration from 2M to 1 OM and protein visualised in soluble fraction when a final 
concentration of 4M Urea was used. Subsequent attempts to refold proteins either on 
column or through serial dialysis yielded little or no observable soluble protein. 
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Figure 3.55 - Representation of the vectors used to express the two derived domains 
of biotin synthase. pET6H/BioB_Nterm encodes a Nterm 6 histidine tag to the protein 
whereas pET28a/BS_Cterm remains untagged. The vectors impart ampicillin and 
kanamycin resistance respectively to the transformed cells. 
BS Nterm BS Ctenn 
AW low" 
'II, - 	_ w 
41 
 dW 
Figure 5.56 - SDS-PAGE of small scale induction of biotin synthase 
truncated proteins. Molecular weight marker used from Sigma, 98k0a - 
Phosphorylase B, 66kDa - BSA, 45kDa - Glutamic Dehycirogenase, 31kDa - AcohoI 
Dehydrogenase, 21kDa, - Myoglobin, 14kDa - Lysosyme. 
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During the design of the experiment the choice of plasmids was crucial to allow 
transformation of cells with both plasmids and selection for both using their 
complementary resistance genes, ampicillin and kanamycin. A transformation of 
HMS174(DE3) with both plasmids was achieved using 2j.il of each plasmid DNA 
solution and overnight growth on LB(amp/kan) plate however transformation 
efficiency was very low with typically only 2-3 colonies found per transformation 
reaction. These colonies were subjected to small scale induction as before and whole 
cells analysed by SDS-PAGE, and the gel is shown in Figure 3.57 showing induced 
and control growths. When large scale induction was performed using conditions 
previously described for 6His-BS approximately 10% of both expressed proteins 
were found to be soluble and CFE displayed the characteristic red/brown colour as 
observed during previous preparations of BS and mutants. 
MW Cont md 
16, 
IM 4..—  BS_N-terni, - 27.4kDa 
lap 4— BS_C-term, - 12.3kDa 
Figure 5.57 - SDS-PAGE of small scale dual induction of biotin synthase 
truncated proteins expressed in same cell. Molecular weight marker used from 
Sigma, 98kDa - Phosphorylase B, 66kDa - BSA, 45kDa - Glutamic Dehydrogenase, 31 kDa - 
Alcohol Dehydrogenase, 21kDa, - Myoglobin, 14kDa - Lysosynie. 
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3.8.1 0 - Purification and Characterisation of Biotin Synthase 
Domain Complex 
The CFE from cells expressing both 611is-BS_N-term and BS_C-term was 
prepared using BufferA for loading onto a Ni-HiTrap column from Amersham-
Pharmacia as described for the intact WT biotin synthase and mutants. When CFE 
was loaded through the column, a red/brown band formed and remained during the 
washing procedure. The band was eluted at approximately 200 mM imidazole 
concentration and yielded three 5m1 fractions red in colour. The elution fractions 
were analysed by SDS-PAGE and fractions 13, 14 and 15 that were red in colour 
showed presence of two co-eluting bands with observed molecular weight of 
approximately 28 kDa and 15 kDa which corresponded to the two expressed protein 
fragments as shown in Figure 3.58. This purification was performed to purify the 
61-lis tagged N-term fragment of biotin synthase however the dual expression of the 
fragments has achieved formation of a complex which has been maintained during 
the column purification and the non tagged C-term fragment is strongly associated 
with the tagged fragment and co-purification was achieved. Upon closer examination 
of the crystal structure it can clearly been proposed that an N-term loop/helix folds 
down over the C-term fragment as seen in Figure 3.53. As seen in the SDS-PAGE 
analysis the complex is destroyed by the conditions used for the gel thus yielding the 
dissociated fragments as expected from the linear sequences. 
MW 	9 	10 	II 	12 	13 	14 	15 	16 	17 
	
Iwo 	VNWqNNW 	 4—BS-term,-27.4kDa 
BS _C-term, –1 2.3kDa 
Figure 5.58 - SIDS-PAGE analysis of purification fractions of biotin synthase 
truncated proteins expressed in same cell showing co-elution from Ni-Hilrap 
column. Molecular weight marker used from Sigma, 98kDa - Phosphorylase B, 
66kDa - BSA, 45kDa - Glutamic Dehydrogenase, 31kDa - Alcohol Dehydrogenase, 21kDa, - 
Myoglobin, 14kDa - Lysosyme. 
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The purified complex seemed to exhibit similar characteristics to the intact protein 
and so simple characterisation of the complex was performed to compare this with 
6His-BS intact proteins. UV-Vis analysis as shown in Figure 3.59 demonstrates that 
the complex displays maxima similar as 6His-BS but shows larger ratios between 
both 330:280 nm and 425:280 nm compared to 6His-BS. This suggests that this 
complex is a viable [Fe-S] cluster binding species and the UV-Vis evidence suggests 
that this species could be similar to that found in the as purified biotin synthase 
protein, namely one or two [2Fe-2S] per monomer. 
Conformation of the components, thought to be the N/C-term complex, of the Fe 
binding truncated mutant was sought with utilisation of our standard LC-MS 
conditions as used previously for simple characterisation of the WT and mutant 
proteins. Due to the formation of the strong complex of the two fragments of biotin 
synthase it was unclear as to its behaviour during our LC-MS conditions. However as 
discussed in Section 3.4 we have evidence to suggest that 6HisWT biotin synthase 
and many mutants display an ion-envelope in which we observe a bias toward lower 
charge states and thus may indicate some existence of some tertiary structure 
maintained during LC-MS conditions. This being the case our observation of the 
complex as a single entity during LC-MS conditions, although surprising, does tend 
to validate our earlier observations are consistent with the assumptions made. The 
spectrum obtained during the LC-MS analysis was transformed and the mass spectra 
are shown in Figure 3.60. The obtained mass is consistent with the calculated mass 
of complex as shown in the table. The ion-envelope shows reasonably well defined 
low charge species (high mlz) but becomes increasingly poor in resolution toward 
the higher charge states (low mlz). The combination of these factors could contribute 
to the 500 Da at 50% peak width and complex multi species transformation peak in 
B. Important factors also affecting the quality of the obtained spectra could be the 
low absolute concentration of the observed complex due to several non specific 
complexes and loss of a portion of the complex during analysis and so some on 
column precipitation. Formation of adducts either non-specific (buffer ions etc.) of 
more pertinent modifications of Biotin synthase formed in vivo will also complicate 
spectra but due to the low resolution further investigation of these is impossible from 
these obtained spectra. 
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Figure 3.59 - UV-Vis scan from 250nm to 600nm of Domain complex and 
6HisWT biotin synthase both at I mg/mi concentration. Bar chart inset 
highlights ratios between 280:330, 280:425 and 330:425 wavelengths. 
Figure 3.60 - Transformed Mass Spectrum observed after LC-MS analysis of domain 
complex showing maintenance of complex throughout LC-MS conditions and 
confirming molecular weight of complex compared to calculated protein mass, shown 
in table. Inset A = Ion envelope used for transformation, Inset B = Zoomed 
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Appendix 
Sequence and secondary structure of 6HisBS 
1 GSSHHHHHHD YDIPTTENLY FQGSAHRPRW TL!TELE KP LLLLFEA 
siiiiioc 
51 QQVHRQHFDP RQVQVSTLLS IKTGACPEDC KYCPQSSRYK TGLEAERLME 
101 VEQVLESAPYAKAAGSTRFC MGAAWKNPHE RDMPYLEQMV QGVKAIIGLEA 
ilo 	 10  
151 CMTLGTLSES QAQRLANAGL DYYNHNLDTS PEFYGNIITT RTYQERLDTL 
- 0 0 (__0 •-c o 
201 EKVRDAIIilYV CSGGIVGLGE TVKDRAGLLL QLANLPTPPE SVPINMLVKV 
251 KGTPLADNDD VDAFDFIRTI AVARIMMPTS YVRLSAGREQ MNEQTQANCF 
c- 
301 MAGANSIFYG CKLLTTPNPE EDYDLQLFPK LGLNPQQTAV LAGDNEQQQR 
Cl 
351 LEQALMTPDT DEYYNAAAL 
Key to 	sheet 	a helix 
secondary [J) 	Et-.== Structure 
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